424B5
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-124358
The
information contained in this preliminary prospectus supplement
is not complete and may be changed. This preliminary prospectus
supplement and the accompanying prospectus are not an offer to
sell nor do they seek an offer to buy these securities in any
jurisdiction where the offer or sale is not permitted.
|
Subject to completion.
Preliminary Prospectus Supplement dated December 14, 2006
Prospectus Supplement
(To Prospectus dated April 27, 2005)
$
%
Fixed-to-Floating
Rate Junior Subordinated Debentures due 2066
MetLife, Inc. is offering $
aggregate principal amount of its %
Fixed-to-Floating
Rate Junior Subordinated Debentures due 2066, which are part of
subordinated debt securities referred to in the
accompanying base prospectus and which we refer to as the
junior subordinated debentures in this prospectus
supplement. The junior subordinated debentures will bear
interest on their principal amount from the date they are issued
to but excluding December 15, 2036, or earlier redemption,
at an annual fixed rate of %, payable semi-annually
in arrears on each June 15 and December 15, beginning
June 15, 2007, and, solely in the event that the junior
subordinated debentures are not repaid or otherwise redeemed on
or before the scheduled redemption date (as described below),
from and including December 15, 2036 to but excluding
December 15, 2066, or earlier redemption, at an annual rate
equal to three-month LIBOR plus a margin equal to %,
payable quarterly in arrears on each March 15,
June 15, September 15 and December 15, subject to
our right or, in certain circumstances, requirement to defer
interest payments as described in this prospectus supplement
under Description of the Junior Subordinated
Debentures.
We have agreed to repay the junior subordinated debentures on
December 15, 2036, which we refer to as the scheduled
redemption date, but only to the extent that we have
raised sufficient net proceeds during the
180-day
period ending on the notice date (as defined herein) for the
scheduled redemption date from the issuance of certain
qualifying capital securities, as described in this
prospectus supplement. We will covenant to use our commercially
reasonable efforts to raise sufficient net proceeds during such
180-day
period from the issuance of qualifying capital securities to
permit repayment of the junior subordinated debentures in full
on the scheduled redemption date, subject to certain
market disruption events described herein and
subject to our right to otherwise redeem the junior subordinated
debentures as described below. If any junior subordinated
debentures are not repaid or otherwise redeemed on the scheduled
redemption date, they will remain outstanding and will bear
interest at a floating rate specified above, payable quarterly
in arrears and, subject to the limitations described in the
immediately preceding sentence, we will continue to use our
commercially reasonable efforts to raise sufficient net proceeds
during the
90-day
period ending on the notice date for each subsequent interest
payment date from the issuance of qualifying capital securities
to permit repayment of the junior subordinated debentures in
full on such interest payment date. We refer to each such
180-day and
90-day
period as a QCS proceeds collection period. On
December 15, 2066, we must pay any remaining principal and
interest on the junior subordinated debentures in full whether
or not we have sold a sufficient amount of qualifying capital
securities.
We may redeem, at our option, the junior subordinated
debentures, subject to certain provisions described in this
prospectus supplement under Description of the Replacement
Capital Covenant:
|
|
|
|
|
in whole or in part, at any time on or after December 15,
2031, at their principal amount plus accrued and unpaid interest
to the date of redemption, which we refer to as the par
redemption amount; provided that if the junior
subordinated debentures are not redeemed in whole, at least
$50 million aggregate principal amount of the junior
subordinated debentures (excluding any junior subordinated
debentures held by us or any of our affiliates) must remain
outstanding after giving effect to such redemption;
|
|
|
in whole or in part, at any time prior to December 15,
2031, in cases not involving a tax event or
rating agency event, in each case as defined in this
prospectus supplement, at the par redemption amount or, if
greater, the make-whole redemption amount calculated
as described in this prospectus supplement; provided that if the
junior subordinated debentures are not redeemed in whole, at
least $50 million aggregate principal amount of the junior
subordinated debentures (excluding any junior subordinated
debentures held by us or any of our affiliates) must remain
outstanding after giving effect to such redemption; and
|
|
|
in whole, but not in part, at any time prior to
December 15, 2031, within 180 days after the
occurrence of a tax event or a rating agency event, at the par
redemption amount or, if greater, the special event
make-whole redemption amount calculated as described in
this prospectus supplement.
|
The junior subordinated debentures will be issued in
denominations of $1,000 and integral multiples of $1,000, and
will be our junior subordinated unsecured obligations issued
under a subordinated indenture. The payment of principal of and
interest on the junior subordinated debentures, to the extent
provided in the subordinated indenture, will be subordinated to
the prior payment in full of all of our present and future
senior indebtedness (as defined herein) and will be structurally
subordinated to all existing and future obligations of our
subsidiaries.
As further described in this prospectus supplement, if we have
optionally deferred interest payments for a period of more than
five consecutive years or if we have failed to satisfy certain
financial tests, which failure we refer to as a trigger
event, and such failure continues as of the 30th day prior
to an interest payment date, we may satisfy our obligation to
pay interest on the junior subordinated debentures on any
subsequent interest payment date (other than any interest that
has accrued during an optional deferral period of less than five
years and prior to the occurrence of a trigger event, which may
continue to be deferred to the extent provided herein or be paid
out of any source of funds), only to the extent of net proceeds
from the sale of qualifying APM securities (as
defined in this prospectus supplement) received by us during the
180 days prior to such interest payment date. We refer to
this method of funding the payment of accrued and unpaid
interest as the alternative payment mechanism. An
event of default will occur, among other things, if non-payment
of interest, due to an optional deferral, the continuance of a
trigger period or otherwise, continues for ten consecutive years
without all accrued and unpaid interest (including compounded
interest) having been paid in full. In certain events of our
bankruptcy, insolvency or receivership prior to the maturity or
redemption of any junior subordinated debentures, whether
voluntary or not, a holder of junior subordinated debentures
will have no claim for interest that is unpaid as a result of
certain consequences of a trigger event (including compounded
interest thereon) and has not been settled through the
application of the alternative payment mechanism to the extent
the amount of such interest exceeds 25% of the then outstanding
principal amount of such holders junior subordinated
debentures. For the avoidance of doubt, this limitation on
claims for unpaid interest does not apply to amounts of interest
deferred on an optional basis, and holders will have a full
claim for, and right to receive, such amounts.
See Risk Factors beginning on
page S-19
of this prospectus supplement to read about important factors
you should consider before buying the junior subordinated
debentures.
Neither the Securities and Exchange Commission nor any other
regulatory body has approved or disapproved of these securities
or passed upon the adequacy of this prospectus supplement or the
accompanying prospectus. Any representation to the contrary is a
criminal offense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price to
|
|
|
Underwriting
|
|
|
Proceeds, Before Expenses,
|
|
|
|
Investors(1)
|
|
|
Discount
|
|
|
to MetLife, Inc.(2)
|
|
|
Per Junior Subordinated Debenture
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Plus accrued interest, if any, from
December , 2006.
|
|
|
(2)
|
|
The underwriters will reimburse us
for substantially all costs and expenses of this offering. See
page S-71 of this prospectus supplement.
|
The underwriters expect to deliver the junior subordinated
debentures, in book-entry form only, through the facilities of
The Depository Trust Company (DTC) for the accounts
of its participants, including Clearstream Banking,
société anonyme, Luxembourg (Clearstream
Luxembourg)
and/or
Euroclear Bank N.V./S.A. (Euroclear), on or about
December , 2006.
|
|
|
Goldman,
Sachs & Co. |
JPMorgan |
Merrill
Lynch & Co. |
HSBC
|
|
|
|
|
|
|
|
|
Banc of
America
|
|
Deutsche
|
|
Lehman
|
|
Morgan
|
|
Wachovia
|
Securities LLC
|
|
Bank Securities
|
|
Brothers
|
|
Stanley
|
|
Securities
|
|
|
|
|
|
|
|
|
|
Guzman &
|
|
Ramirez &
|
|
Siebert Capital
|
|
Toussaint Capital
|
|
The Williams
|
Company
|
|
Co., Inc.
|
|
Markets
|
|
Partners LLC
|
|
Capital Group, L.P.
|
The date of this prospectus
supplement is December , 2006.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
Prospectus Supplement
|
|
|
|
S-3
|
|
|
|
|
S-4
|
|
|
|
|
S-19
|
|
|
|
|
S-26
|
|
|
|
|
S-31
|
|
|
|
|
S-31
|
|
|
|
|
S-32
|
|
|
|
|
S-33
|
|
|
|
|
S-56
|
|
|
|
|
S-66
|
|
|
|
|
S-70
|
|
|
|
|
S-72
|
|
|
|
|
S-74
|
|
|
Prospectus
|
About This Prospectus
|
|
|
1
|
|
Where You Can Find More Information
|
|
|
1
|
|
Special Note Regarding
Forward-Looking Statements
|
|
|
2
|
|
MetLife, Inc.
|
|
|
3
|
|
The Trusts
|
|
|
3
|
|
Use of Proceeds
|
|
|
5
|
|
Ratio of Earnings to Fixed Charges
|
|
|
5
|
|
Description of Securities
|
|
|
5
|
|
Description of Debt Securities
|
|
|
5
|
|
Description of Capital Stock
|
|
|
14
|
|
Description of Depositary Shares
|
|
|
20
|
|
Description of Warrants
|
|
|
22
|
|
Description of Purchase Contracts
|
|
|
23
|
|
Description of Units
|
|
|
24
|
|
Description of
Trust Preferred Securities
|
|
|
25
|
|
Description of Guarantees
|
|
|
27
|
|
Plan of Distribution
|
|
|
30
|
|
Legal Opinions
|
|
|
32
|
|
Experts
|
|
|
32
|
|
You should rely only on the information contained or
incorporated by reference in this prospectus supplement and the
accompanying prospectus. Neither we nor the underwriters have
authorized anyone to provide you with additional or different
information. If anyone provided you with additional or different
information, you should not rely on it. Neither we nor the
underwriters are making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted. You
should assume that the information contained in this prospectus
supplement, the accompanying prospectus and the documents
incorporated by reference, is accurate only as of their
respective dates. Our business, financial condition, results of
operations and prospects may have changed since those dates.
S-2
The junior subordinated debentures are offered for sale in those
jurisdictions in the United States, Asia, Europe and elsewhere
where it is lawful to make such offers. The distribution of this
prospectus supplement and the accompanying prospectus and the
offering or sale of the junior subordinated debentures in some
jurisdictions may be restricted by law. Persons into whose
possession this prospectus supplement and the accompanying
prospectus come are required by us and the underwriters to
inform themselves about and to observe any applicable
restrictions. This prospectus supplement and the accompanying
prospectus may not be used for or in connection with an offer or
solicitation by any person in any jurisdiction in which that
offer or solicitation is not authorized or to any person to whom
it is unlawful to make that offer or solicitation. See
Offering Restrictions in this prospectus supplement.
ABOUT
THIS PROSPECTUS SUPPLEMENT
You should read this prospectus supplement along with the
accompanying prospectus carefully before you invest in the
junior subordinated debentures. Both documents contain important
information you should consider before making your investment
decision. This prospectus supplement and the accompanying
prospectus contain the terms of this offering of junior
subordinated debentures. The accompanying prospectus contains
information about our securities generally, some of which does
not apply to the junior subordinated debentures covered by this
prospectus supplement. This prospectus supplement may add,
update or change information in the accompanying prospectus. If
the information in this prospectus supplement is inconsistent
with any information in the accompanying prospectus, the
information in this prospectus supplement will apply and will
supersede the inconsistent information in the accompanying
prospectus.
It is important for you to read and consider all information
contained in this prospectus supplement and the accompanying
prospectus in making your investment decision. You should also
read and consider the additional information under the caption
Where You Can Find More Information in the
accompanying prospectus.
Unless otherwise stated or the context otherwise requires,
references in this prospectus supplement and the accompanying
prospectus to MetLife, we,
our, or us refer to MetLife, Inc.,
together with its direct and indirect subsidiaries, while
references to MetLife, Inc. or the Holding
Company refer only to the holding company on an
unconsolidated basis.
S-3
SUMMARY
This summary contains basic information about us and this
offering. Because it is a summary, it does not contain all of
the information that you should consider before investing in the
junior subordinated debentures. You should read this entire
prospectus supplement and the accompanying prospectus carefully,
including the section entitled Risk Factors, our
financial statements and the notes thereto incorporated by
reference into this prospectus supplement and the accompanying
prospectus, before making an investment decision.
MetLife
We are a leading provider of insurance and other financial
services to millions of individual and institutional customers
throughout the United States. We offer life insurance,
annuities, automobile and homeowners insurance and retail
banking services to individuals, as well as group insurance,
reinsurance, and retirement & savings products and
services to corporations and other institutions. Outside the
United States, we have direct insurance operations in the Latin
America, Europe and Asia Pacific regions.
We are one of the largest insurance and financial services
companies in the United States. We believe that our franchises
and brand names uniquely position us to be the preeminent
provider of protection and savings and investment products in
the United States. In addition, our international operations are
focused on markets where the demand for insurance, savings and
investment products is expected to grow rapidly in the future.
On July 1, 2005, MetLife, Inc. completed the acquisition of
The Travelers Insurance Company, excluding certain assets, most
significantly, Primerica, from Citigroup Inc.
(Citigroup), and substantially all of
Citigroups international insurance businesses
(collectively, Travelers) for $12.1 billion.
The results of Travelers operations were included in our
financial statements beginning July 1, 2005. As a result of
the acquisition, our management increased significantly the size
and scale of our core insurance and annuity products and
expanded our presence in both the retirement & savings
domestic and international markets. The distribution agreements
executed with Citigroup as part of the acquisition provide us
with one of the broadest distribution networks in the industry.
The initial consideration paid by the Holding Company for the
acquisition consisted of approximately $10.9 billion in
cash and 22,436,617 shares of the Holding Companys
common stock with a market value of approximately
$1.0 billion to Citigroup and approximately
$100 million in other transaction costs. Additional
consideration of $115 million was paid by the Holding
Company to Citigroup in 2006. In addition to cash on-hand, the
purchase price was financed through the issuance of common
stock, debt securities, common equity units and preferred stock.
We divide our business into five operating segments:
|
|
|
|
|
Institutional (42% of 2005
revenues). Our Institutional segment offers a
broad range of group insurance and retirement & savings
products and services to corporations and other institutions.
|
|
|
|
|
|
Our group insurance products and services include group life
insurance, non-medical health insurance products such as
accidental death and dismemberment, long-term care, short -and
long-term disability and dental insurance, and related
administrative services. We offer group insurance products as
employer-paid benefits or as voluntary benefits where all or a
portion of the premiums are paid by the employee. We have built
a leading position in the U.S. group insurance market
through long-standing relationships with many of the largest
corporate employers in the United States. We distribute our
group insurance products and services through a regional sales
force consisting, as of December 31, 2005, of 379 marketing
representatives. Voluntary products are sold through the same
sales channels, as well as by specialists for these products.
|
|
|
|
Our institutional retirement & savings products and
services include an array of annuity and investment products, as
well as guaranteed interest products and other stable value
products, accumulation and income annuities, and separate
account contracts for the investment of defined benefit and
defined contribution plan assets. We distribute
retirement & savings products and services through
dedicated sales teams and relationship managers located in 21
offices around the country, as well as through the distribution
channels in the Individual segment and in the group insurance
area, which enable us to better reach and service customers,
brokers, consultants and other intermediaries.
|
S-4
|
|
|
|
|
Individual (31% of 2005 revenues). Our
Individual segment offers a wide variety of protection and asset
accumulation products aimed at serving the financial needs of
our individual customers throughout their entire life cycle.
Individual segment products include traditional, universal and
variable life insurance and variable and fixed annuities, as
well as disability insurance, long-term care insurance products,
mutual funds and other products offered by our other businesses.
|
Our Individual segment products are distributed nationwide
through the agency distribution group, which is comprised of two
distribution channels, and the independent distribution group,
which is comprised of three distribution channels.
|
|
|
|
|
The agency distribution group is comprised of two distribution
channels, the MetLife distribution channel and the New England
Financial distribution channel. The MetLife distribution
channel, which focuses on large middle-income and affluent
markets, including multicultural markets, had 5,804 agents under
contract in 109 agencies at December 31, 2005. The New
England Financial distribution channel, which targets high
net-worth individuals, owners of small businesses and executives
of small- to medium-sized companies, included 49 general
agencies providing support to 2,006 agents and a network of
independent brokers throughout the United States at
December 31, 2005.
|
|
|
|
The independent distribution group is comprised of three
distribution channels, including coverage and point of sale
models for risk-based products, and the annuity model for
accumulation-based products. Both the coverage and point of sale
models sell universal life, variable universal life, traditional
life, long-term care and disability income products. The annuity
model sells both fixed and variable annuities, as well as income
annuities. As of December 31, 2005, there were 34 regional
coverage wholesalers, 57 regional points of sale
wholesalers and 138 regional annuity wholesalers.
|
|
|
|
|
|
Auto & Home (7% of 2005
revenues). Our Auto & Home segment
offers personal lines property and casualty insurance directly
to employees through employer-sponsored programs, as well as
through a variety of retail distribution channels, including the
agency distribution group, independent agents, property and
casualty specialists and direct response marketing.
|
|
|
|
International (8% of 2005
revenues). Our International segment provides
life insurance, accident and health insurance, credit insurance,
annuities and retirement & savings products to both
individuals and groups. We focus on emerging markets primarily
within the Latin America region, the Asia Pacific region and
Europe. In Latin America, we operate in Mexico and Chile (which
together generated approximately 85% of our 2005 Latin America
premiums and fees), as well as Brazil, Argentina and Uruguay. In
the Asia Pacific region we operate in South Korea and Taiwan
(which together generated approximately 91% of our total 2005
Asia Pacific premiums and fees), as well as Australia, Japan,
Hong Kong and China. In Europe, we operate in the United Kingdom
and Belgium (which together generated approximately 75% of our
2005 Europe premiums and fees), as well as Poland and India,
whose results are included in Europe.
|
|
|
|
Reinsurance (10% of 2005 revenues). Our
Reinsurance segment is primarily comprised of our interest in
the life reinsurance business of Reinsurance Group of America,
Incorporated (RGA), a publicly traded company (New
York Stock Exchange: RGA). We owned approximately 53% of
RGAs outstanding common shares at December 31, 2005.
|
Corporate & Other contains the excess capital not
allocated to the operating segments, various
start-up
entities, including MetLife Bank, National Association, a
national bank, and run-off entities, as well as the elimination
of all intersegment amounts.
For the year ended December 31, 2005, we had total revenue
of $44.7 billion and net income of $4.7 billion. At
September 30, 2006, we had cash and invested assets of
$327.1 billion, total assets of $516.2 billion and
stockholders equity of $31.6 billion.
MetLife, Inc. is incorporated under the laws of the State of
Delaware. MetLife, Inc.s principal executive offices are
located at 200 Park Avenue, New York, New York
10166-0188
and its telephone number is
(212) 578-2211.
S-5
The
Offering
|
|
|
Issuer
|
|
MetLife, Inc. |
|
Securities
|
|
%
Fixed-to-Floating
Rate Junior Subordinated Debentures due 2066 (the junior
subordinated debentures) |
|
|
|
The junior subordinated debentures will be issued under an
indenture, dated June 21, 2005, between MetLife, Inc. and
The Bank of New York Trust Company, N.A. (as successor to
J.P. Morgan Trust Company, National Association), as
trustee, as supplemented by the third supplemental indenture, to
be dated as of the closing date of this offering (the indenture,
as supplemented by the third supplemental indenture, is referred
to as the subordinated indenture). The junior
subordinated debentures will be issued in denominations of
$1,000 principal amount and integral multiples of $1,000. |
|
Aggregate Principal Amount
|
|
$ |
|
Final Maturity Date
|
|
The junior subordinated debentures will mature on
December 15, 2066 (the final maturity date and,
together with any earlier date on which the junior subordinated
debentures become due and payable, whether pursuant to a notice
of redemption, acceleration or otherwise, the maturity
date). |
|
Scheduled Redemption Date
|
|
We have agreed to repay the principal amount of the junior
subordinated debentures, together with accrued and unpaid
interest, on December 15, 2036, which we refer to as the
scheduled redemption date, subject to certain
limitations. |
|
|
|
We are required to repay the junior subordinated debentures on
the scheduled redemption date only to the extent that we have
raised sufficient net proceeds during the applicable QCS
proceeds collection period from the issuance of certain
qualifying capital securities permitted to be issued pursuant to
the replacement capital covenant, described under
Description of the Replacement Capital Covenant. We
will covenant to use our commercially reasonable efforts,
subject to a market disruption event (as defined below) and
subject to our right to otherwise redeem the junior subordinated
debentures as described under Optional
Redemption below, to raise sufficient net proceeds during
the applicable QCS proceeds collection period from the issuance
of qualifying capital securities to permit repayment of the
junior subordinated debentures in full on the scheduled
redemption date, which we refer to as the replacement
capital obligation. |
|
|
|
If we have not raised sufficient net proceeds from the issuance
of qualifying capital securities to permit repayment of all
principal and accrued and unpaid interest, including any
compounded interest, to the extent permitted by law, on the
junior subordinated debentures on the scheduled redemption date,
we will continue to use commercially reasonable efforts, subject
to the limitations described in the immediately preceding
paragraph, to raise sufficient net proceeds during the
applicable QCS proceeds collection period from the issuance of
qualifying capital securities to permit repayment of the junior
subordinated debentures on the next interest payment date, and
on each interest payment date thereafter, until the junior
subordinated debentures are paid in full. Until the junior
subordinated debentures are so |
S-6
|
|
|
|
|
paid in full, they will remain outstanding from quarter to
quarter and bear interest at the floating rate specified herein,
payable quarterly in arrears, until repaid in accordance with
their terms. |
|
|
|
Notwithstanding the foregoing, if we redeem the junior
subordinated debentures when any deferred interest remains
unpaid and at a time when the alternative payment mechanism is
otherwise applicable, the unpaid deferred interest (including
compounded interest, to the extent permitted by law) may only be
paid pursuant to the alternative payment mechanism (other than
any interest that has accrued during an optional deferral period
of less than five years and prior to the occurrence of a trigger
event, which may be paid out of any source of funds), except
that on the final maturity date and on the acceleration date of
the junior subordinated debentures, we may pay any accrued and
unpaid interest without regard to the source of funds. |
|
|
|
Although under the replacement capital covenant the principal
amount of junior subordinated debentures that we may repay,
redeem or purchase at any time may be based on the net cash
proceeds from certain issuances of our common stock, rights to
acquire common stock, mandatorily convertible preferred stock
and debt exchangeable for equity in addition to qualifying
capital securities, we have no obligation under the subordinated
indenture to use commercially reasonable efforts to issue any
securities other than qualifying capital securities or to use
the proceeds of the issuance of any other securities to repay
the junior subordinated debentures on the scheduled redemption
date or at any time thereafter. |
|
|
|
For more information, see Description of the Junior
Subordinated Debentures Repayment of Principal;
Replacement Capital Obligation. |
|
Interest
|
|
Subject to the provisions described below under
Optional Deferral and
Trigger Event, interest on the junior
subordinated debentures will accrue: |
|
|
|
from the issue date to but excluding
December 15, 2036, or earlier redemption, at a fixed rate
equal to % per year, payable semi-annually in
arrears on June 15 and December 15 of each year,
commencing on June 15, 2007; and
|
|
|
|
solely in the event that the junior subordinated
debentures are not repaid or otherwise redeemed on or before the
scheduled redemption date, from and including December 15,
2036 to but excluding December 15, 2066 or earlier
redemption, at an annual rate equal to three-month LIBOR plus a
margin equal to %, payable quarterly in arrears on
March 15, June 15, September 15 and
December 15 of each year.
|
|
Use of Proceeds
|
|
We intend to use the net proceeds from this offering to repay
commercial paper indebtedness issued in the fourth quarter of
2006 to repay $500 million of 5.25% Senior Notes due
December 1, 2006, and for general corporate purposes. As of
December 13, 2006, such commercial paper indebtedness had a
weighted average interest rate of 5.26% and a weighted average
maturity of 30 days. |
S-7
|
|
|
Anticipated Ratings
|
|
Moodys Investors Service, Inc. (Moodys):
A3 (Stable) |
|
|
|
Standard & Poors Ratings Services, a division of
The McGraw-Hill Companies, Inc. (Standard &
Poors): BBB+ (Stable) |
|
|
|
An explanation of the significance of ratings may be obtained
from the rating agencies. Generally, rating agencies base their
ratings on such material and information, and such of their own
investigations, studies and assumptions, as they deem
appropriate. The rating of the junior subordinated debentures
should be evaluated independently from similar ratings of other
securities. A credit rating of a security is not a
recommendation to buy, sell or hold securities and may be
subject to review, revision, suspension, reduction or withdrawal
at any time by the assigning rating agency. |
|
Optional Redemption
|
|
Subject to the provisions described below under
Replacement Capital Covenant, we may, at
our option, redeem the junior subordinated debentures: |
|
|
|
in whole or in part, at any time on or after
December 15, 2031, at their principal amount plus accrued
and unpaid interest to the date of redemption; provided that if
the junior subordinated debentures are not redeemed in whole, at
least $50 million aggregate principal amount of the junior
subordinated debentures (excluding any junior subordinated
debentures held by us or any of our affiliates) must remain
outstanding after giving effect to such redemption;
|
|
|
|
in whole or in part, at any time prior to
December 15, 2031, in cases not involving a tax event or
rating agency event, at their principal amount plus accrued and
unpaid interest to the date of redemption or, if greater, the
make-whole redemption amount; provided that if the
junior subordinated debentures are not redeemed in whole, at
least $50 million aggregate principal amount of the junior
subordinated debentures (excluding any junior subordinated
debentures held by us or any of our affiliates) must remain
outstanding after giving effect to such redemption; and
|
|
|
|
in whole, but not in part, at any time prior to
December 15, 2031, within 180 days after the
occurrence of a tax event or rating agency
event, at their principal amount plus accrued and unpaid
interest to the date of redemption or, if greater, the
special event make-whole redemption amount.
|
|
|
|
For more information and the definitions of tax
event, rating agency event, make-whole
redemption amount and special event make-whole
redemption amount, see Description of the Junior
Subordinated Debentures Optional Redemption. |
|
Replacement Capital Covenant
|
|
Around the time of the initial issuance of the junior
subordinated debentures, we will enter into a replacement
capital covenant in which we will covenant for the benefit
of holders of one or more designated series of our indebtedness
(which will initially be our 5.70% Senior Notes due 2035), other
than the junior subordinated debentures, that we will not repay,
redeem or purchase the junior subordinated debentures on or
before December 15, 2056, unless, subject to certain
limitations, during the applicable measurement |
S-8
|
|
|
|
|
period (as defined herein) we have received proceeds from
the sale of specified securities in the specified amounts
described therein. |
|
|
|
The replacement capital covenant will terminate upon the
occurrence of certain events, including an acceleration of the
junior subordinated debentures due to the occurrence of an event
of default. The replacement capital covenant is not intended for
the benefit of holders of the junior subordinated debentures and
may not be enforced by them, except that we will agree in the
subordinated indenture that we will not amend the replacement
capital covenant to impose additional restrictions on the type
or amount of qualifying capital securities that we may include
for purposes of determining when repayment, redemption or
purchase of the junior subordinated debentures is permitted,
except with the consent of the holders of a majority in
principal amount of the junior subordinated debentures. |
|
Optional Deferral
|
|
So long as (i) no event of default with respect to the
junior subordinated debentures has occurred and is continuing
and (ii) no trigger event (as defined below) has occurred
and the related trigger period (as defined below) is continuing,
we may elect to defer one or more interest payments on the
junior subordinated debentures at any time and from time to time
for up to ten years, which we refer to as an optional
deferral period, without triggering an event of default
under the subordinated indenture; provided that no such optional
deferral period may end on a date other than an interest payment
date or extend beyond the maturity date of the junior
subordinated debentures. Deferred interest will continue to
accrue and compound periodically, to the extent permitted by
applicable law, at the rate of interest applicable to the junior
subordinated debentures. |
|
|
|
During the first five years of an optional deferral period, we
may pay deferred interest out of any source of funds. If
interest remains unpaid after five years of optional deferral,
the alternative payment mechanism described below in this
summary under Alternative Payment
Mechanism will apply, with the consequence, among others,
that we must (except on the final maturity date or upon the
acceleration of the junior subordinated debentures following an
event of default (the acceleration date)) make
commercially reasonable efforts to sell shares of our common
stock (unless such interest has been (or is being) paid from the
proceeds of qualifying warrants (as defined below)) and may pay
optionally deferred interest only out of the net proceeds of
qualifying APM securities, except that on the final maturity
date and on the acceleration date of the junior subordinated
debentures, we may pay any accrued and unpaid interest without
regard to the source of funds. |
|
|
|
Additionally, during any optional deferral period the
restrictions on payment by us of dividends and other
distributions on capital stock and certain other securities
described below in this summary under Payment
Restrictions will apply. An event of default will occur if
non-payment of interest, due to an optional deferral, the
continuation of a trigger period or otherwise, continues for ten
consecutive years or extends beyond the final maturity date of
the junior subordinated debentures without all accrued and
unpaid interest (including compounded interest) having been paid
in full. |
S-9
|
|
|
|
|
Upon the termination of any optional deferral period and the
payment of all amounts then due, we may commence a new optional
deferral period, subject to the above requirements. There is no
limit to the number of such new optional deferral periods that
we may begin. See Description of the Junior Subordinated
Debentures Optional Deferral. |
|
Trigger Event
|
|
The subordinated indenture provides that if, as of the
30th
day prior to an interest payment date (and regardless of whether
a notice of an optional deferral has been delivered), a trigger
event has occurred and the related trigger period is continuing,
the alternative payment mechanism described in this summary
under Alternative Payment Mechanism will
apply. |
|
|
|
Any interest that is accrued and unpaid during a trigger period
will continue to accrue and compound periodically, to the extent
permitted by applicable law, at the rate of interest then
applicable to the junior subordinated debentures, and the
restrictions on payment by us of dividends and other
distributions on capital stock and certain other securities
described below in this summary under Payment
Restrictions will apply. |
|
|
|
An event of default will occur if non-payment of interest, due
to an optional deferral period, the continuation of a trigger
period or otherwise, continues for ten consecutive years or
extends beyond the final maturity date of the junior
subordinated debentures without all accrued and unpaid interest
(including compounded interest) having been paid in full. |
|
|
|
A trigger event will have occurred if one of the
following conditions exists as of the date which is 30 days
prior to any interest payment date: |
|
|
|
(i) the covered insurance subsidiaries risk-based
capital ratio is less than 175% of the company action level for
such subsidiaries, in the case of each covered insurance
subsidiary based on the most recent annual financial statements
for the year ended prior to such interest payment date for which
such subsidiary has filed its annual statement with the
applicable state insurance commissioners (annual statements for
a year are generally required to be filed on or before
March 1st of the following year); or
|
|
|
|
(ii) (x) the trailing four quarters consolidated net income
amount, for the period ending on the last day of the quarter
that is two quarters prior to the most recently completed
quarter is zero or a negative amount, and (y) the adjusted
stockholders equity amount, as of the last day of the most
recently completed quarter and as of the end of the quarter that
is two quarters before the most recently completed quarter, has
declined by 10% or more as compared to the adjusted
stockholders equity amount at the end of the benchmark
quarter (the date that is ten quarters prior to the most
recently completed quarter).
|
|
|
|
Trigger period means a period commencing upon the
occurrence of a trigger event and continuing until we are able
again to satisfy both tests for an interest payment date. |
S-10
|
|
|
|
|
In addition, in the case of a trigger event described in
clause (ii) above, such trigger period will continue until
we are able again to satisfy the two tests in clauses (i)
and (ii) above for an interest payment date and our
adjusted stockholders equity amount has increased, or has
declined by less than 10%, in either case as compared to the
adjusted stockholders equity amount at the end of the
benchmark quarter for each interest payment date as to which a
trigger event had occurred under clause (ii) above. |
|
|
|
For example, if we failed to satisfy the test in
clause (ii) above for three consecutive interest payment
dates, we would be able to make interest payments on the junior
subordinated debentures on the fourth interest payment date only
if, as of such interest payment date: (1) we satisfied the
tests in each of clauses (i) and (ii) above for that
fourth interest payment date and (2) our adjusted
stockholders equity amount as of the last completed
quarter for that interest payment date had increased from, or
was less than 10% below, its level at the end of the benchmark
quarter for each of the prior three interest payment dates for
which a trigger event had occurred under clause (ii) above.
In effect, our adjusted stockholders equity amount as of
the most recently completed quarter for that interest payment
date would have to be greater than, or less than 10% below, its
level as of the end of not only the tenth quarter, but also each
of the eleventh, twelfth and thirteenth quarters, preceding the
most recently completed quarter. |
|
|
|
Once a trigger period is no longer continuing, subsequent
interest may be paid in cash from any source. However, any
unpaid interest that accrued during the continuance of a trigger
period may only be satisfied using the alternative payment
mechanism, except that on the final maturity date and on the
acceleration date of the junior subordinated debentures we may
pay any accrued and unpaid interest without regard to the source
of funds. Any accrued and unpaid interest will in all events be
due and payable upon the maturity date of the junior
subordinated debentures, subject to the restrictions described
below under Limitation on Claims in the Event
of Our Bankruptcy, Insolvency or Receivership. |
|
|
|
For more information, see Description of the Junior
Subordinated Debentures Trigger Event and
Description of the Junior Subordinated
Debentures Consequences of a Trigger Event. |
|
Alternative Payment Mechanism
|
|
Subject to certain conditions and exceptions described herein,
if (1) we have optionally deferred interest payments
otherwise due on the junior subordinated debentures for a period
of more than five consecutive years, or (2) a trigger event
has occurred and the related trigger period is continuing on an
interest payment date (regardless of whether a notice of an
optional deferral has been delivered): |
|
|
|
we may satisfy our obligation to pay interest on the
junior subordinated debentures (i) in the case of an event
described in (1) above, on any subsequent interest payment
date and (ii) in the case of an event described in
(2) above, on such interest payment date (in each case,
other than any interest that has accrued during an optional
deferral period of less than five years and prior to the
occurrence of a trigger event, which may continue to be deferred
to the extent
|
S-11
|
|
|
|
|
provided herein or be paid out of any source of funds), only to
the extent of net proceeds from the sale of qualifying APM
securities (as defined below) received by us during the
180 days prior to such interest payment date. We refer to
this method of funding the payment of accrued and unpaid
interest as the alternative payment mechanism. |
|
|
|
If a trigger period is no longer continuing and at the
termination of the trigger period there is no unpaid interest
from an optional deferral period that had continued for more
than five years, subsequent interest payments may be paid in
cash from any source. However, any unpaid interest that accrued
during the continuance of a trigger period, or an optional
deferral period that extended for more than five years, may only
be satisfied using the alternative payment mechanism except that
on the final maturity date and on the acceleration date of the
junior subordinated debentures, we may pay any accrued and
unpaid interest without regard to the source of funds. Any
accrued and unpaid interest will in all events be due and
payable on the maturity date of the junior subordinated
debentures, except for foregone interest if certain events of
bankruptcy, insolvency or receivership, whether voluntary or
not, occur prior to the maturity or redemption of the junior
subordinated debentures. See Limitation on
Claims in the Event of Our Bankruptcy, Insolvency or
Receivership; and |
|
|
|
we must make commercially reasonable
efforts to sell shares of our common stock, the sale of
which will provide sufficient cash proceeds to pay any amount
due to the holders of the junior subordinated debentures in
satisfaction of all accrued and unpaid interest, together with
any compounded interest, to the extent permitted by law (unless
such interest has been paid (or is being paid) from the sale of
qualifying warrants, as defined below).
|
|
|
|
Our obligation to make commercially reasonable efforts to sell
our common stock to satisfy our obligation to pay interest is
subject to market disruption events, does not apply to interest
that has been deferred during an optional deferral period of
less than five years, and does not apply on the final maturity
date or on the acceleration date of the junior subordinated
debentures. See Description of the Junior Subordinated
Debentures Alternative Payment Mechanism. |
|
|
|
The sale of qualifying warrants to pay deferred interest,
subject to the restrictions and requirements set forth herein,
is an option that may be exercised at our sole discretion,
subject to such restrictions and requirements, and we will under
no circumstances be obligated to sell qualifying warrants or to
apply the proceeds of any such sale to pay deferred interest on
the junior subordinated debentures. No class of investors of our
securities, or any other party, may require us to issue
qualifying warrants. |
|
|
|
Qualifying APM securities means (1) shares of
our common stock, and (2) net share settled warrants to
purchase our common stock that we can sell at our sole
discretion and that have an exercise price greater than the
current market price of our common stock as of their date of
issuance, that we are not entitled to redeem for cash and that
the |
S-12
|
|
|
|
|
holders of such warrants are not entitled to require us to
repurchase for cash in any circumstance (qualifying
warrants). |
|
|
|
Commercially reasonable efforts to sell our common
stock, means commercially reasonable efforts to complete the
offer and sale of our common stock to third parties that are not
our subsidiaries in public offerings or private placements,
provided that we will be deemed to have made such commercially
reasonable efforts during a market disruption event
or for so long as we are prevented from selling shares of our
common stock in accordance with the alternative payment
mechanism because we do not have shares available for issuance,
regardless of whether we make any offers or sales during such
market disruption event. For the avoidance of doubt, we will not
be considered to have made commercially reasonable efforts to
effect a sale of our common stock if we determine to not pursue
or complete such sale due to pricing, dividend rate or dilution
considerations. |
|
|
|
Any interest payment made pursuant to the alternative payment
mechanism will first be allocated to payment of the interest due
on that interest payment date for the current interest period.
Any payment of interest in excess of the amount of interest due
on that interest payment date for the current interest period
will be applied first against any then existing accrued and
unpaid interest with respect to prior interest periods for which
interest must be paid pursuant to the alternative payment
mechanism, in chronological order beginning with the earliest
interest period for which interest has not been paid in full and
for which such interest must be paid pursuant to the alternative
payment mechanism, including compounded interest. |
|
|
|
In the event that we defer an interest payment on the junior
subordinated debentures and on other securities that rank
equally with the junior subordinated debentures and contain
similar requirements to pay interest pursuant to the alternative
payment mechanism, we will apply any net proceeds so raised on a
pro rata basis towards our obligations to pay interest on the
junior subordinated debentures and such equally ranking
securities in proportion to the total amounts that are due on
the junior subordinated debentures and such securities, or on
such other basis as any regulatory authority may instruct
(taking into account the availability of proceeds of preferred
shares or other securities to settle deferred interest under any
such other securities). Notwithstanding the foregoing, a partial
payment will be applied (i) only to optionally deferred
interest payments, to the extent that the source of such partial
payment is other than proceeds from the sale of qualifying APM
securities, and (ii) first to interest that is unpaid
during a trigger period and second to optionally deferred
interest payments, to the extent that the source of such partial
payment is the sale of qualifying APM securities. |
|
|
|
Under the subordinated indenture, we will be required to use
commercially reasonable efforts to seek shareholder consent to
increase the number of authorized shares of our common stock if,
at any date, |
S-13
|
|
|
|
|
our shares available for issuance (as defined below) fall below
the greater of: |
|
|
|
shares
(as adjusted for any stock split, stock dividend,
reclassification, recapitalization,
split-up,
combination, exchange of shares or similar transaction), and
|
|
|
|
three times the number of shares that we would need
to issue to raise sufficient proceeds to pay (assuming a price
per share equal to the average trading price of shares of our
common stock over the ten-trading day period preceding such
date) then outstanding deferred interest on the junior
subordinated debentures (including compounded interest thereon),
plus twelve additional months of interest (including compounded
interest) on the junior subordinated debentures, up to a total
of ten years of interest (including compounded interest). For
purposes of determining the amounts accruing during a floating
rate period, the interest will be computed by reference to spot
three-month LIBOR on the calculation date plus a margin equal
to %.
|
|
|
|
Our shares available for issuance will be calculated
in two steps. First, we will deduct from the number of
authorized and unissued shares of our common stock, the maximum
number of shares of our common stock that can be issued under
existing options, warrants, convertible securities, any
equity-linked contracts and other agreements which require us to
issue a determinable number of shares of our common stock. After
we deduct that number of shares of our common stock from the
number of authorized and unissued shares of our common stock, we
will allocate on a pro rata basis, or such other basis as we
determine is appropriate, the remaining authorized and unissued
shares of our common stock to the alternative payment mechanism
and to any other similar commitment that is of an indeterminate
nature and under which we are then required to issue shares of
our common stock. If the number of authorized and unissued
shares of our common stock remaining after the two steps
described above is not sufficient to satisfy the remaining
commitments, we will be obligated to use commercially reasonable
efforts to seek shareholder consent to increase the number of
the authorized shares of our common stock as described above.
The definition of shares available for issuance will
have the effect of giving absolute priority for issuance to
those reservations and commitments under which we are able to
determine the maximum number of shares of our common stock
irrespective of the date on which they were entered into. |
|
|
|
If we elect to satisfy our obligation to pay deferred interest
pursuant to the alternative payment mechanism by issuing
qualifying warrants, we will only do so if the total number of
shares of our common stock underlying such qualifying warrants
applied to pay interest on the junior subordinated debentures
pursuant to the alternative payment mechanism, together with the
total number of shares of our common stock underlying all prior
issuances of qualifying warrants so applied, does not exceed an
amount equal to 15% of the total number of our issued and
outstanding common shares as of the date of any proposed
issuance. |
S-14
|
|
|
|
|
For more information, see Description of the Junior
Subordinated Debentures Alternative Payment
Mechanism. |
|
Market Disruption Events
|
|
A market disruption event means the occurrence or
existence of any of the following events or sets of
circumstances: |
|
|
|
trading in securities generally on any national
securities exchange or
over-the-counter
market, on which our common stock is then listed or traded (as
of the date of this prospectus supplement, the New York Stock
Exchange), is suspended or the settlement of such trading
generally is materially disrupted or minimum prices are
established on any such exchange or such market by the
Securities and Exchange Commission (the SEC), by
such exchange or by any other regulatory body or governmental
authority having jurisdiction, and the establishment of such
minimum prices materially disrupts or otherwise has a material
adverse effect on trading in, and the issuance and sale of, our
common stock;
|
|
|
|
we were required to obtain the consent or approval
of our stockholders, a regulatory body or governmental authority
to issue or sell our common stock pursuant to the alternative
payment mechanism or to issue or sell qualifying capital
securities pursuant to the replacement capital obligation and,
after using our commercially reasonable efforts to obtain such
consent or approval, we fail to obtain that consent or approval;
|
|
|
|
a material disruption or banking moratorium occurs
or has been declared in commercial banking or securities
settlement or clearance services in the United States;
|
|
|
|
there shall have occurred such a material adverse
change in general domestic or international economic, political
or financial conditions, including without limitation as a
result of terrorist activities, or the effect of international
conditions on the financial markets in the United States is
such, as to make it, in our judgment, impracticable to proceed
with the issuance and sale of our common stock pursuant to the
alternative payment mechanism or the issuance and sale of
qualifying capital securities pursuant to the replacement
capital obligation;
|
|
|
|
an event occurs and is continuing as a result of
which the offering document for the offer and sale of our common
stock pursuant to the alternative payment mechanism or the offer
and sale of qualifying capital securities pursuant to the
replacement capital obligation would, in our reasonable
judgment, contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or
necessary to make the statements therein not misleading and
either (1) the disclosure of that event at such time, in
our judgment, would have a material adverse effect on our
business or (2) the disclosure relates to a previously
undisclosed proposed or pending material business transaction,
and we have a bona fide reason for keeping the same confidential
or its disclosure would impede our ability to consummate such
transaction; provided that no single suspension period
contemplated by this bullet point may exceed 90 consecutive days
and multiple suspension periods
|
S-15
|
|
|
|
|
contemplated by this bullet point may not exceed an aggregate of
180 days in any
360-day
period; or |
|
|
|
we reasonably believe that the offering document for
the offer and sale of our common stock pursuant to the
alternative payment mechanism or the offer and sale of
qualifying capital securities pursuant to the replacement
capital obligation would not be in compliance with a rule or
regulation of the SEC (for reasons other than those referred to
in the bullet point directly above) and we are unable to comply
with such rule or regulation or such compliance is
impracticable; provided that that no single suspension period
contemplated by this bullet point may exceed 90 consecutive days
and multiple suspension periods contemplated by this bullet
point may not exceed an aggregate of 180 days in any
360-day
period.
|
|
Payment Restrictions
|
|
On any date on which accrued interest through the most recent
interest payment date has not been paid in full, whether because
of an optional deferral or a trigger event, subject to certain
exceptions detailed under Description of the Junior
Subordinated Debentures Certain Restrictions during
Optional Deferral Periods or Following a Trigger Event, we
will not, and will not permit any of our subsidiaries to: |
|
|
|
declare or pay any dividends on, make any
distribution with respect to, or redeem, purchase, acquire or
make a liquidation payment with respect to, any shares of our
capital stock;
|
|
|
|
make any payment of principal, premium, if any, or
interest on or repay, repurchase or redeem any debt securities
issued by us that rank equally with or junior to the junior
subordinated debentures, other than any payment, purchase or
redemption in respect of debt securities that rank equally with
the junior subordinated debentures (parity debt
securities) made ratably and in proportion to the
respective amount of (1) accrued and unpaid amounts on such
parity debt securities, on the one hand, and (2) accrued
and unpaid amounts on the junior subordinated debentures, on the
other hand; or
|
|
|
|
make any guarantee payments with respect to the
foregoing, if such guarantee ranks equally with or junior to the
junior subordinated debentures, other than any payment in
respect of guarantees that rank equally with the junior
subordinated debentures (parity guarantees) made
ratably and in proportion to the respective amount of
(1) accrued and unpaid amounts on such parity guarantees,
on the one hand, and (2) accrued and unpaid amounts on the
junior subordinated debentures, on the other hand.
|
|
Subordination
|
|
The payment of principal of and interest on the junior
subordinated debentures, to the extent provided in the
subordinated indenture, will be subordinated to the prior
payment in full of all of our present and future senior
indebtedness, as defined in Description of the Junior
Subordinated Debentures Subordination. Senior
indebtedness will not include (1) indebtedness incurred for
the purchase of goods or materials or for services obtained in
the ordinary course of business (i.e., trade accounts payable),
which will rank equally in right of payment and upon liquidation
with the junior subordinated debentures, (2) any
indebtedness which by its terms ranks equally with or
subordinated to the junior subordinated debentures in right of
payment |
S-16
|
|
|
|
|
or upon liquidation, (3) indebtedness owed by us to our
subsidiaries, which also will rank equally in right of payment
and upon liquidation to the junior subordinated debentures, and
(4) any liability for Federal, state, local or other taxes
owed or owing by us or by our subsidiaries. In addition, the
rights of the holders of the junior subordinated debentures will
be structurally subordinated to all existing and future
obligations of our subsidiaries. |
|
|
|
The subordinated indenture places no limitation on the amount of
additional senior indebtedness that we may incur. As of
September 30, 2006 we had $10.4 billion of senior
indebtedness outstanding at the parent company level and our
subsidiaries had total liabilities of $473.0 billion, all
of which will be effectively senior to the junior subordinated
debentures. |
|
|
|
We expect from time to time to incur additional senior
indebtedness. |
|
Limitation on Claims in the
Event of Our Bankruptcy,
Insolvency or Receivership
|
|
In certain events of our bankruptcy, insolvency or receivership
prior to the maturity or redemption of any junior subordinated
debentures, whether voluntary or not, a holder of junior
subordinated debentures will have no claim for, and thus no
right to receive, interest that is unpaid as a result of certain
consequences of a trigger event (including compounded interest
thereon) and has not been settled through the application of the
alternative payment mechanism to the extent the amount of such
interest exceeds 25% of the then outstanding principal amount of
the junior subordinated debentures. For the avoidance of doubt,
this limitation on claims for unpaid interest does not apply to
amounts of interest deferred on an optional basis, and holders
will have a full claim for, and right to receive such amounts. |
|
Events of Default
|
|
The subordinated indenture will provide the following events of
default with respect to the junior subordinated debentures: |
|
|
|
the failure to pay interest (including compounded
interest) in full, whether due to an optional deferral, during a
trigger period or otherwise, after the conclusion of a period of
10 consecutive years following the commencement of any deferral
period or on the final maturity date;
|
|
|
|
default in the payment of the principal of, and
premium, if any, on the junior subordinated debentures when
due; or
|
|
|
|
certain events of bankruptcy, insolvency, or
receivership, whether voluntary or not.
|
|
|
|
The subordinated indenture does not include as an event of
default failure to comply with covenants, including the
alternative payment mechanism. |
|
Material United States Federal Income Tax Considerations
|
|
There is no statutory, judicial or administrative authority that
directly addresses the U.S. Federal income tax treatment of
securities similar to the junior subordinated debentures. Based
on, among other things, certain assumptions and certain
representations made by us, Debevoise & Plimpton LLP,
our special tax counsel, will render its |
S-17
|
|
|
|
|
opinion generally to the effect that, although the matter is not
free from doubt, the junior subordinated debentures will be
treated as indebtedness for U.S. Federal income tax
purposes. Such opinion is not binding on the Internal Revenue
Service (IRS) or any court and there can be no
assurance that the IRS or a court will agree with such opinion.
By acquiring an interest in a junior subordinated debenture,
each beneficial owner of a junior subordinated debenture agrees
to treat the junior subordinated debentures as indebtedness for
U.S. Federal income tax purposes. See Material United
States Federal Income Tax Considerations. |
|
Form
|
|
The junior subordinated debentures will be represented by one or
more global securities registered in the name of Cede &
Co., as nominee for The Depository Trust Company
(DTC). Beneficial interests in the junior
subordinated debentures will be represented through book-entry
accounts of financial institutions acting on behalf of
beneficial owners as direct and indirect participants in DTC.
Investors may elect to hold interests in the global securities
through either the DTC (in the United States), or Clearstream
Luxembourg or Euroclear if they are participants in those
systems. |
|
Trustee and Principal Paying Agent
|
|
The Bank of New York Trust Company, N.A. (as successor to
J.P. Morgan Trust Company, National Association) |
|
Governing Law
|
|
New York |
|
Risk Factors
|
|
Before investing in the junior subordinated debentures you
should consider the risk factors included in or incorporated by
reference into this prospectus supplement and the accompanying
prospectus. |
S-18
RISK
FACTORS
Your investment in the junior subordinated debentures will
involve certain risks described below. However, this prospectus
supplement and the accompanying prospectus do not describe all
of the risks involving an investment in our securities. You
should also read the Risk Factors set forth in our Annual Report
on
Form 10-K
for the year ended December 31, 2005 (the 2005
Form 10-K).
You should note, however, that our business, financial
condition, results of operations and prospectus may have changed
since the date of the 2005
Form 10-K.
Therefore, you should review the information included in the
Risk Factors set forth in the 2005
Form 10-K
as such information has been modified and supplemented in
documents subsequently filed by us with the SEC and incorporated
by reference in the accompanying prospectus, as well as the
information provided in this prospectus supplement.
In consultation with your own financial and legal advisors,
you should carefully consider the information included in or
incorporated by reference in this prospectus supplement and the
accompanying prospectus, and pay special attention to the
following discussion of risks relating to the junior
subordinated debentures before deciding whether an investment in
the securities offered hereby is suitable for you. The junior
subordinated debentures will not be an appropriate investment
for you if you are not knowledgeable about significant features
of the securities offered hereby or financial matters in
general. You should not purchase the junior subordinated
debentures unless you understand, and know that you can bear,
these investment risks.
Risks
Relating to the Junior Subordinated Debentures
We May
Elect to Defer Interest Payments on the Junior Subordinated
Debentures for up to Ten Years.
So long as (i) no event of default with respect to the
junior subordinated debentures has occurred and is continuing
and (ii) no trigger event has occurred and the related
trigger period is continuing, we may elect to defer one or more
interest payments on the junior subordinated debentures at any
time and from time to time for up to ten years. During the first
five years of an optional deferral period (as defined herein),
we may pay deferred interest out of any source of funds. If
interest remains unpaid after five years of optional deferral,
the alternative payment mechanism described below under
Description of the Junior Subordinated
Debentures Alternative Payment Mechanism will
apply, with the consequence, among others, that we must (except
on the final maturity date or upon the acceleration of the
junior subordinated debentures following an event of default)
make commercially reasonable efforts to sell our common stock
(unless such deferred interest has been paid (or is being paid)
from the sale of qualifying warrants) as described under
Description of the Junior Subordinated
Debentures Alternative Payment Mechanism and
may pay such optionally deferred interest only out of the net
proceeds from the issuance of common stock or qualifying
warrants. An event of default will occur if non-payment of
interest, due to an optional deferral, during a trigger period
or otherwise, continues for 10 consecutive years or extends
beyond the maturity date of the junior subordinated debentures,
without all accrued and unpaid interest (including compounded
interest) having been paid in full. Upon termination of any
optional deferral period and the payment of all amounts then
due, we may commence a new optional deferral period, subject to
certain requirements. There is no limit to the number of such
new optional deferral periods that we may begin. See
Description of the Junior Subordinated
Debentures Optional Deferral. Holders of the
junior subordinated debentures are subject to the risk that we
will not be able to pay the junior subordinated debentures
following an optional deferral, or that such payments, if made,
will not adequately compensate them for not having been paid on
the scheduled interest payment dates.
We
Will Be Permitted to Pay Interest on the Junior Subordinated
Debentures Only with Proceeds from the Issuance of Qualifying
APM Securities if We Fail to Achieve Specified Capital Adequacy
or Net Income and Stockholders Equity
Levels.
If we fail to achieve specified capital adequacy or net income
and stockholders equity levels, a trigger event will
occur, in which case we will only be able to make interest
payments in accordance with the alternative payment mechanism,
as described under Description of the Junior Subordinated
Debentures Alternative Payment Mechanism.
S-19
We May
Not Be Able to Sell Our Common Stock or Qualifying Warrants When
and in the Amount Necessary to Pay Interest on the Junior
Subordinated Debentures.
Our ability to raise proceeds by issuing our common stock or
qualifying warrants after five years of optional deferral or
following the occurrence of a trigger event will depend on,
among other things, market conditions at the time, the
acceptability to prospective investors of the terms of the
securities issued, our financial performance and a variety of
other factors beyond our control, including our ability to
obtain any required consents or approvals, such as any
corporate, stockholder, governmental or regulatory authorization
that may be required. Accordingly, there could be circumstances
in which we would wish to or be required to pay interest on the
junior subordinated debentures and sufficient cash is available
for that purpose, but we cannot do so because we have not been
able to obtain proceeds from sales of our common stock or
qualifying warrants sufficient for that purpose. We will not be
obligated to make commercially reasonable efforts to satisfy our
obligation to pay all unpaid interest on the junior subordinated
debentures by selling common stock up to our shares available
for issuance when the alternative payment mechanism applies if a
market disruption event has occurred and for so long as it
continues, as described under Description of the Junior
Subordinated Debentures Alternative Payment
Mechanism. Additionally, if the number of shares of our
common stock necessary to raise sufficient proceeds to pay all
unpaid interest would exceed our shares available for issuance
(as defined under that caption) and consent of our shareholders
to increase the amount of our authorized shares has not been
obtained (our having used commercially reasonable efforts to
obtain such consent) then no breach of our obligations under the
alternative payment mechanism will occur by reason of our
failure to sell our common stock or to raise sufficient proceeds
to satisfy our obligation to pay unpaid interest.
Holders
of the Junior Subordinated Debentures Have Limited Rights to
Accelerate Payments of the Amounts Due on the Junior
Subordinated Debentures.
Holders of the junior subordinated debentures may accelerate
payment of the junior subordinated debentures only upon the
occurrence and continuation of the following events:
|
|
|
|
|
the failure to pay interest (including compounded interest), in
full whether due to an optional deferral, during a trigger
period or otherwise, after the conclusion of a period of 10
consecutive years following the commencement of any deferral
period or on the maturity date;
|
|
|
|
default in the payment of the principal of, or premium, if any,
on the junior subordinated debentures when due; or
|
|
|
|
certain events of bankruptcy, insolvency or receivership,
whether voluntary or not.
|
A failure to comply with or breach of our other covenants in the
subordinated indenture with respect to the junior subordinated
debentures (an other covenant default), including
the covenants to sell common stock through the alternative
payment mechanism to meet certain interest payment obligations,
and to use our commercially reasonable efforts to seek consent
of our shareholders to increase the number of authorized shares
of our common stock if, at any date, our shares available for
issuance falls below the amount specified under
Description of the Junior Subordinated
Debentures Alternative Payment Mechanism, will
not result in the acceleration of payment of the junior
subordinated debentures.
The
Aftermarket Price of the Junior Subordinated Debentures May Be
Discounted Significantly if We Defer Interest Payments or We Are
Unable to Pay Interest.
If we defer interest payments on the junior subordinated
debentures due to an optional deferral or a trigger event, you
may be unable to sell your junior subordinated debentures at a
price that reflects the value of deferred amounts. To the extent
a trading market develops for the junior subordinated
debentures, that market may not continue during such a deferral
period or following a trigger event, or during periods in which
investors perceive that there is a likelihood of a deferral or a
trigger event, and you may be unable to sell junior subordinated
debentures at those times, either at a price that reflects the
value of required payments under the junior subordinated
debentures or at all.
S-20
An
Active After-Market for the Junior Subordinated Debentures May
Not Develop.
The junior subordinated debentures constitute a new issue of
securities with no established trading market. We cannot assure
you that an active after-market for the junior subordinated
debentures will develop or be sustained or that holders of the
junior subordinated debentures will be able to sell their junior
subordinated debentures at favorable prices or at all. Although
the underwriters have indicated to us that they intend to make a
market in the junior subordinated debentures, as permitted by
applicable laws and regulations, they are not obligated to do so
and may discontinue any such market-making at any time without
notice. Accordingly, no assurance can be given as to the
liquidity of, or trading markets for, the junior subordinated
debentures. The junior subordinated debentures are not listed
and we do not plan to apply to list the junior subordinated
debentures on any securities exchange or to include them in any
automated quotation system.
As a
Holding Company, MetLife, Inc. Depends on the Ability of Its
Subsidiaries to Transfer Funds to It to Pay Dividends and Meet
its Obligations.
MetLife, Inc. is a holding company for its insurance and
financial subsidiaries and does not have any significant
operations of its own. Dividends from its subsidiaries and
permitted payments to it under its tax sharing arrangements with
its subsidiaries are its principal sources of cash to meet its
obligations and to pay preferred and common dividends. In the
event that the Holding Company is not able to receive sufficient
dividends from its subsidiaries, it would make it more likely
that the option to defer interest payments on the junior
subordinated debentures would be exercised
and/or that
a trigger event would occur.
The payment of dividends and other distributions to the Holding
Company by its insurance subsidiaries is regulated by insurance
laws and regulations. In general, dividends in excess of
prescribed limits are deemed special and require
insurance regulatory approval. In addition, insurance regulators
may prohibit the payment of ordinary dividends or other payments
by its insurance subsidiaries to the Holding Company if they
determine that the payment could be adverse to our policyholders
or contractholders.
The maximum amount of dividends which can be paid to the Holding
Company by its subsidiaries Metropolitan Life Insurance Company
(Metropolitan Life), MetLife Insurance Company of
Connecticut (formerly The Travelers Insurance Company)
(MICC), Metropolitan Property and Casualty Insurance
Company and Metropolitan Tower Life Insurance Company
(MTL), in 2006, without prior regulatory approval,
is $863 million, $0 million, $178 million and
$85 million, respectively. In the third quarter of 2006,
after receiving regulatory approval from the Connecticut
Commissioner of Insurance, MICC paid a $917 million
dividend to the Holding Company. MetLife Mexico S.A. also paid
$116 million in dividends to the Holding Company. During
the nine months ended September 30, 2006, no other
subsidiaries paid dividends to the Holding Company. During the
fourth quarter of 2006, the Holding Companys subsidiary,
MTL, closed on the sale of its Peter Cooper Village and
Stuyvesant Town properties located in Manhattan, New York.
Subsequent to this sale, MTL received regulatory approval to
dividend $2.3 billion of these proceeds to the Holding
Company. See Capitalization.
Any payment of interest, dividends, distributions, loans or
advances by our foreign subsidiaries to the Holding Company
could be subject to taxation or other restrictions on dividends
or repatriation of earnings under applicable law, monetary
transfer restrictions and foreign currency exchange regulations
in the jurisdiction in which such foreign subsidiaries operate.
If
Interest Payments on the Junior Subordinated Debentures Are
Deferred, Holders of the Junior Subordinated Debentures Will Be
Required to Recognize Income for U.S. Federal Income Tax
Purposes in Advance of the Receipt of Cash Attributable to Such
Income.
If interest payments on the junior subordinated debentures are
deferred, the junior subordinated debentures would be treated as
issued with original issue discount (OID) at the
time of such deferral, and all stated interest due after such
deferral would be treated as OID. In such case, a United States
holder would be required to include such stated interest in
income as it accrues, regardless of its regular method of
accounting, using a constant yield method, before such United
States holder receives any payment attributable to such income,
and would not separately report the actual cash payments of
interest on the junior subordinated debentures as taxable
income. See
S-21
Material United States Federal Income Tax
Considerations United States Holders
Interest Income and Original Issue Discount.
We May
Redeem the Junior Subordinated Debentures Prior to the Maturity
Date and You May Not Be Able to Reinvest in a Comparable
Security.
We have the option to redeem the junior subordinated debentures
for cash, in whole or in part, at any time on or after
December 15, 2031. The redemption price will equal 100% of
the principal amount of the junior subordinated debentures to be
redeemed, plus accrued and unpaid interest, together with any
compounded interest, to the extent permitted by law, on the
junior subordinated debentures to the redemption date (the
par redemption amount); provided that if the junior
subordinated debentures are not redeemed in whole, at least
$50 million aggregate principal amount of the junior
subordinated debentures (excluding any junior subordinated
debentures held by us or our affiliates) must remain outstanding
after giving effect to such redemption. See Description of
the Junior Subordinated Debentures Optional
Redemption.
Additionally, in cases not involving a tax event (as
defined herein) or rating agency event, (as defined
herein) we have the option to redeem the junior subordinated
debentures for cash, in whole or in part, at any time prior to
December 15, 2031 at a redemption price equal to the
greater of (i) the par redemption amount and (ii) a
treasury-based make-whole redemption amount as
defined herein; provided that if the junior subordinated
debentures are not redeemed in whole, at least $50 million
aggregate principal amount of the junior subordinated debentures
(excluding any junior subordinated debentures held by us or any
of our affiliates) must remain outstanding after giving effect
to such redemption. See Description of the Junior
Subordinated Debentures Optional Redemption.
Finally, if a tax event or rating agency
event has occurred, we have the option to redeem the
junior subordinated debentures for cash, in whole, but not in
part, at any time prior to December 15, 2031 at a
redemption price equal to the greater of (i) the par
redemption amount of the junior subordinated debentures to be
redeemed and (ii) a treasury-based special event
make-whole redemption amount as defined herein. See
Description of the Junior Subordinated
Debentures Optional Redemption.
In the event we choose to redeem your junior subordinated
debentures, you may not be able to reinvest the redemption
proceeds in a comparable security at an effective interest rate
as high as the interest rate on the junior subordinated
debentures.
The
Junior Subordinated Debentures Are Effectively Subordinated to
Almost All of Our Other Indebtedness.
Our obligations under the junior subordinated debentures are
subordinate and junior in right of payment to all of our senior
indebtedness (including trust preferred securities of statutory
trusts and our related subordinated debentures and guarantees
issued under the subordinated indenture), except any
indebtedness that by its terms is subordinated to, or ranks on
an equal basis with, the junior subordinated debentures and
certain other indebtedness, including indebtedness incurred in
the ordinary course of business. This means that we cannot make
any payments on the junior subordinated debentures if we default
on a payment of senior indebtedness and do not cure the default
within the applicable grace period, if the holders of the senior
indebtedness have the right to accelerate the maturity of the
senior indebtedness and request that we cease payments on the
junior subordinated debentures or if the terms of our senior
indebtedness otherwise restrict us from making payments to
junior creditors.
As of September 30, 2006, we had approximately
$10.4 billion of debt outstanding at the parent company
level and our subsidiaries had outstanding $473.0 billion
of total liabilities (including liabilities to policyholders and
contractholders, including $4.2 billion of debt (excluding
in each case, intercompany liabilities)), $483.4 billion of
which will be senior in priority to the junior subordinated
debentures. This senior indebtedness includes approximately
$2.1 billion of junior subordinated indebtedness that we
issued to statutory trusts, which will rank senior to the junior
subordinated debentures and at least equally with any other
junior subordinated debt that we might issue in the future, but
which is subordinated and junior in right of payment to our
current and future senior debt securities.
S-22
Due to the subordination provisions described in
Description of the Junior Subordinated
Debentures Subordination, in the event of our
insolvency, funds which we would otherwise use to pay the
holders of the junior subordinated debentures will be used to
pay the holders of senior indebtedness to the extent necessary
to pay the senior indebtedness in full. As a result of those
payments, our general creditors may recover less, ratably, than
the holders of our senior indebtedness and these general
creditors may recover more, ratably, than the holders of the
junior subordinated debentures. In addition, the holders of our
senior indebtedness may, under certain circumstances, restrict
or prohibit us from making payments on the junior subordinated
debentures.
There are no terms in the subordinated indentures or the junior
subordinated debentures that limit our ability to incur
additional indebtedness, and we expect from time to time to
incur additional indebtedness constituting senior indebtedness.
Upon
the Occurrence of a Bankruptcy, Insolvency or Receivership with
Respect to Us, Claims for Payment May Be Limited.
In certain events of our bankruptcy, insolvency or receivership
prior to the maturity or redemption of the junior subordinated
debentures, whether voluntary or not, a holder of junior
subordinated debentures will have no claim for interest that is
unpaid as a result of certain consequences of a trigger event
(including compounded interest thereon, to the extent permitted
by law) and has not been settled through the application of the
alternative payment mechanism to the extent the amount of such
interest exceeds 25% of the then outstanding principal amount of
such holders junior subordinated debentures. See
Description of the Junior Subordinated
Debentures Limitation on Claims in the Event of Our
Bankruptcy, Insolvency or Receivership. For the avoidance
of doubt, this limitation on claims for unpaid interest does not
apply to amounts of interest deferred on an optional basis, and
holders will have a full claim for, and right to receive, such
amounts.
In the
Event that the Junior Subordinated Debentures Are Not Repaid or
Otherwise Redeemed on the Scheduled Redemption Date, the
Junior Subordinated Debentures Will Accrue Interest at a
Floating Rate, which May Decline Below the Fixed Rate Specified
herein from Time to Time.
At the conclusion of the fixed rate period for the junior
subordinated debentures on December 15, 2036, in the event
that the junior subordinated debentures are not repaid or
otherwise redeemed on the scheduled redemption date, the junior
subordinated debentures will begin to accrue interest at a
floating rate. The floating rate may be volatile over time and
could be substantially less than the fixed rate, which could
reduce the value of the junior subordinated debentures in any
available after-market, apart from the reduction in current
interest income.
Our
Replacement Capital Obligation Is Subject to Issuance of
Qualifying Capital Securities.
Our obligation to repay the junior subordinated debentures on
the scheduled redemption date of December 15, 2036 (which
we refer herein as the scheduled redemption date) is
limited. We are required to repay the junior subordinated
debentures on the scheduled redemption date only to the extent
that we have raised sufficient net proceeds during the QCS
proceeds collection period from the issuance of qualifying
capital securities permitted to be issued pursuant to the
replacement capital covenant as described under
Description of the Junior Subordinated
Debentures Repayment of Principal; Replacement
Capital Obligation and Description of the Junior
Subordinated Debentures Description of the
Replacement Capital Covenant (the replacement
capital obligation). If we have not raised sufficient
proceeds from the issuance of qualifying capital securities to
permit repayment of the junior subordinated debentures on the
scheduled redemption date, the unpaid amount will remain
outstanding until (i) we have redeemed the junior
subordinated debentures in full in accordance with this
requirement, (ii) the junior subordinated debentures are
otherwise paid in full on December 15, 2066, the final
maturity date, or (iii) upon the occurrence of an event of
default resulting in the acceleration of the junior subordinated
debentures. Our ability to raise proceeds in connection with the
replacement capital obligation to repay the junior subordinated
debentures will depend on, among other things, market conditions
at the time the obligations arises, as well as the acceptability
to prospective investors of the terms of the qualifying capital
securities. Although we have agreed to use our commercially
reasonable efforts to raise sufficient net proceeds during the
QCS proceeds collection period from the issuance of qualifying
capital securities to repay the junior subordinated debentures
on the scheduled redemption date (or, if we have not raised
sufficient net proceeds during the QCS proceeds collection
period, on the next interest
S-23
payment date (as defined herein), and on each interest payment
date thereafter, until the junior subordinated debentures are
paid in full) our failure to do so would not be an event of
default giving rise to a right of acceleration or similar remedy
until December 15, 2066, and we will be excused from using
our commercially reasonable efforts to raise such proceeds if
certain market disruption events occur.
Moreover, we are entering into a replacement capital covenant
for the benefit of holders of a designated series of our
indebtedness that ranks senior to the junior subordinated
debentures (which will initially be our 5.70% Senior Notes due
2035), pursuant to which we will covenant that neither we nor
any of our subsidiaries will repay, redeem or repurchase junior
subordinated debentures on or before December 15, 2056,
unless during the applicable measurement period we or our
subsidiaries have received sufficient proceeds from the sale of
qualifying capital securities, mandatorily convertible preferred
stock, debt exchangeable for equity, common stock or rights to
acquire common stock. Although under the replacement capital
covenant, the principal amount of junior subordinated debentures
that we may repay may be based on the net proceeds from certain
issuances of common stock, rights to acquire common stock,
mandatorily convertible preferred stock and debt exchangeable
for equity in addition to qualifying capital securities, under
the subordinated indenture, we have no obligation to use
commercially reasonable efforts to issue any securities that may
satisfy our obligation under the replacement capital obligation
other than qualifying capital securities, nor do we have any
obligation to use the proceeds of the issuance of any securities
other than qualifying capital securities, to repay the junior
subordinated debentures on the scheduled redemption date or at
any time thereafter pursuant to the replacement capital
obligation.
The replacement capital covenant is not intended for the benefit
of holders of the junior subordinated debentures and may not be
enforced by them, except that we will agree in the subordinated
indenture that we will not amend the replacement capital
covenant to impose additional restrictions on the type or amount
of qualifying capital securities that we may include for
purposes of determining when repayment, redemption or purchase
of the junior subordinated debentures is permitted, except with
the consent of the holders of a majority in principal amount of
the junior subordinated debentures.
General
Market Conditions and Unpredictable Factors Could Adversely
Affect Market Prices for the Junior Subordinated
Debentures.
There can be no assurance about the market prices for the junior
subordinated debentures. Several factors, many of which are
beyond our control, will influence the market value of the
junior subordinated debentures. Factors that might influence the
market value of the junior subordinated debentures include, but
are not limited to:
|
|
|
|
|
whether interest payments have been made and are likely to be
made on the junior subordinated debentures from time to time;
|
|
|
|
our creditworthiness, financial condition, performance and
prospects;
|
|
|
|
regulatory investment classifications of the junior subordinated
debentures for purposes of certain types of investors and
whether those classifications have changed;
|
|
|
|
the market for similar securities; and
|
|
|
|
economic, financial, geopolitical, regulatory or judicial events
that affect us or the financial markets generally.
|
If you purchase junior subordinated debentures, whether in this
offering or in the secondary market, the junior subordinated
debentures may subsequently trade at a discount to the price
that you paid for them.
If the
Holders of the Junior Subordinated Debentures Waive Our
Covenants to Mandatorily Defer Interest under Certain
Circumstances or to Pay Certain Deferred Interest Only with
Proceeds from the Sale of Our Qualifying APM Securities, Our
Credit Ratings May Be Negatively Affected.
The subordinated indenture contains covenants that require us to
defer interest payments on the junior subordinated debentures if
a trigger event has occurred. The subordinated indenture also
contains covenants that require us to pay interest deferred as a
result of a trigger event only through the alternative payment
mechanism with proceeds from the sale of our qualifying APM
securities.
S-24
These covenants may be amended, and compliance with these
covenants may be waived, with the consent of the holders of a
majority of the aggregate principal amount of the junior
subordinated debentures, and no holder of our senior
indebtedness will have the right to enforce these covenants.
Although, in the short term, holders of the junior subordinated
debentures may have an economic incentive to waive these
covenants in order to receive current or deferred interest, if
such covenants are waived and we pay interest during a period
where we would otherwise be required to defer interest following
a trigger event or to pay any such deferred interest, with funds
received from any other source, our credit ratings could be
negatively affected, which in turn may harm the market price for
the junior subordinated debentures and have an adverse effect on
our business and financial condition.
The
Ratings on the Junior Subordinated Debentures Could Be
Lowered.
We expect that Moodys will assign a rating to the junior
subordinated debentures of A3 (stable) and that
Standard & Poors will assign a rating to the
junior subordinated debentures of BBB+ (stable). In addition,
other rating agencies may assign credit ratings to the junior
subordinated debentures with or without any solicitation from us
and without any provision of information from us. Generally,
rating agencies base their ratings on such material and
information, and such of their own investigative studies and
assumptions, as they deem appropriate. There is no assurance
that any rating will apply for any given period of time or that
a rating may not be adjusted or withdrawn. A downgrade or
potential downgrade in these ratings, the assignment of a new
rating that is lower than existing ratings, or a downgrade or
potential downgrade in the ratings assigned to us, our
subsidiaries or any of our securities could adversely affect the
price and liquidity of the junior subordinated debentures.
Moreover, the rating methodologies for securities with features
similar to the junior subordinated debentures are still
developing and the rating agencies may change their
methodologies in the future. This may include, for example, the
relationship between ratings assigned to an issuers senior
securities and ratings assigned to securities with features
similar to the junior subordinated debentures, sometimes called
notching. If the rating agencies were to change
their practices for rating such securities in the future and the
ratings of the junior subordinated debentures were to be
subsequently lowered, this may have a negative impact on the
trading price of the junior subordinated debentures.
S-25
SELECTED
HISTORICAL CONSOLIDATED FINANCIAL INFORMATION FOR
METLIFE
The following table sets forth selected historical consolidated
financial information for MetLife. The selected historical
consolidated financial information as of and for the years ended
December 31, 2005 and 2004 has been derived from our
audited consolidated financial statements included in our Annual
Report on
Form 10-K
for the year ended December 31, 2005; the selected
historical consolidated financial information as of and for the
year ended December 31, 2003 has been derived from our
audited consolidated financial statements included in our Annual
Report on
Form 10-K
for the year ended December 31, 2003; the selected
historical consolidated financial information as of and for the
year ended December 31, 2002 has been derived from our
audited consolidated financial statements included in our Annual
Report on
Form 10-K
for the year ended December 31, 2002; and the selected
historical consolidated financial information as of and for the
year ended December 31, 2001 has been derived from our
audited consolidated financial statements included in our Annual
Report on
Form 10-K
for the year ended December 31, 2001. This selected
consolidated financial information should be read in conjunction
with and is qualified by reference to these financial statements
and the related notes. The selected historical consolidated
financial information as of and for the nine months ended
September 30, 2006 and 2005 has been derived from the
unaudited interim condensed consolidated financial statements
included in our Quarterly Report on
Form 10-Q
for the nine months ended September 30, 2006. The following
consolidated statements of income and consolidated balance sheet
data have been prepared in conformity with GAAP. Some previously
reported amounts have been reclassified to conform with the
presentation for the nine months ended September 30, 2006.
Each of our Annual Reports on
Form 10-K
for the years ended December 31, 2005, 2003, 2002 and 2001,
and our Quarterly Report on
Form 10-Q
for the nine months ended September 30, 2006, are
incorporated by reference in the accompanying prospectus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
September 30,
|
|
|
Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
Statements of Income Data
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
19,433
|
|
|
$
|
18,514
|
|
|
$
|
24,860
|
|
|
$
|
22,200
|
|
|
$
|
20,575
|
|
|
$
|
19,020
|
|
|
$
|
16,962
|
|
Universal life and investment-type
product policy fees
|
|
|
3,548
|
|
|
|
2,716
|
|
|
|
3,828
|
|
|
|
2,867
|
|
|
|
2,495
|
|
|
|
2,145
|
|
|
|
1,888
|
|
Net investment income (2)
|
|
|
12,594
|
|
|
|
10,713
|
|
|
|
14,817
|
|
|
|
12,272
|
|
|
|
11,386
|
|
|
|
11,040
|
|
|
|
11,041
|
|
Other revenues
|
|
|
1,002
|
|
|
|
948
|
|
|
|
1,271
|
|
|
|
1,198
|
|
|
|
1,199
|
|
|
|
1,166
|
|
|
|
1,340
|
|
Net investment gains (losses)
(2)(3)(4)
|
|
|
(1,074
|
)
|
|
|
268
|
|
|
|
(93
|
)
|
|
|
175
|
|
|
|
(551
|
)
|
|
|
(895
|
)
|
|
|
(713
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues (5)(6)(7)(8)
|
|
|
35,503
|
|
|
|
33,159
|
|
|
|
44,683
|
|
|
|
38,712
|
|
|
|
35,104
|
|
|
|
32,476
|
|
|
|
30,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
19,448
|
|
|
|
19,018
|
|
|
|
25,506
|
|
|
|
22,662
|
|
|
|
20,811
|
|
|
|
19,455
|
|
|
|
18,329
|
|
Interest credited to policyholder
account balances
|
|
|
3,839
|
|
|
|
2,764
|
|
|
|
3,925
|
|
|
|
2,997
|
|
|
|
3,035
|
|
|
|
2,950
|
|
|
|
3,084
|
|
Policyholder dividends
|
|
|
1,268
|
|
|
|
1,261
|
|
|
|
1,679
|
|
|
|
1,666
|
|
|
|
1,731
|
|
|
|
1,803
|
|
|
|
1,802
|
|
Other expenses
|
|
|
7,794
|
|
|
|
6,591
|
|
|
|
9,267
|
|
|
|
7,813
|
|
|
|
7,168
|
|
|
|
6,862
|
|
|
|
6,894
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses (5)(6)(7)(8)
|
|
|
32,349
|
|
|
|
29,634
|
|
|
|
40,377
|
|
|
|
35,138
|
|
|
|
32,745
|
|
|
|
31,070
|
|
|
|
30,109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before provision for income tax
|
|
|
3,154
|
|
|
|
3,525
|
|
|
|
4,306
|
|
|
|
3,574
|
|
|
|
2,359
|
|
|
|
1,406
|
|
|
|
409
|
|
Provision for income tax (2)(5)(6)
|
|
|
855
|
|
|
|
1,025
|
|
|
|
1,228
|
|
|
|
996
|
|
|
|
585
|
|
|
|
418
|
|
|
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
2,299
|
|
|
|
2,500
|
|
|
|
3,078
|
|
|
|
2,578
|
|
|
|
1,774
|
|
|
|
988
|
|
|
|
263
|
|
Income from discontinued
operations, net of income tax (2)(5)(6)
|
|
|
131
|
|
|
|
1,505
|
|
|
|
1,636
|
|
|
|
266
|
|
|
|
469
|
|
|
|
617
|
|
|
|
210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before cumulative effect of
a change in accounting
|
|
|
2,430
|
|
|
|
4,005
|
|
|
|
4,714
|
|
|
|
2,844
|
|
|
|
2,243
|
|
|
|
1,605
|
|
|
|
473
|
|
Cumulative effect of a change in
accounting, net of income tax (9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(86
|
)
|
|
|
(26
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
2,430
|
|
|
|
4,005
|
|
|
|
4,714
|
|
|
|
2,758
|
|
|
|
2,217
|
|
|
|
1,605
|
|
|
|
473
|
|
Preferred stock dividends
|
|
|
100
|
|
|
|
31
|
|
|
|
63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charge for conversion of
company-obligated mandatorily redeemable securities of
subsidiary trusts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
shareholders
|
|
$
|
2,330
|
|
|
$
|
3,974
|
|
|
$
|
4,651
|
|
|
$
|
2,758
|
|
|
$
|
2,196
|
|
|
$
|
1,605
|
|
|
$
|
473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S-26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At September 30,
|
|
|
At December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
Balance Sheet Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General account assets
|
|
$
|
378,912
|
|
|
$
|
353,776
|
|
|
$
|
270,039
|
|
|
$
|
251,085
|
|
|
$
|
217,733
|
|
|
$
|
194,256
|
|
Separate account assets
|
|
|
137,274
|
|
|
|
127,869
|
|
|
|
86,769
|
|
|
|
75,756
|
|
|
|
59,693
|
|
|
|
62,714
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets (5)(6)
|
|
$
|
516,186
|
|
|
$
|
481,645
|
|
|
$
|
356,808
|
|
|
$
|
326,841
|
|
|
$
|
277,426
|
|
|
$
|
256,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life and health policyholder
liabilities (10)
|
|
$
|
265,177
|
|
|
$
|
258,881
|
|
|
$
|
193,612
|
|
|
$
|
177,947
|
|
|
$
|
162,986
|
|
|
$
|
148,598
|
|
Property and casualty policyholder
liabilities
|
|
|
3,516
|
|
|
|
3,490
|
|
|
|
3,180
|
|
|
|
2,943
|
|
|
|
2,673
|
|
|
|
2,610
|
|
Short-term debt
|
|
|
1,706
|
|
|
|
1,414
|
|
|
|
1,445
|
|
|
|
3,642
|
|
|
|
1,161
|
|
|
|
355
|
|
Long-term debt
|
|
|
10,711
|
|
|
|
9,888
|
|
|
|
7,412
|
|
|
|
5,703
|
|
|
|
4,411
|
|
|
|
3,614
|
|
Junior subordinated debt securities
|
|
|
2,134
|
|
|
|
2,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities
|
|
|
64,058
|
|
|
|
48,868
|
|
|
|
41,566
|
|
|
|
39,701
|
|
|
|
27,852
|
|
|
|
21,761
|
|
Separate account liabilities
|
|
|
137,274
|
|
|
|
127,869
|
|
|
|
86,769
|
|
|
|
75,756
|
|
|
|
59,693
|
|
|
|
62,714
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities (5)(6)
|
|
|
484,576
|
|
|
|
452,544
|
|
|
|
333,.984
|
|
|
|
305,692
|
|
|
|
258,776
|
|
|
|
239,652
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company-obligated mandatorily
redeemable securities of subsidiary trusts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,265
|
|
|
|
1,256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, at par value (11)
|
|
|
1
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, at par value (11)
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
|
|
8
|
|
Additional paid-in capital (11)
|
|
|
17,397
|
|
|
|
17,274
|
|
|
|
15,037
|
|
|
|
14,991
|
|
|
|
14,968
|
|
|
|
14,966
|
|
Retained earnings (11)
|
|
|
13,195
|
|
|
|
10,865
|
|
|
|
6,608
|
|
|
|
4,193
|
|
|
|
2,807
|
|
|
|
1,349
|
|
Treasury stock, at cost (11)
|
|
|
(878
|
)
|
|
|
(959
|
)
|
|
|
(1,785
|
)
|
|
|
(835
|
)
|
|
|
(2,405
|
)
|
|
|
(1,934
|
)
|
Accumulated other comprehensive
income (11)
|
|
|
1,887
|
|
|
|
1,912
|
|
|
|
2,956
|
|
|
|
2,792
|
|
|
|
2,007
|
|
|
|
1,673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
31,610
|
|
|
|
29,101
|
|
|
|
22,824
|
|
|
|
21,149
|
|
|
|
17,385
|
|
|
|
16,062
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
516,186
|
|
|
$
|
481,645
|
|
|
$
|
356,808
|
|
|
$
|
326,841
|
|
|
$
|
277,426
|
|
|
$
|
256,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S-27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
September 30,
|
|
|
At or for the Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions, except per share data)
|
|
|
Other Data (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common
shareholders
|
|
$
|
2,330
|
|
|
$
|
3,974
|
|
|
$
|
4,651
|
|
|
$
|
2,758
|
|
|
$
|
2,196
|
|
|
$
|
1,605
|
|
|
$
|
473
|
|
Return on common equity (12)
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
18.5
|
%
|
|
|
12.5
|
%
|
|
|
11.4
|
%
|
|
|
9.6
|
%
|
|
|
2.9
|
%
|
Return on common equity, excluding
accumulated other comprehensive income
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
20.4
|
%
|
|
|
14.4
|
%
|
|
|
13.0
|
%
|
|
|
10.8
|
%
|
|
|
3.2
|
%
|
Income from Continuing
Operations Available to Common Shareholders Per Common Share
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.89
|
|
|
$
|
3.31
|
|
|
$
|
4.03
|
|
|
$
|
3.43
|
|
|
$
|
2.38
|
|
|
$
|
1.40
|
|
|
$
|
0.36
|
|
Diluted
|
|
$
|
2.86
|
|
|
$
|
3.28
|
|
|
$
|
3.99
|
|
|
$
|
3.41
|
|
|
$
|
2.34
|
|
|
$
|
1.35
|
|
|
$
|
0.35
|
|
Income (loss) from Discontinued
Operations Per Common Share (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.17
|
|
|
$
|
2.02
|
|
|
$
|
2.18
|
|
|
$
|
0.35
|
|
|
$
|
0.63
|
|
|
$
|
0.88
|
|
|
$
|
0.28
|
|
Diluted
|
|
$
|
0.17
|
|
|
$
|
2.00
|
|
|
$
|
2.17
|
|
|
$
|
0.35
|
|
|
$
|
0.63
|
|
|
$
|
0.85
|
|
|
$
|
0.27
|
|
Cumulative Effect of a Change in
Accounting Per Common Share (1)(9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(0.11
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
|
|
|
$
|
|
|
Diluted
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(0.11
|
)
|
|
$
|
(0.03
|
)
|
|
$
|
|
|
|
$
|
|
|
Net Income Available to Common
Shareholders Per Common Share (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
3.06
|
|
|
$
|
5.33
|
|
|
$
|
6.21
|
|
|
$
|
3.67
|
|
|
$
|
2.97
|
|
|
$
|
2.28
|
|
|
$
|
0.64
|
|
Diluted
|
|
$
|
3.03
|
|
|
$
|
5.28
|
|
|
$
|
6.16
|
|
|
$
|
3.65
|
|
|
$
|
2.94
|
|
|
$
|
2.20
|
|
|
$
|
0.62
|
|
Dividends Declared Per Common
Share (1)
|
|
|
N/A
|
|
|
|
N/A
|
|
|
$
|
0.52
|
|
|
$
|
0.46
|
|
|
$
|
0.23
|
|
|
$
|
0.21
|
|
|
$
|
0.20
|
|
|
|
|
|
(1)
|
On July 1, 2005, we acquired Travelers. The results of this
acquisition are reflected in the 2006 and 2005 selected
financial data.
|
|
|
(2)
|
In accordance with SFAS No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets
(SFAS 144), income related to real estate
sold or classified as
held-for-sale
for transactions initiated on or after January 1, 2002 is
presented as discontinued operations. The following table
presents the components of income from discontinued real estate
operations (see footnotes 5 and 6):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
September 30,
|
|
|
Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
Investment income
|
|
$
|
193
|
|
|
$
|
319
|
|
|
$
|
395
|
|
|
$
|
649
|
|
|
$
|
719
|
|
|
$
|
842
|
|
|
$
|
750
|
|
Investment expense
|
|
|
(127
|
)
|
|
|
(196
|
)
|
|
|
(244
|
)
|
|
|
(388
|
)
|
|
|
(421
|
)
|
|
|
(466
|
)
|
|
|
(440
|
)
|
Net investment gains (losses)
|
|
|
91
|
|
|
|
1,969
|
|
|
|
2,125
|
|
|
|
146
|
|
|
|
420
|
|
|
|
585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
157
|
|
|
|
2,092
|
|
|
|
2,276
|
|
|
|
407
|
|
|
|
718
|
|
|
|
961
|
|
|
|
310
|
|
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
4
|
|
|
|
|
|
|
|
1
|
|
Provision (benefit) for income tax
|
|
|
56
|
|
|
|
743
|
|
|
|
808
|
|
|
|
138
|
|
|
|
261
|
|
|
|
349
|
|
|
|
113
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued
operations, net of income tax
|
|
$
|
101
|
|
|
$
|
1,349
|
|
|
$
|
1,468
|
|
|
$
|
256
|
|
|
$
|
453
|
|
|
$
|
612
|
|
|
$
|
196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
Net investment gains (losses) exclude amounts related to real
estate operations reported as discontinued operations in
accordance with SFAS 144.
|
|
|
(4)
|
Net investment gains (losses) presented include scheduled
periodic settlement payments on derivative instruments that do
not qualify for hedge accounting under SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities,
as amended, of $203 million and $63 million for
the nine months ended September 30, 2006 and 2005,
respectively, and $99 million, $51 million,
$84 million, $32 million and $24 million for the
years ended December 31, 2005, 2004, 2003, 2002 and 2001,
respectively. Additionally,
|
S-28
|
|
|
|
|
excluded from net investment gains (losses) for the nine months
ended September 30, 2006 and 2005 is $1 million and
($7) million, respectively, and for the year ended
December 31, 2005 is ($13) million related to
revaluation losses on derivatives used to hedge interest rate
and currency risk on policyholder account balances that do not
qualify for hedge accounting. Such amounts are included within
interest credited to policyholder account balances.
|
|
|
|
|
(5)
|
On September 29, 2005, we completed the sale of
P.T. Sejahtera (MetLife Indonesia) to a third
party. In accordance with SFAS 144, the assets, liabilities
and operations of MetLife Indonesia have been reclassified into
discontinued operations for all years presented. The following
tables present the operations of MetLife Indonesia:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
|
|
|
|
|
|
|
Ended
|
|
|
|
|
|
|
September 30,
|
|
|
Years Ended December 31,
|
|
|
|
2005
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
4
|
|
|
$
|
5
|
|
|
$
|
3
|
|
Expenses
|
|
|
10
|
|
|
|
10
|
|
|
|
14
|
|
|
|
9
|
|
|
|
8
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision for
income tax
|
|
|
(5
|
)
|
|
|
(5
|
)
|
|
|
(9
|
)
|
|
|
(5
|
)
|
|
|
(3
|
)
|
|
|
(3
|
)
|
Provision (benefit) for income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued
operations, net of income tax
|
|
|
(5
|
)
|
|
|
(5
|
)
|
|
|
(9
|
)
|
|
|
(5
|
)
|
|
|
(3
|
)
|
|
|
(3
|
)
|
Net investment gains, net of income
tax
|
|
|
10
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued
operations, net of income tax
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
(9
|
)
|
|
$
|
(5
|
)
|
|
$
|
(3
|
)
|
|
$
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31,
|
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
General account assets
|
|
$
|
31
|
|
|
$
|
27
|
|
|
$
|
23
|
|
|
$
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
31
|
|
|
$
|
27
|
|
|
$
|
23
|
|
|
$
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life and health policyholder
liabilities
|
|
$
|
24
|
|
|
$
|
17
|
|
|
$
|
11
|
|
|
$
|
8
|
|
Other liabilities
|
|
|
4
|
|
|
|
3
|
|
|
|
5
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
28
|
|
|
$
|
20
|
|
|
$
|
16
|
|
|
$
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6)
|
On January 31, 2005, we sold our wholly-owned subsidiary,
SSRM Holdings, Inc. (SSRM), to a third party. In
accordance with SFAS 144, the assets, liabilities and
operations of SSRM have been reclassified into discontinued
operations for all years presented. The following tables present
the operations of SSRM:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
September 30,
|
|
|
Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
19
|
|
|
$
|
19
|
|
|
$
|
328
|
|
|
$
|
231
|
|
|
$
|
239
|
|
|
$
|
254
|
|
Expenses
|
|
|
|
|
|
|
38
|
|
|
|
38
|
|
|
|
296
|
|
|
|
197
|
|
|
|
225
|
|
|
|
230
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision for
income tax
|
|
|
|
|
|
|
(19
|
)
|
|
|
(19
|
)
|
|
|
32
|
|
|
|
34
|
|
|
|
14
|
|
|
|
24
|
|
Provision (benefit) for income tax
|
|
|
|
|
|
|
(5
|
)
|
|
|
(5
|
)
|
|
|
13
|
|
|
|
13
|
|
|
|
6
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued
operations, net of income tax
|
|
|
|
|
|
|
(14
|
)
|
|
|
(14
|
)
|
|
|
19
|
|
|
|
21
|
|
|
|
8
|
|
|
|
17
|
|
Net investment gain, net of income
tax
|
|
|
30
|
|
|
|
165
|
|
|
|
177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued
operations, net of income tax
|
|
$
|
30
|
|
|
$
|
151
|
|
|
$
|
163
|
|
|
$
|
19
|
|
|
$
|
21
|
|
|
$
|
8
|
|
|
$
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S-29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31,
|
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
General account assets
|
|
$
|
379
|
|
|
$
|
183
|
|
|
$
|
198
|
|
|
$
|
203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
379
|
|
|
$
|
183
|
|
|
$
|
198
|
|
|
$
|
203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
$
|
19
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Long-term debt
|
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
14
|
|
Other liabilities
|
|
|
221
|
|
|
|
70
|
|
|
|
78
|
|
|
|
80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
240
|
|
|
$
|
70
|
|
|
$
|
92
|
|
|
$
|
94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7)
|
Includes the following combined financial statement data of
Conning Corporation, which was sold in 2001:
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2001
|
|
|
|
(In millions)
|
|
|
Total revenues
|
|
$
|
32
|
|
|
|
|
|
|
Total expenses
|
|
$
|
33
|
|
|
|
|
|
|
|
|
|
|
|
As a result of this sale, an investment gain of $25 million
was recorded for the year ended December 31, 2001.
|
|
|
|
|
(8)
|
Included in total revenues and total expenses for the year ended
December 31, 2002 are $421 million and
$358 million, respectively, related to Aseguradora Hidalgo
S.A., which was acquired in June 2002.
|
|
|
(9)
|
The cumulative effect of a change in accounting, net of income
tax, for the period ended December 31, 2004, resulted from
the adoption of Statement of Position
03-1,
Accounting and Reporting by Insurance Enterprises for Certain
Nontraditional Long-Duration Contracts and for Separate
Accounts. The cumulative effect of a change in accounting,
net of income tax, for the period ended December 31, 2003,
resulted from the adoption of Financial Accounting Standards
Board Statement 133 Implementation Issue No. B36,
Embedded Derivatives: Modified Coinsurance Arrangements and
Debt Instruments That Incorporate Credit Risk Exposures That Are
Unrelated or Only Partially Related to the Creditworthiness of
the Obligor under Those Instruments.
|
|
|
(10)
|
Policyholder liabilities include future policy benefits and
other policyholder funds. Life and health policyholder
liabilities also include policyholder account balances,
policyholder dividends payable and the policyholder dividend
obligation.
|
|
(11)
|
For additional information regarding these items, see
Notes 1 and 14 to the Consolidated Financial Statements
contained in our Annual Report on
Form 10-K
for the year ended December 31, 2005.
|
|
(12)
|
Return on common equity is defined as net income available to
common shareholders divided by average common stockholders
equity.
|
S-30
RATIO OF
EARNINGS TO FIXED CHARGES
The following table sets forth our historical ratio of earnings
to fixed charges for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
For the Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
Ratio of Earnings to Fixed Charges
|
|
|
1.72
|
|
|
|
1.93
|
|
|
|
1.91
|
|
|
|
2.03
|
|
|
|
1.73
|
|
|
|
1.47
|
|
|
|
1.10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For purposes of this computation, earnings are defined as income
before provision for income taxes and discontinued operations
and excluding undistributed income and losses from equity method
investments, minority interest and fixed charges, excluding
capitalized interest. Fixed charges are the sum of interest and
debt issue costs, interest credited to policyholder account
balances and an estimated interest component of rent expense.
USE OF
PROCEEDS
We intend to use the net proceeds from this offering to repay
commercial paper indebtedness issued in the fourth quarter of
2006 to repay $500 million of 5.25% Senior Notes due
December 1, 2006, and for general corporate purposes. As of
December 13, 2006, such commercial paper indebtedness had a
weighted average interest rate of 5.26% and a weighted average
maturity of 30 days.
S-31
CAPITALIZATION
The following table sets forth our historical and unaudited pro
forma capitalization as of September 30, 2006, (i) on
an actual basis and (ii) as adjusted to give effect to this
offering of junior subordinated debentures and the application
of the proceeds therefrom:
|
|
|
|
|
|
|
|
|
|
|
At September 30, 2006
|
|
|
|
Actual
|
|
|
As Adjusted
|
|
|
|
(In millions)
|
|
|
Short-term debt
|
|
$
|
1,706
|
|
|
|
|
|
Long-term debt (1)
|
|
|
10,711
|
|
|
|
|
|
Junior subordinated debt securities
|
|
|
2,134
|
|
|
|
|
|
Shares subject to mandatory
redemption
|
|
|
278
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
14,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity:
|
|
|
|
|
|
|
|
|
Preferred stock, at par value
|
|
|
1
|
|
|
|
|
|
Common stock, at par value
|
|
|
8
|
|
|
|
|
|
Additional paid-in capital
|
|
|
17,397
|
|
|
|
|
|
Retained earnings (2)
|
|
|
13,195
|
|
|
|
|
|
Treasury stock, at cost (3)
|
|
|
(878
|
)
|
|
|
|
|
Accumulated other comprehensive
income
|
|
|
1,887
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
31,610
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
46,439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
On December 1, 2006, $500 million aggregate principal
amount of 5.25% Senior Notes matured and was repaid with
proceeds from the sale of commercial paper. The Company intends
to use a portion of the proceeds of this offering to repay
commercial paper indebtedness. See Use of Proceeds.
|
|
|
(2)
|
On November 17, 2006, the Holding Companys
subsidiary, MTL, sold its Peter Cooper Village and Stuyvesant
Town properties located in Manhattan, New York, for
$5.4 billion. This sale resulted in a gain of approximately
$3 billion, net of income tax, with a corresponding
increase in retained earnings.
|
|
|
(3)
|
As of December 1, 2006, the Holding Company repurchased
approximately 8.6 million shares of its outstanding common
stock at an aggregate cost of $500 million of which
approximately 4.6 million shares, or $268 million,
were purchased in the open market and approximately
4.0 million shares, or $232 million, was purchased
under an accelerated common stock repurchase agreement. The
ultimate cost of the shares purchased under the accelerated
common stock repurchase agreement is expected to be determined
in February 2007.
|
S-32
DESCRIPTION
OF THE JUNIOR SUBORDINATED DEBENTURES
We will issue the %
fixed-to-floating
rate junior subordinated debentures due 2066, which are part of
the subordinated debt securities referred to in the
accompanying base prospectus and are referred to as the
junior subordinated debentures in this prospectus
supplement, under the Indenture dated as of June 21, 2005
between us and The Bank of New York Trust Company, N.A. (as
successor to J.P. Morgan Trust Company, National
Association), as subordinated indenture trustee, as supplemented
by the third supplemental indenture to be dated as of the date
of completion of this offering, between us and the subordinated
indenture trustee. We refer to the indenture, as supplemented by
the third supplemental indenture, as the subordinated
indenture). The following description of certain terms of
the junior subordinated debentures and certain provisions of the
subordinated indenture in this prospectus supplement supplements
the description under Description of Debt Securities
in the accompanying base prospectus and, to the extent it is
inconsistent with that description, replaces the description in
the accompanying base prospectus. This description is only a
summary of the material terms and does not purport to be
complete. We urge you to read the subordinated indenture in its
entirety because it, and not this description, will define your
rights as a beneficial holder of the junior subordinated
debentures. We will file the third supplemental indenture and
the form of junior subordinated debentures as exhibits to a
Current Report on
Form 8-K,
which will be incorporated by reference in the accompanying base
prospectus. You may also request copies of these documents from
us at our address set forth under Where You Can Find More
Information in the accompanying base prospectus. In this
section, any reference to we, us,
our or the Company shall refer to
MetLife, Inc. and not any of its subsidiaries.
General
We will initially issue $
aggregate principal amount of the junior subordinated
debentures. We may from time to time, without the consent of the
existing holders of the junior subordinated debentures, create
and issue further junior subordinated debentures having the same
terms and conditions as the junior subordinated debentures being
offered hereby in all respects, except for issue date, issue
price and, if applicable, the first interest payment date and
the amount of interest thereon due on such interest payment
date. Additional junior subordinated debentures issued in this
manner will be consolidated with, and will form a single series
with, the previously outstanding junior subordinated debentures
unless such additional junior subordinated debentures will not
be treated as fungible with the previously issued and
outstanding junior subordinated debentures for U.S. Federal
income tax purposes.
The junior subordinated debentures will be issued in
denominations of $1,000 principal amount and integral multiples
of $1,000.
The junior subordinated debentures will not be subject to a
sinking fund provision. The entire principal amount of the
junior subordinated debentures will mature and become due and
payable, together with any accrued and unpaid interest thereon,
including compounded interest (as defined under
Optional Deferral), if any, on
December 15, 2066 (the final maturity date and
together with any earlier date on which the junior subordinated
debentures become due and payable, whether pursuant to a notice
of redemption, acceleration or otherwise, the maturity
date). However, we have agreed to repay the principal
amount of the junior subordinated debentures, together with
accrued and unpaid interest, including compounded interest, if
any, on December 15, 2036, the scheduled redemption
date, subject to certain limitations described below under
Repayment of Principal; Replacement Capital
Obligation.
Interest
Subject to the provisions relating to optional deferral and
trigger events, as described below, interest on the junior
subordinated debentures will accrue:
|
|
|
|
|
from the date of initial issuance to but excluding
December 15, 2036, or earlier redemption (the fixed
rate period) at an annual rate equal to %,
payable semi-annually in arrears on June 15 and
December 15 of each year, commencing on June 15,
2007; and
|
S-33
|
|
|
|
|
solely in the event that the junior subordinated debentures are
not repaid or otherwise redeemed on or before the scheduled
redemption date, from and including December 15, 2036 to
but excluding December 15, 2066 or earlier maturity date
(the floating rate period), at an annual rate equal
to three-month LIBOR (as defined below) plus a margin equal
to %, payable quarterly in arrears on March 15,
June 15, September 15 and December 15 of each
year.
|
We refer to the dates on which interest on the junior
subordinated debentures is payable as interest payment
dates; provided, that the final interest payment date in
respect of the junior subordinated debentures will be the
maturity date. We refer to the period beginning on and
including ,
2006 and ending on but excluding the first interest payment date
and each successive period beginning on and including an
interest payment date and ending on but excluding the next
succeeding interest payment date as an interest
period.
Interest payments will include accrued interest from and
including the later of the issue date and the last date in
respect of which interest has been paid or duly provided for to,
but not including, the next succeeding interest payment date or
the maturity date, as the case may be. The amount of interest
payable for any full interest payment period during the fixed
rate period will be computed on the basis of a
360-day year
comprised of twelve
30-day
months and during the floating rate period on the basis of a
360-day year
and the actual number of days elapsed. The amount of interest
payable for any period shorter than a full interest period for
which interest is computed will be computed on the basis of
30-day
months and, for periods of less than a
30-day
month, the actual number of days elapsed per
30-day
month. In the event that any date on which interest is payable
on the junior subordinated debentures is not a business day,
payment of the interest payable on such date will be made
(i) with respect to interest payment dates during the fixed
rate period on the next succeeding day that is a business day,
without any interest or other payment in respect of any such
delay, and (ii) with respect to interest payment dates
during the floating rate period on the next succeeding day that
is a business day, unless such date falls in the next calendar
month, in which case the preceding business day. Subject to
applicable law, interest not paid on any payment date will
accrue and compound on each interest payment date, at a rate per
year equal to the then applicable rate of interest on the junior
subordinated debentures until paid.
Business day means any day which is not (i) a
Saturday, a Sunday or a legal holiday, and (ii) a day on
which banking institutions or trust companies located in New
York City are authorized or obligated by law to close, and, on
or after December 15, 2036, a day which is not a London
banking day (as defined below).
For the purposes of calculating interest due on the junior
subordinated debentures after December 15, 2036 and on or
prior to the maturity date:
|
|
|
|
|
Three-month LIBOR means, with respect to any
interest period, the rate (expressed as a percentage per annum)
for deposits in U.S. dollars for a three-month period
commencing on the first day of that interest period and ending
on the next interest payment date (the relevant
period) that appears on MoneyLine Telerate Page 3750
as of 11:00 a.m. (London time) on the LIBOR determination
date for that interest period. If such rate does not appear on
MoneyLine Telerate Page 3750, LIBOR will be determined on
the basis of the rates at which deposits in U.S. dollars
for the relevant period and in a principal amount of not less
than $1,000,000 are offered to prime banks in the London
interbank market by four major banks in the London interbank
market selected by the calculation agent (after consultation
with us), at approximately 11:00 a.m., London time on the
LIBOR determination date for that interest period. The
calculation agent will request the principal London office of
each such bank to provide a quotation of its rate. If at least
two such quotations are provided, three-month LIBOR with respect
to that interest period will be the arithmetic mean (rounded
upward if necessary to the nearest whole multiple of 0.00001%)
of such quotations. If fewer than two quotations are provided,
three-month LIBOR with respect to that interest period will be
the arithmetic mean (rounded upward if necessary to the nearest
whole multiple of 0.00001%) of the rates quoted by three major
banks in New York City selected by the calculation agent (after
consultation with us), at approximately 11:00 a.m., New
York City time, on the first day of that interest period for
loans in U.S. dollars to leading European banks for the
relevant period and in a principal amount of not less than
$1,000,000. However, if fewer than three banks selected by the
calculation agent to provide quotations are quoting as described
above, three-month LIBOR for that interest period will be the
same as LIBOR as determined for the previous interest period or,
in the case of the interest period beginning on
December 15, 2036, %. The
|
S-34
|
|
|
|
|
establishment of three-month LIBOR for each three-month interest
period beginning on or after December 15, 2036 by the
calculation agent shall (in the absence of manifest error) be
final and binding.
|
|
|
|
|
|
Calculation agent means The Bank of New York Trust
Company, N.A., or any other firm appointed by us, acting as
calculation agent.
|
|
|
|
London banking day means any day on which commercial
banks are open for general business (including dealings in
deposits in U.S. dollars) in London, England.
|
|
|
|
LIBOR determination date means the second London
banking day immediately preceding the first day of the relevant
interest period.
|
|
|
|
MoneyLine Telerate Page means the display on
Moneyline Telerate, Inc., or any successor service, on Telerate
Page 3750 or any replacement page or pages on that service.
|
|
|
|
Telerate Page 3750 means the display designated
on page 3750 on MoneyLine Telerate Page (or such other page
as may replace the 3750 page on the service or such other
service as may be nominated by the British Bankers
Association for the purpose of displaying London interbank
offered rates for U.S. Dollar deposits).
|
Record
Dates
For so long as the junior subordinated debentures are
represented by one or more global certificates, interest in
respect of each junior subordinated debenture will be payable on
each interest payment date to the person in whose name the
junior subordinated debenture is registered at the close of
business on the business day next preceding the interest payment
date, which shall be the record date for such interest payment
date. In the event the junior subordinated debentures at any
time are not represented solely by one or more global
certificates, we will have the right to select different record
dates, which will be at least one business day before an
interest payment date. See Book-Entry
System.
Optional
Deferral
So long as (i) no event of default with respect to the
junior subordinated debentures has occurred and is continuing
and (ii) no trigger event (as defined below) has occurred
and the related trigger period (as defined below) is continuing,
we may elect to defer one or more interest payments on the
junior subordinated debentures at any time and from time to time
for up to ten years (which may include a combination of
semi-annual and quarterly interest periods), each of which we
refer to as an optional deferral period, without
giving rise to an event of default and acceleration under the
subordinated indenture; provided that no such optional deferral
period may end on a date other than an interest payment date or
extend beyond the maturity date of the junior subordinated
debentures. During the first five years of an optional deferral
period, we may pay deferred interest out of any source of funds.
If interest remains unpaid after five years of an optional
deferral period, the alternative payment mechanism described
below under Alternative Payment
Mechanism will apply, with the consequence, among others,
that we must (except on the final maturity date or upon the
acceleration of the junior subordinated debentures following an
event of default (the acceleration date)) make
commercially reasonable efforts (as defined below) to sell
shares of our common stock (unless such interest has been (or is
being) paid from the proceeds of qualifying warrants (as defined
below)) to satisfy our obligation to pay interest on the junior
subordinated debentures. If such efforts are successful, we must
pay optionally deferred interest out of the net proceeds from
the sale of our common stock on the next succeeding interest
payment date following such five-year period. In addition, we
cannot pay such optionally deferred interest following the fifth
anniversary of any optional deferral period from sources other
than the net proceeds from the sale of qualifying APM securities
(as defined below), except that on the final maturity date and
on the acceleration date of the junior subordinated debentures,
we may pay any accrued and unpaid interest without regard to the
source of funds. Any accrued and unpaid interest will in all
events be due and payable on the maturity date of the junior
subordinated debentures, except for foregone interest if certain
events of bankruptcy, insolvency or receivership, whether
voluntary or not, occur prior to the maturity or redemption of
the junior subordinated debentures. See
Limitation on Claims in the Event of Our
Bankruptcy, Insolvency or Receivership. Our use of sources
other than the net proceeds from the sale of qualifying APM
securities to fund interest payments after the fifth year of an
optional deferral period would (except as otherwise provided
above) be a breach of our obligations
S-35
under the junior subordinated debentures but would not be an
event of default or result in acceleration under the
subordinated indenture. Additionally, during any optional
deferral period the restrictions on payment by us of dividends
and other distributions on capital stock described below under
Certain Restrictions during Optional Deferral
Periods or Following a Trigger Event will apply. An event
of default will occur if non-payment of interest, due to an
optional deferral, the continuation of a trigger period or
otherwise, continues for ten consecutive years or extends beyond
the final maturity date of the junior subordinated debentures,
without all accrued and unpaid interest (including compounded
interest, as defined below) having been paid in full. Deferred
interest will continue to accrue during deferral periods at the
then-applicable interest rate on the junior subordinated
debentures, compounded on each interest payment date, subject to
applicable law.
If a trigger event (as defined below) occurs after commencement
of an optional deferral period, the optional deferral period
will be deemed suspended for so long as the related trigger
period (as defined below) is continuing. Once the trigger period
is no longer continuing, our right to optionally defer payment
of interest will resume, subject to the limitations and
consequences described herein. For example, if we have elected
to defer interest payments on interest payment dates for three
years, and then a trigger event occurs and a trigger period
caused thereby continues for an additional three years, the next
interest payment date after the trigger period is no longer
continuing will be treated as an interest payment date that is
three years into an optional deferral period.
We must provide a notice to the holders of the junior
subordinated debentures of our election to defer interest not
more than 30 and not less than 15 days prior to the
relevant interest payment date. A notice of optional deferral,
once given, will be irrevocable and the deferral of payments on
the related interest payment date will be considered an optional
deferral, unless a trigger event has occurred as of the
30th day prior to such interest payment date, in which case
the provisions under the heading Consequences
of a Trigger Event will be applicable for all purposes.
When an optional deferral period ends and we have paid all
accrued and unpaid interest on the junior subordinated
debentures, together with interest thereon, to the extent
permitted by applicable law compounded on each interest payment
date, which we refer to as compounded interest, we
may begin a new optional deferral period, subject to the terms
described above. There is no limit on the number of optional
deferral periods that we may begin. Any deferral of interest on
the junior subordinated debentures by our election under this
provision is referred to as an optional deferral.
We have no current intention to exercise our right of optional
deferral.
Trigger
Event
If and to the extent that a trigger event has occurred and the
related trigger period is continuing as of the 30th day
prior to an interest payment date, and regardless of any notice
of optional deferral that has been previously delivered, we may
pay interest on the junior subordinated debentures (other than
any interest that had accrued during an optional deferral period
of less than five years and prior to the occurrence of a trigger
event, which may continue to be deferred to the extent provided
herein unpaid or be paid out of any source of funds) only to the
extent that such interest is paid through the alternative
payment mechanism, as described below under
Alternative Payment Mechanism.
A trigger event will have occurred if one of the
following conditions exists as of the date which is 30 days
prior to any interest payment date:
(i) the covered insurance subsidiaries risk-based
capital ratio is less than 175% of the company action level for
such subsidiaries, in the case of each covered insurance
subsidiary based on the most recent annual financial statements
for the year ended prior to such interest payment date for which
such subsidiary has filed its annual statement with the
applicable state insurance commissioners (annual statements for
a year are generally required to be filed on or before
March 1st of the following year); or
(ii) (x) the trailing four quarters consolidated net
income amount, for the period ending on the last day of the
quarter that is two quarters prior to the most recently
completed quarter is zero or a negative amount, and (y) the
adjusted stockholders equity amount, as of the last day of
the most recently completed quarter and as of the end of the
quarter that is two quarters before the most recently completed
quarter, has declined by 10% or
S-36
more as compared to the adjusted stockholders equity
amount at the end of the benchmark quarter (the date that is ten
quarters prior to the most recently completed quarter).
Trigger period means a period commencing upon the
occurrence of a trigger event and continuing until we are able
again to satisfy both tests for an interest payment date.
In addition, in the case of a trigger event described in
clause (ii) above, such trigger period will continue until
we are able again to satisfy the two tests in clauses (i)
and (ii) above for an interest payment date and our
adjusted stockholders equity amount has increased, or has
declined by less than 10%, in either case as compared to the
adjusted stockholders equity amount at the end of the
benchmark quarter for each interest payment date as to which a
trigger event had occurred under clause (ii) above.
For example, if we failed to satisfy the test in
clause (ii) above for three consecutive interest payment
dates, we would be able to make interest payments on the junior
subordinated debentures on the fourth interest payment date only
if, as of such interest payment date: (1) we satisfied the
tests in each of clauses (i) and (ii) above for that
fourth interest payment date and (2) our adjusted
stockholders equity amount as of the last completed
quarter for that interest payment date had increased from, or
was less than 10% below, its level at the end of the benchmark
quarter for each of the prior three interest payment dates for
which a trigger event had occurred under clause (ii) above.
In effect, our adjusted stockholders equity amount as of
the most recently completed quarter for that interest payment
date would have to be greater than, or less than 10% below, its
level as of the end of not only the tenth quarter, but also each
of the eleventh, twelfth and thirteenth quarters, preceding the
most recently completed quarter.
As used in this section:
Adjusted stockholders equity amount means, as
of any quarter end and subject to certain adjustments, our
stockholders equity as reflected on our consolidated GAAP
balance sheet as of such quarter end, minus accumulated other
comprehensive income as reflected on such consolidated balance
sheet.
Covered insurance subsidiaries means our largest
U.S. life insurance subsidiaries (in terms of general
admitted assets) that collectively account for 80% or more of
the general account admitted assets of all of our U.S. life
insurance subsidiaries.
GAAP means, at any date or for any period,
U.S. generally accepted accounting principles as in effect
on such date or for such period.
U.S. life insurance subsidiary means any of our
subsidiaries that is organized under the laws of any state in
the United States and is licensed as a life insurance company in
any state in the United States but does not include any
subsidiary of a life insurance subsidiary.
Risk-based capital ratio means the ratio that
insurance companies are required to calculate and report to
their regulators as of the end of each year in accordance with
prescribed procedures. The ratio measures the relationship of
the insurances companies total adjusted capital
calculated in accordance with those prescribed procedures,
relative to a standard that is determined based on the magnitude
or various risks present in the insurers operations. For
all covered insurance subsidiaries, calculated on a combined
basis, this ratio equals the sum of total adjusted capital
amounts for covered insurance subsidiaries divided by the sum of
company action level amounts for those same subsidiaries. The
NAICs model risk-based capital, or RBC, law
sets forth the RBC levels, ranging from the company action level
to the mandatory control level, at which certain corrective
actions are required and at which a state insurance regulator is
authorized and expected to take regulatory action.
The highest RBC level is known as the company action
level. If an insurance companys total adjusted
capital is higher than the company action level, no corrective
action is required to be taken. At progressively lower levels of
total adjusted capital, an insurance company faces increasingly
rigorous levels of corrective action, including the submission
of a comprehensive financial plan to the insurance regulator in
its state of domicile, a mandatory examination or analysis of
the insurers business and operations by the regulator and
the issuance of appropriate corrective orders to address the
insurance companys financial problems, and, at the lowest
levels, either voluntary or mandatory action by the regulator to
place the insurer under regulatory control. The company action
level is twice the level (known as the authorized control
level) below which the regulator is authorized (but not
yet required) to place the insurance company under regulatory
control.
S-37
Trailing four quarters consolidated net income
amount means, for any fiscal quarter, the sum of our
consolidated GAAP net income for the four fiscal quarters ending
as of the last day of such fiscal quarter.
For purposes of these tests as determined as of
September 30, 2006:
|
|
|
|
|
For the quarter ended on March 31, 2006, our trailing four
quarters consolidated net income amount was $4,474 million;
|
|
|
|
the adjusted stockholders equity amount as of
September 30, 2006 and as of March 31, 2006, as
compared to such amount as of March 31, 2004, had increased
by 57% and by 48%, respectively; and
|
|
|
|
the risk-based capital ratio for our covered insurance
subsidiaries, calculated on a combined basis, as of
December 31, 2005 was above the level specified in
clause (i) above.
|
With the exception of statutory accounting terms such as
general account admitted assets and terms that have
specific insurance regulatory meanings such as risk-based
capital, all financial terms used in this caption
Trigger Event will be determined in
accordance with GAAP as applied to and reflected in the related
financial statements of the Company as of the relevant dates,
except as provided in the next sentence. If because of a change
in GAAP that results in a cumulative effect of a change in
accounting principle or a restatement, either:
|
|
|
|
|
consolidated net income of the Company is higher or lower than
it would have been absent such change, then, for purposes of
making the calculations described in clause (ii) of the
second paragraph of this caption, Trigger
Event, commencing with the fiscal quarter for which such
changes in GAAP becomes effective, such consolidated net income
will be calculated on a pro forma basis as if such change had
not occurred; or
|
|
|
|
the adjusted stockholders equity amount as of a quarter
end is higher or lower than it would have been absent such
change, then, for purposes of the calculations described in
clause (ii) of the second paragraph of this caption,
Trigger Event, the adjusted
stockholders equity amount will be calculated on a pro
forma basis as if such change had not occurred, subject to
certain limitations described in the subordinated indenture.
|
If after the end of the benchmark quarter for an interest
payment date and before the end of the next quarter we issue a
material amount of equity securities to fund an acquisition of a
business or assets, with the consequence that the adjusted
stockholders equity amount as of the end of subsequent
quarters is higher than otherwise would have been the case, then
for purposes of making the calculation described in
clause (ii)(y) in the definition of the term trigger
event above, commencing with the quarter end after such
issuance of a material amount of equity securities, the adjusted
stockholders equity amount will be calculated on a pro
forma basis without giving effect to the issuance of such a
material amount of equity securities until the later of
(x) the first quarter end that is more than ten quarters
after the end of the benchmark quarter and (y) if a trigger
event occurs before the quarter end determined pursuant to
clause (x), the first quarter end as of which a trigger
period is no longer continuing. A material amount of
equity securities means equity securities that result in
an increase in the adjusted stockholders equity amount
equal to or exceeding the greater of (i) 1.5% of our
stockholders equity as of the end of the relevant
benchmark quarter and (ii) $100 million, in each case
calculated without giving effect to this paragraph.
If, at any relevant time or for any relevant period we are not a
reporting company under the Securities Exchange Act of 1934, as
amended (the Exchange Act), then for any such
relevant dates and periods we shall prepare and, post on our
website the financial statements that we would have been
required to file with the SEC had we continued to be a reporting
company under the Exchange Act, in each case on or before the
dates that we would have been required to file such financial
statements had we continued to be a large accelerated
filer within the meaning of
Rule 12b-2
under the Exchange Act.
Consequences
of a Trigger Event
On any interest payment date during the period commencing upon
the occurrence of a trigger event and continuing until the
related trigger period is no longer continuing (regardless of
whether notice of an optional deferral has been delivered), we
may satisfy our obligation to pay interest on the junior
subordinated debentures only to the extent of net proceeds from
the sale of qualifying APM securities received by us during the
180 days
S-38
prior to such interest payment date, and we may not pay interest
on any such interest payment date (other than any interest that
had accrued during an optional deferral period of less than five
years and prior to the occurrence of a trigger event, which may
continue to be deferred to the extent provided herein or be paid
out of any source of funds) except to the extent of such net
proceeds from the sale of qualifying APM securities, provided
that on the final maturity date and on the acceleration date of
the junior subordinated debentures, we may pay any accrued and
unpaid interest without regard to the source of funds.
With respect to any interest payment date, if a trigger event
has occurred and the related trigger period is continuing as of
the 30th day prior to such interest payment date
(regardless of whether a notice of optional deferral has been
delivered), we will be required to make commercially reasonable
efforts to satisfy our obligation to pay interest on the junior
subordinated debentures on such interest payment date using the
alternative payment mechanism, except with respect to any
interest that has been deferred during an optional deferral
period of less than five years and except on the final maturity
date and on the acceleration date of the junior subordinated
debentures. If a market disruption event prevents us from making
such payment in accordance with the alternative payment
mechanism, or for so long as we are prevented from selling
qualifying APM securities in accordance with the alternative
payment mechanism because we do not have shares available for
issuance, we shall be deemed to have made commercially
reasonable efforts to satisfy our obligation to pay interest.
See Alternative Payment Mechanism. Our
use of other sources to fund interest payments during a trigger
period would be a breach of our obligations under the junior
subordinated debentures but would not be an event of default or
result in acceleration under the subordinated indenture. Any
interest that is accrued and unpaid during a trigger period will
be deferred and will continue to accrue and compound on each
interest payment date, to the extent permitted by applicable
law. An event of default will occur if non-payment of interest,
due to a trigger event or otherwise, continues for ten
consecutive years or extends beyond the maturity date of the
junior subordinated debentures, without all accrued and unpaid
interest (including compounded interest) having been paid in
full.
In the event that a trigger period is no longer continuing and
at the termination of the trigger period there is no unpaid
interest from an optional deferral period that had continued for
more than five years, we may pay subsequent interest in cash
from any source of funds. However, any unpaid interest that
accrued during the continuance of a trigger period, or an
optional deferral period that extended for more than five years,
may only be satisfied using the alternative payment mechanism,
except that on the final maturity date and on the acceleration
date of the junior subordinated debentures, we may pay any
accrued and unpaid interest without regard to the source of
funds. Any accrued and unpaid interest will in all events be due
and payable upon the maturity date of the junior subordinated
debentures, except for foregone interest if certain events of
bankruptcy, insolvency or receivership, whether voluntary or
not, occur prior to the maturity or redemption of the junior
subordinated debentures. See Limitation on
Claims in the Event of Our Bankruptcy, Insolvency or
Receivership.
Not earlier than the 30th day nor later than the
15th day prior to each interest payment date during a
trigger period, we will give notice of the continuance of such
trigger period to the holders of the junior subordinated
debentures. Such notice will, depending on which condition is
relied upon in determining that a trigger event has occurred,
set forth either (x) the covered insurance
subsidiaries risk-based capital ratio, or (y) the
trailing four quarters consolidated net income amounts and the
adjusted stockholders equity amounts, as applicable, and
the extent to which these amounts must increase in order for
payments of interest from sources other than the alternative
payment mechanism to resume.
Certain
Restrictions during Optional Deferral Periods or Following a
Trigger Event
On any date on which accrued interest through the most recent
interest payment date has not been paid in full, whether because
of an optional deferral or a trigger event, subject to certain
exceptions described below, we will not, and will not permit any
of our subsidiaries to:
|
|
|
|
|
declare or pay any dividends on, make any distribution with
respect to, or redeem, purchase, acquire or make a liquidation
payment with respect to, any shares of our capital stock, other
than:
|
|
|
|
|
(1)
|
any purchase, redemption or other acquisition of shares of our
capital stock in connection with (a) any employment
contract, employee or benefit plan or other similar arrangement,
(b) a dividend reinvestment or stockholder purchase plan,
or (c) the issuance of our capital stock, or securities
convertible into
|
S-39
|
|
|
|
|
or exercisable for such capital stock, as consideration in an
acquisition transaction entered into prior to the applicable
optional deferral or trigger event, as the case may be;
|
|
|
|
|
(2)
|
any exchange, redemption or conversion of any class or series of
our capital stock, or the capital stock of one of our
subsidiaries, for any other class or series of our capital
stock, or of any class or series of our indebtedness for any
class or series of our capital stock;
|
|
|
(3)
|
any purchase of, or payment of cash in lieu of, fractional
interests in shares of our capital stock pursuant to the
conversion or exchange provisions of such capital stock or the
securities being converted or exchanged;
|
|
|
(4)
|
any declaration of a dividend in connection with any rights
plan, or the issuance of rights, stock or other property under
any rights plan, or the redemption or repurchase of rights
pursuant thereto; or
|
|
|
(5)
|
any dividend in the form of stock, warrants, options or other
rights where the dividend stock or stock issuable upon exercise
of such warrants, options or other rights is the same stock as
that on which the dividend is being paid or ranks junior to such
stock.
|
|
|
|
|
|
make any payment of principal, premium, if any, or interest on
or repay, repurchase or redeem any debt securities issued by us
that rank equally with or junior to the junior subordinated
debentures, other than any payment, repurchase or redemption in
respect of debt securities that rank equally with the junior
subordinated debentures (parity debt securities)
made ratably and in proportion to the respective amount of
(1) accrued and unpaid amounts on such parity debt
securities, on the one hand, and (2) accrued and unpaid
amounts on the junior subordinated debentures, on the other
hand; or
|
|
|
|
make any guarantee payments with respect to the foregoing, if
such guarantee ranks equally with or junior to the junior
subordinated debentures, other than any payment in respect of
guarantees that rank equally with the junior subordinated
debentures (parity guarantees and, together with the
parity debt securities, the parity securities) made
ratably and in proportion to the respective amount of
(1) accrued and unpaid amounts on such parity guarantees,
on the one hand, and (2) accrued and unpaid amounts on the
junior subordinated debentures, on the other hand.
|
The restrictions described above shall not apply to:
|
|
|
|
|
any payment of current interest in respect of parity securities
that is made pro rata to the amounts due on such parity
securities (including the junior subordinated debentures) and
any payments of deferred interest on parity securities that, if
not made, would cause us to breach the terms of the instrument
governing such parity securities; provided that such payments
are made in accordance with the second paragraph immediately
following the definition of the term market disruption
event provided under Alternative Payment
Mechanism to the extent it applies;
|
|
|
|
any payment of principal in respect of parity securities having
the same scheduled redemption date as the junior subordinated
debentures, as required under a provision of such parity
securities that is substantially the same as the provision
described below under Optional
Redemption, and that is made on a pro rata basis among one
or more series of parity securities having such a provision and
the junior subordinated debentures; or
|
|
|
|
any purchase or acquisition of our capital stock by any of our
separate accounts.
|
For the avoidance of doubt, guarantee payments we shall be
permitted to make include payments pursuant to the:
|
|
|
|
|
Guarantee Agreement, dated as of June 21, 2005, with
respect to the 4.82% trust preferred securities issued by
MetLife Capital Trust II;
|
|
|
|
Guarantee Agreement, dated as of June 21, 2005, with
respect to the 4.91% trust preferred securities issued by
MetLife Capital Trust III;
|
|
|
|
Common Securities Guarantee Agreement, dated as of June 21,
2005, with respect to the common securities issued by MetLife
Capital Trust II; and
|
S-40
|
|
|
|
|
Common Securities Guarantee Agreement, dated as of June 21,
2005, with respect to the common securities issued by MetLife
Capital Trust III.
|
Alternative
Payment Mechanism
Subject to certain conditions and exceptions described below, if:
|
|
|
|
|
we have optionally deferred interest payments otherwise due on
the junior subordinated debentures for a period of more than
five consecutive years, or
|
|
|
|
a trigger event has occurred and the related trigger period is
continuing on an interest payment date (regardless of whether a
notice of an optional deferral has been delivered),
|
then:
|
|
|
|
|
we may satisfy our obligation to pay interest on the junior
subordinated debentures (i) in the case of an event
described in the first bullet point above, on any subsequent
interest payment date and (ii) in the case of an event
described in the second bullet point above, on such interest
payment date (in each case, other than any interest that has
accrued during an optional deferral period of less than five
years and prior to the occurrence of a trigger event, which may
continue to be deferred to the extent provided herein or be paid
out of any source of funds), only to the extent of net proceeds
from the sale of qualifying APM securities received by us during
the 180 days prior to such interest payment date. We refer
to this method of funding the payment of accrued and unpaid
interest as the alternative payment mechanism;
|
|
|
|
|
|
If a trigger period is no longer continuing and at the
termination of the trigger period there is no unpaid interest
from an optional deferral period that had continued for more
than five years, subsequent interest payments may be paid in
cash from any source. However, any unpaid interest that accrued
during the continuance of a trigger period, or an optional
deferral period that extended for more than five years, may only
be satisfied using the alternative payment mechanism except that
on the final maturity date and on the acceleration date of the
junior subordinated debentures, we may pay any accrued and
unpaid interest without regard to the source of funds. Any
accrued and unpaid interest will in all events be due and
payable on the maturity date of the junior subordinated
debentures, except for foregone interest if certain events of
bankruptcy, insolvency or receivership, whether voluntary or
not, occur prior to the maturity or redemption of the junior
subordinated debentures. See Limitation on
Claims in the Event of Our Bankruptcy, Insolvency or
Receivership; and
|
|
|
|
|
|
we must make commercially reasonable efforts to sell
shares of our common stock, the sale of which will provide
sufficient cash proceeds to pay any amount due to the holders of
the junior subordinated debentures in satisfaction of all
accrued and unpaid interest, together with any compounded
interest, to the extent permitted by law (unless such interest
has been paid (or is being paid) from the sale of qualifying
warrants).
|
Such obligation will continue until all unpaid interest has been
paid in full or, if such obligation has arisen only because a
trigger event has occurred and the related trigger period is
continuing, until such trigger period is no longer continuing.
Our obligation to make commercially reasonable efforts to sell
our common stock to satisfy our obligation to pay interest is
subject to market disruption events, does not apply to interest
that has accrued during an optional deferral period of less than
five years, and does not apply on the final maturity date and on
the acceleration date of the junior subordinated debentures.
The sale of qualifying warrants to pay deferred interest,
subject to the restrictions and requirements set forth herein,
is an option that may be exercised at our sole discretion,
subject to such restrictions and requirements, and we will under
no circumstances be obligated to sell qualifying warrants or to
apply the proceeds of any such sale to pay deferred interest on
the junior subordinated debentures. No class of investors of our
securities, or any other party, may require us to issue
qualifying warrants.
The net proceeds (i) received by us from the sale of
qualifying APM securities during the 180 days prior to any
interest payment date on which we are required to use the
alternative payment mechanism, and (ii) designated by us at
or before the time of such sale as available to pay interest on
the junior subordinated debentures will, at the time such
proceeds are delivered to the subordinated indenture trustee to
satisfy the relevant interest payment, be deemed
S-41
to satisfy our obligations to pay interest on the junior
subordinated debentures pursuant to the alternative payment
mechanism.
As used in this section:
Commercially reasonable efforts to sell our common
stock, means commercially reasonable efforts to complete the
offer and sale of our common stock to third parties that are not
our subsidiaries in public offerings or private placements,
provided that we will be deemed to have made such commercially
reasonable efforts during a market disruption event
or for so long as we are prevented from selling our common stock
in accordance with the alternative payment mechanism because we
do not have shares available for issuance, regardless of whether
we make any offers or sales during such market disruption event.
For the avoidance of doubt, we will not be considered to have
made commercially reasonable efforts to effect a sale of our
common stock if we determine to not pursue or complete such sale
due to pricing, dividend rate or dilution considerations.
Qualifying APM securities means:
|
|
|
|
|
shares of our common stock; and
|
|
|
|
net share settled warrants to purchase our common stock that we
can sell at our sole discretion and that have an exercise price
greater than the current market price of our common stock as of
their date of issuance, that we are not entitled to redeem for
cash and that the holders of which are not entitled to require
us to repurchase for cash in any circumstance, which we refer to
as qualifying warrants.
|
The current market price of our common stock on any
date will be the closing sale price per share (or if no closing
sale price is reported, the average of the bid and ask prices
or, if more than one in either case, the average of the average
bid and the average ask prices) on that date as reported in
composite transactions by the New York Stock Exchange or, if our
common stock is not then listed on the New York Stock Exchange,
as reported by the principal U.S. securities exchange on
which our common stock is traded or quoted. If our common stock
is not either listed or quoted on any U.S. securities
exchange on the relevant date, the current market
price will be the last quoted bid price for our common
stock in the
over-the-counter
market on the relevant date as reported by the National
Quotation Bureau or similar organization. If our common stock is
not so quoted, the current market price will be the
average of the mid-point of the last bid and ask prices for our
common stock on the relevant date from each of at least three
nationally recognized independent investment banking firms
selected by us for this purpose.
A market disruption event means the occurrence or
existence of any of the following events or sets of
circumstances:
|
|
|
|
|
trading in securities generally on any national securities
exchange or
over-the-counter
market, on which our common stock is then listed or traded (as
of the date of this prospectus supplement, the New York Stock
Exchange), is suspended or the settlement of such trading
generally is materially disrupted or minimum prices are
established on any such exchange or such market by the SEC, by
such exchange or by any other regulatory body or governmental
authority having jurisdiction, and the establishment of such
minimum prices materially disrupts or otherwise has a material
adverse effect on trading in, and the issuance and sale of, our
common stock;
|
|
|
|
we were required to obtain the consent or approval of our
stockholders, a regulatory body or governmental authority to
issue or sell our common stock pursuant to the alternative
payment mechanism or to issue or sell qualifying capital
securities pursuant to the replacement capital obligation and,
after using our commercially reasonable efforts to obtain such
consent or approval, we fail to obtain that consent or approval;
|
|
|
|
a material disruption or banking moratorium occurs or has been
declared in commercial banking or securities settlement or
clearance services in the United States;
|
|
|
|
there shall have occurred such a material adverse change in
general domestic or international economic, political or
financial conditions, including without limitation as a result
of terrorist activities, or the effect of international
conditions on the financial markets in the United States is
such, as to make it, in our judgment, impracticable to proceed
with the issuance and sale of our common stock pursuant to the
alternative payment
|
S-42
|
|
|
|
|
mechanism or the issuance and sale of qualifying capital
securities pursuant to the replacement capital obligation;
|
|
|
|
|
|
an event occurs and is continuing as a result of which the
offering document for our common stock pursuant to the
alternative payment mechanism or the offer and sale of
qualifying capital securities pursuant to the replacement
capital obligation would, in our reasonable judgment, contain an
untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein not misleading and either (1) the
disclosure of that event at such time, in our judgment, would
have a material adverse effect on our business, or (2) the
disclosure relates to a previously undisclosed proposed or
pending material business transaction, and we have a bona fide
reason for keeping the same confidential or its disclosure would
impede our ability to consummate such transaction; provided that
no single suspension period contemplated by this bullet point
may exceed 90 consecutive days and multiple suspension periods
contemplated by this bullet point may not exceed an aggregate of
180 days in any
360-day
period; or
|
|
|
|
we reasonably believe that the offering document for the offer
and the sale of our common stock pursuant to the alternative
payment mechanism or the offer and sale of qualifying capital
securities pursuant to the replacement capital obligation would
not be in compliance with a rule or regulation of the SEC (for
reasons other than those referred to in the bullet point
directly above) and we are unable to comply with such rule or
regulation or such compliance is impracticable; provided that no
single suspension period contemplated by this bullet point may
exceed 90 consecutive days and multiple suspension periods
contemplated by this bullet point may not exceed an aggregate of
180 days in any
360-day
period.
|
Any interest payment made pursuant to the alternative payment
mechanism will first be allocated to payment of the interest due
on that interest payment date for the current interest period.
Any payment of interest in excess of the amount of interest due
on that interest payment date for the current interest period
will be applied first against any then existing accrued and
unpaid interest with respect to prior interest periods for which
interest must be paid pursuant to the alternative payment
mechanism, in chronological order beginning with the earliest
interest period for which interest has not been paid in full and
for which such interest must be paid pursuant to the alternative
payment mechanism, including compounded interest.
In the event that we defer an interest payment on the junior
subordinated debentures and on other securities that rank
equally with the junior subordinated debentures and contain
similar requirements to pay interest pursuant to the alternative
payment mechanism, we will apply any net proceeds so raised on a
pro rata basis towards our obligations to pay interest on the
junior subordinated debentures and such equally ranking
securities in proportion to the total amounts that are due on
the junior subordinated debentures and such securities, or on
such other basis as any regulatory authority may instruct
(taking into account the availability of proceeds of preferred
shares or other securities to settle deferred interest under any
such other securities). Notwithstanding the foregoing, a partial
payment will be applied (i) only to optionally deferred
interest payments, to the extent that the source of such partial
payment is other than proceeds from the sale of qualifying APM
securities, and (ii) first to interest that is unpaid
during a trigger period and second to optionally deferred
interest payments, to the extent that the source of such partial
payment is the sale of qualifying APM securities.
Under the subordinated indenture, we will be required to use
commercially reasonable efforts to seek shareholder consent to
increase the number of authorized shares of our common stock if,
at any date, our shares available for issuance fall below the
greater of:
|
|
|
|
|
shares
(as adjusted for any stock split, stock dividend,
reclassification, recapitalization,
split-up,
combination, exchange of shares or similar transaction); and
|
|
|
|
three times the number of shares that we would need to issue to
raise sufficient proceeds to pay (assuming a price per share
equal to the average trading price of shares of our common stock
over the ten-trading day period preceding such date) then
outstanding deferred interest on the junior subordinated
debentures (including compounded interest thereon), plus twelve
additional months of interest (including compounded interest) on
the junior subordinated debentures, up to a total of ten years
of interest (including compounded interest). For purposes of
determining the amounts accruing during a floating rate period,
the interest will be computed by reference to spot three-month
LIBOR on the calculation date plus a margin equal
to %.
|
S-43
An other covenant default (as defined under
Subordinated Indenture Events of
Default) will occur if we do not use our commercially
reasonable efforts to seek consent of our shareholders to
increase the number of authorized shares of our common stock if,
at any date, our shares available for issuance fall below the
amount specified above. Although an other covenant default will
not constitute an event of default or result in acceleration, it
will constitute a default under the subordinated indenture and
could give rise to a claim against us relating to the specific
breach; however, the remedy of holders of the junior
subordinated debentures may be limited to direct monetary
damages (if any). See Subordinated Indenture
Events of Default.
Our shares available for issuance will be calculated
in two steps. First, we will deduct from the number of
authorized and unissued shares of our common stock, the maximum
number of shares of our common stock that can be issued under
existing options, warrants, convertible securities, any
equity-linked contracts and other agreements which require us to
issue a determinable number of shares of our common stock. After
we deduct that number of shares of our common stock from the
number of authorized and unissued shares of our common stock, we
will allocate on a pro rata basis, or such other basis as we
determine is appropriate, the remaining authorized and unissued
shares to the alternative payment mechanism and to any other
similar commitment that is of an indeterminate nature and under
which we are then required to issue shares of our common stock.
If the number of authorized and unissued shares of our common
stock remaining after the two steps described above is not
sufficient to satisfy the remaining commitments, we will be
obligated to use commercially reasonable efforts to seek
shareholder consent to increase the number of authorized and
unissued shares of our common stock as described above. The
definition of shares available for issuance will
have the effect of giving absolute priority for issuance to
those reservations and commitments under which we are able to
determine the maximum number of shares of our common stock that
could be issued in connection therewith, irrespective of the
date on which they were entered into.
We will be permitted to modify the definition of shares
available for issuance and the related provisions of the
subordinated indenture without the consent of holders of the
junior subordinated debentures provided that (i) we have
determined, in good faith, that such modification is not
materially adverse to such holders, (ii) the rating
agencies then rating the junior subordinated debentures confirm
the then current ratings of the junior subordinated debentures
and (iii) the number of shares available for issuance after
giving effect to such modification will not fall below the then
applicable threshold set forth in the third preceding paragraph
above.
If we elect to satisfy our obligation to pay deferred interest
pursuant to the alternative payment mechanism by issuing
qualifying warrants, we will only do so if the total number of
shares of our common stock underlying such qualifying warrants
applied to pay interest on the junior subordinated debentures
pursuant to the alternative payment mechanism, together with the
total number of shares of our common stock underlying all prior
issuances of qualifying warrants so applied, does not exceed an
amount equal to 15% of the total number of our issued and
outstanding shares of common stock as of the date of any
proposed issuance.
Limitation
on Claims in the Event of Our Bankruptcy, Insolvency or
Receivership
The subordinated indenture provides that a holder of junior
subordinated debentures, by such holders acceptance of the
junior subordinated debentures, agrees that in certain events of
our bankruptcy, insolvency or receivership prior to the maturity
or redemption of any junior subordinated debentures, whether
voluntary or not, such holder of junior subordinated debentures
will have no claim for, and thus no right to receive, interest
that is unpaid as a result of certain consequences of a trigger
event (including any compounded interest thereon, to the extent
permitted by law) and has not been settled through the
application of the alternative payment mechanism to the extent
the amount of such interest exceeds 25% of the then outstanding
principal amount of such holders junior subordinated
debentures. We refer to the unpaid interest for which the holder
has no claim pursuant to the limitations described in this
paragraph as foregone interest. For the avoidance of
doubt, this limitation on claims for unpaid interest does not
apply to amounts of interest deferred on an optional basis, and
holders will have a full claim for, and right to receive, such
amounts.
Consolidation,
Merger, Conveyance, Sale of Assets and Other Transfers
The provisions of the subordinated indenture relating to our
possible consolidation, merger, conveyance, sale of assets and
other transfers will apply to the junior subordinated
debentures. You should refer to the description of
S-44
these provisions under Description of Debt
Securities Restrictive Covenants and
Description of Debt Securities Consolidation,
Merger, Sale of Assets and Other Transactions in the
accompanying base prospectus.
Subordination
The payment of principal of and interest on the junior
subordinated debentures, to the extent provided in the
subordinated indenture, will be subordinated to the prior
payment in full of all of our present and future senior
indebtedness, as defined below.
Subject to the qualifications described below, the term
senior indebtedness includes principal of, and
interest and premium, if any, on, and any other amounts payable
in respect of, the following:
|
|
|
|
|
all of our indebtedness, whether outstanding on the date of the
initial issuance of the junior subordinated debentures or
thereafter created, incurred or assumed, which is for money
borrowed (including, without limitation, trust preferred
securities of statutory trusts and our related subordinated
debentures and guarantees issued under the subordinated
indenture), or which is evidenced by a note or similar
instrument given in connection with the acquisition of any
business, properties or assets, including securities;
|
|
|
|
all of our obligations under leases required or permitted to be
capitalized under generally accepted accounting principles;
|
|
|
|
any indebtedness of others of the kinds described in the first
bullet point above for the payment of which we are responsible
or liable as guarantor or otherwise; and
|
|
|
|
amendments, modifications, renewals, extensions, deferrals and
refundings of any of the above types of indebtedness.
|
The senior indebtedness will continue to be senior indebtedness
and entitled to the benefits of the subordination provisions
irrespective of any amendment, modification or waiver of any
term of the senior indebtedness or extension or renewal of the
senior indebtedness. Notwithstanding anything to the contrary in
the foregoing, senior indebtedness will not include
(1) indebtedness incurred for the purchase of goods or
materials or for services obtained in the ordinary course of
business (i.e., trade accounts payable), which will rank equally
in right of payment and upon liquidation with the junior
subordinated debentures, (2) any indebtedness which by its
terms ranks equally with or subordinated to the junior
subordinated debentures in right of payment or upon liquidation,
(3) indebtedness owed by us to our subsidiaries, which also
will rank equally in right of payment and upon liquidation to
the junior subordinated debentures, and (4) any liability
for Federal, state, local or other taxes owed or owing by us or
by our subsidiaries.
No direct or indirect payment, in cash, property or securities,
by set-off or otherwise, may be made or agreed to be made on
account of the junior subordinated debentures including in
respect of any repayment, redemption, retirement, purchase or
other acquisition of the junior subordinated debentures, if:
|
|
|
|
|
we default in the payment of any principal, or premium, if any,
or interest on any senior indebtedness, whether at maturity or
at a date fixed for prepayment or declaration or
otherwise; or
|
|
|
|
an event of default occurs with respect to any senior
indebtedness permitting the holders thereof to accelerate the
maturity and written notice of such event of default, requesting
that payments on the junior subordinated debentures cease, is
given to us by any holder of senior indebtedness, unless and
until such event of default has been cured or waived or ceases
to exist.
|
All present and future senior indebtedness, which will include
interest accruing after the commencement of any proceeding,
assignment or marshaling of assets described below, will first
be paid in full before any payment, whether in cash, securities
or other property, will be made by us on account of the junior
subordinated debentures in the event of:
|
|
|
|
|
any insolvency, bankruptcy, receivership, liquidation,
reorganization, readjustment, composition or other similar
proceeding relating to us, our creditors or our property;
|
S-45
|
|
|
|
|
any proceeding for our liquidation, dissolution or other
winding-up,
voluntary or involuntary, whether or not involving insolvency or
bankruptcy proceedings;
|
|
|
|
any general assignment by us for the benefit of
creditors; or
|
|
|
|
any other marshaling of our assets.
|
In any such event, payments that would otherwise be made on the
junior subordinated debentures will generally be paid to the
holders of senior indebtedness, or their representatives, in
accordance with the priorities existing among these creditors at
that time until the senior indebtedness is paid in full. If the
payments on the junior subordinated debentures are in the form
of our securities or those of any other corporation under a plan
of reorganization or readjustment and are subordinated to
outstanding senior indebtedness and to any securities issued
with respect to such senior indebtedness under a plan of
reorganization or readjustment, they will be made to the holders
of senior indebtedness and then, if any amounts remain, to the
holders of the junior subordinated debentures. No present or
future holder of any senior indebtedness will be prejudiced in
the right to enforce the subordination of the junior
subordinated debentures by any act or failure to act on our part.
In the event that, notwithstanding any of the foregoing
prohibitions, the subordinated indenture trustee or the holders
of the junior subordinated debentures receive or hold any
payment on account of or in respect of the junior subordinated
debentures at a time when a responsible officer of the
subordinated indenture trustee or such holder has actual
knowledge that such payment should not have been made to it, the
subordinated indenture trustee or such holder, as the case may
be, will hold such payment in trust for the benefit of, and,
upon written request, will pay it over to, the holders of the
senior indebtedness or their agents or representatives, for
application to the payment of all principal, premium, if any,
and interest or any other amounts then payable with respect to
any senior indebtedness.
Senior indebtedness will only be deemed to have been paid in
full if the holders of such senior indebtedness have received
cash, securities or other property which is equal to the amount
of the outstanding senior indebtedness.
After payment in full of all present and future senior
indebtedness, holders of the junior subordinated debentures will
be subrogated to the rights of any holders of senior
indebtedness to receive any further payments that are applicable
to the senior indebtedness until all the junior subordinated
debentures are paid in full. In matters between holders of the
junior subordinated debentures and any other type of our
creditors, any payments that would otherwise be paid to holders
of senior indebtedness and that are made to holders of the
junior subordinated debentures because of this subrogation will
be deemed a payment by us on account of senior indebtedness and
not on account of the junior subordinated debentures.
Moreover, the subordinated indenture provides that a holder of
junior subordinated debentures, by such holders acceptance
of the junior subordinated debentures, agrees that in certain
events of our bankruptcy, insolvency or receivership prior to
the maturity or redemption of any junior subordinated
debentures, whether voluntary or not, such holder of junior
subordinated debentures will have no claim for, and thus no
right to receive, interest that is unpaid due to certain
consequences of a trigger event (including compounded interest
thereon, to the extent permitted by law) and has not been
settled through the application of the alternative payment
mechanism to the extent the amount of such interest exceeds 25%
of the then outstanding principal amount of such holders
junior subordinated debentures. For the avoidance of doubt, this
limitation on claims for unpaid interest does not apply to
amounts of interest deferred on an optional basis, and holders
will have a full claim for, and right to receive, such amounts.
The subordinated indenture places no limitation on the amount of
additional senior indebtedness that we may incur. We expect to
incur from time to time additional senior indebtedness.
In addition to the contractual subordination provisions
described above, the rights of the holders of the junior
subordinated debentures will be structurally subordinated to all
existing and future obligations of our subsidiaries, as we are a
holding company. As a result, we rely primarily on dividends or
other payments from our direct and indirect operating
subsidiaries, which generally are regulated insurance companies,
to pay principal and interest on our outstanding debt
obligations, and to make dividend distributions on our capital
stock. Regulatory rules will, and certain covenants contained in
various debt agreements may, restrict our ability to withdraw
capital from our subsidiaries by dividends, loans or other
payments.
S-46
Due to the subordination provisions described above, in the
event of our insolvency, funds which we would otherwise use to
pay the holders of the junior subordinated debentures would be
used to pay the holders of senior indebtedness to the extent
necessary to pay the senior indebtedness in full. As a result of
these payments, our general creditors may recover less, ratably,
than the holders of our senior indebtedness and these general
creditors may recover more, ratably, than the holders of the
junior subordinated debentures.
As of September 30, 2006, we had approximately
$10.4 billion of debt outstanding at the parent company
level and our subsidiaries had outstanding, $473.0 billion
of total liabilities (including liabilities to policyholders and
contractholders including $4.2 billion of debt (excluding
in each case, intercompany liabilities)), $483.4 billion of
which will be senior in priority to the junior subordinated
debentures. This senior indebtedness includes approximately
$2.1 billion of junior subordinated indebtedness that we
issued to statutory trusts, which will rank senior to the junior
subordinated debentures and at least equally with any other
junior subordinated debt that we might issue in the future, but
which is subordinated and junior in right of payment to our
current and future senior debt securities.
Optional
Redemption
Subject to the provisions described under Description of
the Replacement Capital Covenant, we may, at our option,
redeem the junior subordinated debentures:
|
|
|
|
|
in whole or in part, at any time on or after December 15,
2031, at a cash redemption price equal to the par redemption
amount; provided that if the junior subordinated debentures are
not redeemed in whole, at least $50 million aggregate
principal amount of the junior subordinated debentures
(excluding any junior subordinated debentures held by us or any
of our affiliates) must remain outstanding after giving effect
to such redemption;
|
|
|
|
in whole or in part, at any time prior to December 15,
2031, in cases not involving a tax event or
rating agency event, at a cash redemption price
equal to the greater of (i) the par redemption amount and
(ii) the make-whole redemption amount (as defined below);
provided that if the junior subordinated debentures are not
redeemed in whole, at least $50 million aggregate principal
amount of the junior subordinated debentures (excluding any
junior subordinated debentures held by us or any of our
affiliates) must remain outstanding after giving effect to such
redemption; and
|
|
|
|
in whole, but not in part, at any time prior to
December 15, 2031, within 180 days after the
occurrence of a tax event or a rating agency
event, at a cash redemption price equal to the greater of
(i) the par redemption amount and (ii) the special
event make-whole redemption amount (as defined below).
|
As used in this section:
Par redemption amount means a cash redemption price
of 100% of the principal amount of the junior subordinated
debentures to be redeemed, plus accrued and unpaid interest,
together with any compounded interest, to the extent permitted
by law, on such junior subordinated debentures to the redemption
date.
Make-whole redemption amount means the sum, as
calculated by the premium calculation agent (as defined below),
of the present values of the remaining scheduled payments of
principal (discounted from December 15, 2031) and
interest that would have been payable to and including
December 15, 2031 (discounted from their respective
interest payment dates) on the junior subordinated debentures to
be redeemed (not including any portion of such payments of
interest accrued to the redemption date) to the redemption date
on a semi-annual basis (assuming a
360-day year
consisting of twelve
30-day
months) at the treasury rate plus basis points; plus accrued and
unpaid interest, together with any compounded interest, on the
principal amount of the junior subordinated debentures being
redeemed to the redemption date.
Special event make-whole redemption amount means the
sum, as calculated by the premium calculation agent, of the
present values of the remaining scheduled payments of principal
(discounted from December 15, 2031) and interest that
would have been payable to and including December 15, 2031
(discounted from their respective interest payment dates) on the
junior subordinated debentures to be redeemed (not including any
portion
S-47
of such payments of interest accrued to the redemption date) to
the redemption date on a semi-annual basis (assuming a
360-day year
consisting of twelve
30-day
months) at the treasury rate plus basis points; plus accrued and
unpaid interest, together with any compounded interest, on the
principal amount of the junior subordinated debentures being
redeemed to the redemption date.
For purposes of the preceding definitions:
|
|
|
|
|
Treasury rate means, with respect to any date of
redemption, the yield, under the heading that represents the
average for the immediately preceding week, appearing in the
most recently published statistical release designated H.15(519)
or any successor publication that is published weekly by the
Board of Governors of the Federal Reserve System and that
establishes yields on actively traded U.S. Treasury
securities adjusted to constant maturity under the caption
Treasury Constant Maturities, for the maturity corresponding to
the comparable treasury issue (if no maturity is within three
months before or after the remaining life (as defined below),
yields for the two published maturities most closely
corresponding to the comparable treasury issue will be
determined and the treasury rate will be interpolated or
extrapolated from such yields on a straight line basis, rounding
to the nearest month); or if such release (or any successor
release) is not published during the week preceding the
calculation date or does not contain such yields, the rate per
annum equal to the semi-annual equivalent yield to maturity of
the comparable treasury issue, calculated using a price for the
comparable treasury issue (expressed as a percentage of its
principal amount) equal to the comparable treasury price for
such date of redemption. The treasury rate will be calculated on
the third business day preceding the redemption date.
|
|
|
|
Premium calculation agent means The Bank of New York
Trust Company, N.A., or any other firm appointed by us or, if
that firm is unwilling or unable to select the comparable
treasury issue or calculate the make-whole redemption amount or
special event make-whole redemption amount, an investment
banking institution of national standing appointed by us.
|
|
|
|
Comparable treasury issue means the
U.S. Treasury security selected by the premium calculation
agent as having a maturity comparable to the term remaining from
the early redemption date to December 15, 2031 that would
be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate
debt securities of comparable term.
|
|
|
|
Comparable treasury price means, with respect to an
early redemption date (1) the average of five reference
treasury dealer quotations for such redemption date, after
excluding the highest and lowest reference treasury dealer
quotations, or (2) if the premium calculation agent obtains
fewer than five such reference treasury dealer quotations, the
average of all such quotations.
|
|
|
|
Reference treasury dealer means (1) each of
Goldman, Sachs & Co., J.P. Morgan Securities Inc.
and Merrill Lynch & Co. and their successors, provided,
however, that if any of the foregoing shall cease to be a
primary U.S. government securities dealer in New York City
(a primary treasury dealer) we will substitute
therefor another primary treasury dealer, and (2) any other
primary treasury dealers selected by the premium calculation
agent after consultation with us.
|
|
|
|
Reference treasury dealer quotations means, with
respect to each reference treasury dealer and any early
redemption date, the average, as determined by the premium
calculation agent, of the bid and ask prices for the comparable
treasury issue (expressed in each case as a percentage of its
principal amount) quoted in writing to the premium calculation
agent at 5:00 p.m., New York City time, on the third
business day preceding such redemption date.
|
Tax event means the receipt by us of an opinion of
counsel, rendered by a law firm with experience in such matters,
to the effect that, as a result of (a) any amendment to, or
change (including any announced prospective change) in, the laws
(or any regulations thereunder) of the United States or any
political subdivision or taxing authority thereof or therein,
(b) any official administrative pronouncement (including a
private letter ruling, technical advice memorandum or similar
pronouncement) or judicial decision interpreting or applying
such laws or regulations, or (c) a threatened challenge
asserted in connection with an audit of us or any of our
subsidiaries, or a threatened challenge asserted in writing
against any other taxpayer that has raised capital through the
issuance of securities that are substantially similar to the
junior subordinated debentures, which amendment or change is
S-48
enacted or effective or which pronouncement or decision is
announced or which challenge becomes publicly known on or after
the date of initial issuance of the junior subordinated
debentures, there is more than an insubstantial increase in the
risk that interest accruing or payable by us on the junior
subordinated debentures is not or, at any time subsequent to our
receipt of such opinion, will not be, wholly deductible by us
for U.S. Federal income tax purposes.
Rating agency event means a change by any NRSRO that
rates the junior subordinated debentures, in the equity rating
criteria for securities such as the junior subordinated
debentures as is in effect on the date of this prospectus
supplement, which change results in lower equity credit being
given to the junior subordinated debentures than the equity
credit that would have been given to the junior subordinated
debentures in the absence of such change.
With respect to any redemption of junior subordinated debentures
as a result of a tax event or a rating agency event, the date
fixed for such redemption will be within 180 days following
the occurrence of the tax event or rating agency event, as
applicable; provided, however, that if at that time we are able
to eliminate, within the
180-day
period, the tax event or the rating agency event by taking some
ministerial action (such as making an election or filing a form)
that has no adverse effect on us or the holders of the junior
subordinated debentures, we will pursue such action in lieu of
redemption. We will have no right or obligation to redeem the
junior subordinated debentures while we are pursuing such
measure.
We will mail, or cause the subordinated indenture trustee to
mail, notice of every redemption of junior subordinated
debentures by first class mail, postage prepaid, addressed to
the holders of record of the junior subordinated debentures to
be redeemed at their respective last addresses appearing on the
register. Such mailing will be not less than 15 days and
not more than 30 days before the date fixed for redemption
(each, a notice date). Any notice mailed as provided
in this paragraph will be conclusively presumed to have been
duly given, whether or not the holder receives such notice, but
failure duly to give such notice by mail, or any defect in such
notice or in the mailing of such notice, to any holder of junior
subordinated debentures designated for redemption will not
affect the redemption of any other junior subordinated
debentures. Each notice will state (i) the redemption date;
(ii) the redemption price; (iii) that the junior
subordinated debentures are being redeemed pursuant to the
subordinated indenture or the terms of the junior subordinated
debentures together with the facts permitting such redemption;
(iv) if less than all outstanding junior subordinated
debentures are to be redeemed, the identification (and, in the
case of partial redemption, the principal amounts) of the
particular junior subordinated debentures to be redeemed;
(v) the place or places where the junior subordinated
debentures are to be redeemed; and (vi) that interest on
the junior subordinated debentures to be redeemed will cease to
accrue on the redemption date.
Any junior subordinated debentures to be redeemed pursuant to
the aforementioned notice will, on the date fixed for
redemption, become due and payable at the redemption price. From
and after such date such junior subordinated debentures will
cease to bear interest. Upon surrender of any such junior
subordinated debentures for redemption in accordance with said
notice, such junior subordinated debentures will be paid by us
at the redemption price, subject to certain conditions. If any
junior subordinated debentures called for redemption are not so
paid upon surrender thereof for redemption, the redemption price
will, until paid, bear interest from the redemption date at the
rate prescribed therefor in the junior subordinated debentures.
Any junior subordinated debentures redeemed only in part will be
surrendered in accordance with the provisions of the
subordinated indenture. In exchange for the unredeemed portion
of such surrendered junior subordinated debentures, new junior
subordinated debentures in an aggregate principal amount equal
to the unredeemed portion will be issued.
Repayment
of Principal; Replacement Capital Obligation
The junior subordinated debentures mature on December 15,
2066, which is the final maturity date for the
junior subordinated debentures. However, we have agreed to repay
the principal amount of the junior subordinated debentures,
together with accrued and unpaid interest, on December 15,
2036, which we refer to as the scheduled redemption
date, subject to the limitations described below.
Our obligation to repay the junior subordinated debentures on
the scheduled redemption date is limited. We are required to
repay the junior subordinated debentures on the scheduled
redemption date only to the extent that we have raised
sufficient net proceeds during the applicable QCS proceeds
collection period from the issuance of certain qualifying
capital securities permitted to be issued pursuant to the
replacement capital covenant described
S-49
under Description of the Replacement Capital
Covenant. We will covenant to use our commercially
reasonable efforts, subject to a market disruption event and
subject to our right to otherwise redeem the junior subordinated
debentures as described under Optional
Redemption, to raise sufficient net proceeds during the
applicable QCS proceeds collection period from the issuance of
qualifying capital securities to permit repayment of the junior
subordinated debentures in full on the scheduled redemption
date, which we refer to as the replacement capital
obligation. If we have not raised sufficient net proceeds
during the applicable QCS proceeds collection period to permit
repayment of all principal and accrued and unpaid interest,
including any compounded interest, to the extent permitted by
law, on the junior subordinated debentures on the scheduled
redemption date, we will continue to use commercially reasonable
efforts, subject to the limitations described in the immediately
preceding sentence, to raise sufficient net proceeds during the
applicable QCS proceeds collection period from the issuance of
qualifying capital securities to permit repayment of the junior
subordinated debentures on the next interest payment date, and
on each interest payment date thereafter, until the junior
subordinated debentures are paid in full. Until the junior
subordinated debentures are so paid in full, they will remain
outstanding from quarter to quarter and bear interest at a
floating rate specified herein, payable quarterly in arrears
until repaid in accordance with their terms.
Notwithstanding the foregoing, if we redeem the junior
subordinated debentures when any deferred interest remains
unpaid and at a time when the alternative payment mechanism is
otherwise applicable, the unpaid deferred interest (including
compounded interest, to the extent permitted by law) may only be
paid pursuant to the alternative payment mechanism (other than
any interest that has accrued during an optional deferral period
of less than five years and prior to the occurrence of a trigger
event, which may be paid out of any source of funds), except
that on the final maturity date and on the acceleration date of
the junior subordinated debentures, we may pay any accrued and
unpaid interest without regard to the source of funds.
The replacement capital obligation will continue to apply until
(i) we have redeemed the junior subordinated debentures in
full in accordance with the replacement capital obligation,
(ii) the junior subordinated debentures are otherwise paid
in full on the final maturity date or (iii) upon the
occurrence of an event of default resulting in acceleration of
the junior subordinated debentures. Our failure to use
commercially reasonable efforts to raise sufficient proceeds
from the issuance and sale of qualifying capital securities,
subject to a market disruption event and subject to our right to
otherwise redeem the junior subordinated debentures as described
under Optional Redemption, would be a
breach of covenant under the subordinated indenture, for which
the subordinated indenture trustee and holders of the junior
subordinated debentures, subject to certain conditions, may
bring suit for enforcement. However, in no event will such
failure be an event of default or result in acceleration
thereunder.
If any date fixed for redemption or repayment is not a business
day, then payment of the redemption price or repayment of the
principal amount of the junior subordinated debentures will be
made on the next day that is a business day, without any
interest or other payment as a result of such delay.
We generally may amend or supplement the replacement capital
covenant without the consent of the holders of the junior
subordinated debentures. With respect to the qualifying capital
securities, on the other hand, we have agreed in the
subordinated indenture that we will not amend the replacement
capital covenant to impose additional restrictions on the type
or amount of qualifying capital securities that we may include
for purposes of determining when repayment, redemption or
purchase of the junior subordinated debentures is permitted,
except with the consent of the holders of a majority in
principal amount of the junior subordinated debentures.
Any principal amount of the junior subordinated debentures,
together with accrued and unpaid interest, will be due and
payable on the final maturity date, regardless of the amount of
qualifying capital securities we have issued and sold by that
time.
Although under the replacement capital covenant the principal
amount of junior subordinated debentures that we may repay,
redeem or purchase at any time may be based on the net cash
proceeds from certain issuances of our common stock, rights to
acquire our common stock, debt exchangeable for equity and
mandatorily convertible preferred stock in addition to
qualifying capital securities, we have no obligation under the
subordinated indenture to use commercially reasonable efforts to
issue any securities other than qualifying capital securities or
to use the proceeds of the issuance of any other securities to
repay the junior subordinated debentures on the scheduled
redemption date or at any time thereafter.
S-50
Commercially reasonable efforts to sell our
qualifying capital securities means commercially reasonable
efforts to complete the offer and sale of our qualifying capital
securities to third parties that are not our subsidiaries in
public offerings or private placements. For the avoidance of
doubt, we will not be considered to have made commercially
reasonable efforts to effect a sale of qualifying capital
securities if we determine to not pursue or complete such sale
due to pricing, coupon, dividend rate or dilution considerations.
We will not be required to redeem the junior subordinated
debentures on the scheduled redemption date or any interest
payment date following the scheduled redemption date (and prior
to the final maturity date), as the case may be (each a
required repayment date), to the extent we provide
written certification to the subordinated indenture trustee
(which the trustee will promptly forward upon receipt to each
holder of record of junior subordinated debentures) on the
notice date for such required repayment date certifying that
either:
|
|
|
|
|
a market disruption event was existing and continued during the
entire applicable QCS proceeds collection period; or
|
|
|
|
we were unable after using commercially reasonable efforts to
raise sufficient net proceeds during the applicable QCS proceeds
collection period to permit repayment of the junior subordinated
debentures in full on the applicable required repayment date.
|
Net proceeds from the sale of qualifying capital securities that
we are permitted to apply to repayment of junior subordinated
debentures on and after the scheduled redemption date will be
applied, first, to pay interest that we are not paying from
other sources (other than interest required to be paid pursuant
to the alternative payment mechanism) and, second, to repay the
principal of junior subordinated debentures; provided that if we
raise less than $5 million of net proceeds from the sale of
qualifying capital securities during the applicable QCS proceeds
collection period, we will not be required to repay any junior
subordinated debentures on the scheduled redemption date or the
applicable quarterly interest payment date, as applicable, but
we will use those net proceeds to repay the junior subordinated
debentures on the next quarterly interest payment date as of
which we have raised at least $5 million of net proceeds;
provided, further, that if we are obligated to use commercially
reasonable efforts to sell qualifying capital securities and
apply the net proceeds to payments of principal of or interest
on any outstanding securities in addition to the junior
subordinated debentures, then on any date and for any period the
amount of net proceeds received by us from those sales and
available for such payments shall be applied to the junior
subordinated debentures and those other securities having the
same scheduled repayment date or scheduled redemption date as
the junior subordinated debentures pro rata in accordance with
their respective outstanding principal amounts and none of such
net proceeds shall be applied to any other securities having a
later scheduled repayment date or scheduled redemption date
until the principal of and all accrued and unpaid interest on
the junior subordinated debentures has been paid in full.
Subordinated
Indenture Events of Default
An event of default with respect to the junior subordinated
debentures means:
|
|
|
|
|
the failure to pay interest (including compounded interest) in
full, whether due to an optional deferral, during a trigger
period or otherwise, after the conclusion of a period of 10
consecutive years following the commencement of any deferral
period or on the final maturity date;
|
|
|
|
default in the payment of the principal of, or premium, if any,
on the junior subordinated debentures when due; or
|
|
|
|
certain events of bankruptcy, insolvency or receivership,
whether voluntary or not.
|
Subordinated indenture events of default with respect to the
junior subordinated debentures, which replace the events of
default described in Description of Debt
Securities Events of Default, Notice and
Waiver in the accompanying base prospectus, do not include
failure to comply with or breach of our other covenants in the
subordinated indenture with respect to the junior subordinated
debentures (an other covenant default), including
the covenant to use commercially reasonable efforts to sell our
common stock through the alternative payment mechanism as
described herein. Accordingly, an other covenant default will
not result in the acceleration of payment of the junior
subordinated debentures. Although an other covenant default will
not constitute an event of
S-51
default, it will otherwise constitute a default under the
subordinated indenture and could give rise to a claim against us
relating to the specific breach; however, the remedy of holders
of the junior subordinated debentures may be limited to direct
monetary damages (if any). An other covenant default will only
give rise to possible remedies if it continues for 90 days
after delivery of specified notice.
Holders of the junior subordinated debentures may not themselves
institute a proceeding against us on account of an other
covenant default unless, among other things, the subordinated
indenture trustee fails to institute such a proceeding, subject
to the terms of the subordinated indenture. However, the holders
of a majority in principal amount of the junior subordinated
debentures may direct the subordinated indenture trustee to
bring such a proceeding if an other covenant default continues
for a period of 90 days after delivery of specified notice
to us from the subordinated indenture trustee or to us and the
subordinated indenture trustee from the holders of a majority in
principal amount of the junior subordinated debentures, subject
to the terms of the subordinated indenture. Except with respect
to covenants relating to our obligation to file periodic or
other reports and an annual statement with respect to
subordinated indenture defaults, the subordinated indenture will
not require the subordinated indenture trustee to take any
action in case of an other covenant default (other than to give
notice of such other covenant default to the holders of the
junior subordinated debentures under certain circumstances, as
described below) unless so directed by the holders of the junior
subordinated debentures. In the case of an other covenant
default resulting from our failure or breach in regard to our
obligation under the subordinated indenture to file periodic or
other reports or the annual statement with respect to defaults,
such other covenant default, after its continuance for
90 days after delivery of such specified notice, will be
treated under the subordinated indenture as if it were an event
of default with respect to the junior subordinated debentures,
and the subordinated indenture trustee will have all of the
rights, duties and obligations, and the holders of the junior
subordinated debentures will have all of the rights, in respect
of such other covenant default as if such other covenant default
were such an event of default, except that there will be no
right to accelerate the payment of the junior subordinated
debentures.
The subordinated indenture provides, as to both events of
default and other covenant defaults, that holders of the junior
subordinated debentures only have the right to institute a
direct action against us upon compliance with certain conditions
specified in the subordinated indenture. These conditions
include, among other things, prior notice by the requisite
percentage of holders of the junior subordinated debentures,
offer of indemnification to the subordinated indenture trustee,
and failure of the subordinated indenture trustee to act for
60 days.
Within 90 days after a default, the subordinated indenture
trustee must give to the holders of the junior subordinated
debentures notice of all uncured and unwaived defaults by us
known to it. However, except in the case of default in payment,
the subordinated indenture trustee may withhold such notice if
it determines that such withholding is in the interest of such
holders.
If an event of default occurs in respect of any outstanding
junior subordinated debentures, the subordinated indenture
trustee or the holders of at least 25% in principal amount of
the outstanding junior subordinated debentures may declare the
principal amount, premium, if any, and all unpaid and accrued
interest (other than foregone interest in case of certain events
of bankruptcy, insolvency or receivership, whether voluntary or
not) to be due and payable immediately by written notice thereof
to us, and to the subordinated indenture trustee if given by the
holders of the junior subordinated debentures, subject to the
terms of the subordinated indenture; provided that, in the case
of an event of default involving certain events of bankruptcy,
insolvency or reorganization, acceleration will be automatic.
However, the payment of principal, premium, if any, and interest
on the junior subordinated debentures will remain subordinated
to the extent provided in the subordinated indenture. In
addition, at any time after such a declaration of acceleration
but before a judgment or decree for payment of the money due has
been obtained, the holders of a majority in principal amount of
the junior subordinated debentures may, subject to specified
conditions, rescind and annul such acceleration if all events of
default, other than the non-payment of accelerated principal, or
premium, if any, or interest on the junior subordinated
debentures have been cured or waived as provided in the
subordinated indenture.
Discharge,
Defeasance and Covenant Defeasance
The discharge, defeasance and covenant defeasance provisions of
the subordinated indenture will apply to the junior subordinated
debentures. You should refer to the description of these
provisions under Description of Debt
S-52
Securities Discharge, Defeasance and Covenant
Defeasance in the accompanying base prospectus; provided,
that any defeasance of the junior subordinated debentures will
be subject to the replacement capital covenant described under
Description of the Replacement Capital Covenant in
this prospectus supplement. For the avoidance of doubt, any
reference in the section of this prospectus supplement under the
heading Description of the Replacement Capital
Covenant to any repayment of our securities will be deemed
to include a reference to defeasance of our obligations under
such securities.
Modification
of Subordinated Indenture
The modification provisions of the subordinated indenture will
apply to the junior subordinated debentures. You should refer to
the description of these provisions under Description of
Debt Securities Modification and Waiver in the
accompanying base prospectus.
In addition, we will be permitted to modify, without consent of
holders of the junior subordinated debentures, the definition of
shares available for issuance and the related
provisions of the subordinated indenture provided that
(i) we have determined, in good faith, that such
modification is not materially adverse to such holders,
(ii) the rating agencies then rating the junior
subordinated debentures confirm the then current ratings of the
junior subordinated debentures and (iii) the number of
shares available for issuance after giving effect to such
modification will not fall below the then applicable threshold.
Governing
Law
The subordinated indenture and the junior subordinated
debentures will be governed by, and construed in accordance
with, the laws of the State of New York.
Book-Entry
System
Upon issuance, the junior subordinated debentures will be
represented by one or more fully registered global certificates,
each of which we refer to as a global security. Each such global
security will be deposited with, or on behalf of, DTC and
registered in the name of DTC or a nominee thereof. Initial
settlement for the junior subordinated debentures will be made
in same day funds. Secondary market trading between DTC
participants will occur in the ordinary way in accordance with
DTCs rules and will be settled in immediately available
funds using DTCs
Same-Day
Funds Settlement System. No assurance can be given as to the
effect, if any, of settlement in immediately available funds on
trading activity in the junior subordinated debentures. Unless
and until it is exchanged in whole or in part for junior
subordinated debentures in definitive form, no global security
may be transferred except as a whole by DTC to a nominee of DTC
or by a nominee of DTC to DTC or another nominee of DTC or by
DTC or any such nominee to a successor of DTC or a nominee of
such successor.
Beneficial interests in the junior subordinated debentures will
be represented through book-entry accounts of financial
institutions acting on behalf of beneficial owners as direct and
indirect participants in DTC. Investors may elect to hold
interests in the global securities through either the DTC (in
the United States), or Clearstream Luxembourg or Euroclear if
they are participants in those systems, or, indirectly through
organizations that are participants in those systems.
Clearstream Luxembourg and Euroclear will hold interests on
behalf of their participants through customers securities
accounts in Clearstream Luxembourgs and Euroclears
names on the books of their respective depositaries, which in
turn will hold such interests in customers securities
accounts in the depositaries names on the books of the
Depositary. At the present time, Citibank, N.A. acts as
U.S. depositary for Clearstream Luxembourg and JPMorgan
Chase Bank acts as U.S. depositary for Euroclear (the
U.S. Depositaries).
So long as DTC, or its nominee, is a registered owner of a
global security, DTC or its nominee, as the case may be, will be
considered the sole owner or holder of the junior subordinated
debentures represented by such junior global security for all
purposes under the subordinated indenture. Except as provided
below, the actual owners of the junior subordinated debentures
represented by a junior subordinated debenture (the
beneficial owner) will not be entitled to have the
junior subordinated debentures represented by such global
security registered in their names, will not receive or be
entitled to receive physical delivery of the junior subordinated
debentures in definitive form and will not be considered the
owners or holders thereof under the subordinated indenture.
S-53
Accordingly, each person owning a beneficial interest in a
global security must rely on the procedures of DTC and, if such
person is not a participant of DTC (a participant),
on the procedures of the participant through which such person
owns its interest, to exercise any rights of a holder of the
junior subordinated debentures under the subordinated indenture.
We understand that under existing industry practices, in the
event that we request any action of holders of the junior
subordinated debentures or that an owner of a beneficial
interest that a holder is entitled to give or take under the
subordinated indenture, DTC would authorize the participants
holding the relevant beneficial interests to give or take such
action, and such participants would authorize beneficial owners
owning through such participants to give or take such action or
would otherwise act upon the instructions of beneficial owners.
The following is based on information furnished by DTC:
DTC will act as securities depositary for the junior
subordinated debentures. The junior subordinated debentures will
be issued as fully registered securities registered in the name
of Cede & Co. (DTCs partnership nominee). One or
more global securities will initially represent the junior
subordinated debentures and will be deposited with DTC.
DTC is a limited-purpose trust company organized under the New
York Banking Law, a banking organization within the
meaning of the New York Banking Law, a member of the Federal
Reserve System, a clearing corporation within the
meaning of the New York Uniform Commercial Code, and a
clearing agency registered pursuant to the
provisions of Section 17A of the Exchange Act. DTC holds
securities that its participants deposit with DTC. DTC also
facilitates the settlement among participants of securities
transactions, such as transfers and pledges, in deposited
securities through electronic computerized book-entry changes in
participants accounts, thereby eliminating the need for
physical movement of securities certificates. Direct
participants of DTC (direct participants) include
securities brokers and dealers, banks, trust companies, clearing
corporations and certain other organizations. DTC is owned by a
number of its direct participants and by The New York Stock
Exchange, Inc., the American Stock Exchange, Inc., and the NASD.
Access to DTCs system is also available to others such as
securities brokers and dealers, banks and trust companies that
clear through or maintain a custodial relationship with a direct
participant, either directly or indirectly (indirect
participants). The rules applicable to DTC and its
participants are on file with the SEC.
Purchases of the junior subordinated debentures under DTCs
system must be made by or through direct participants, which
will receive a credit for the junior subordinated debentures on
DTCs records. The ownership interest of each beneficial
owner is in turn to be recorded on the records of direct
participants and indirect participants. Beneficial owners will
not receive written confirmation from DTC of their purchase, but
beneficial owners are expected to receive written confirmations
providing details of the transaction, as well as periodic
statements of their holdings, from the direct participants or
indirect participants through which such beneficial owner
entered into the transaction. Transfers of ownership interests
in the junior subordinated debentures are to be accomplished by
entries made on the books of participants acting on behalf of
beneficial owners. Beneficial owners will not receive
certificates representing their ownership interests in the
junior subordinated debentures, except in the limited
circumstances that may be provided in the subordinated indenture.
To facilitate subsequent transfers, all junior subordinated
debentures deposited with DTC are registered in the name of
DTCs partnership nominee, Cede & Co. The deposit
of the junior subordinated debentures with DTC and their
registration in the name of Cede & Co. effect no change
in beneficial ownership. DTC has no knowledge of the actual
beneficial owners of the junior subordinated debentures.
DTCs records reflect only the identity of the direct
participants to whose accounts such securities are credited,
which may or may not be the beneficial owners. The participants
will remain responsible for keeping account of their holdings on
behalf of their customers.
Conveyance of notices and other communications by DTC to direct
participants, by direct participants to indirect participants,
and by direct participants and indirect participants to
beneficial owners will be governed by arrangements among them,
subject to any statutory or regulatory requirements as may be in
effect from time to time.
Neither DTC nor Cede & Co. will consent or vote with
respect to the junior subordinated debentures. Under its usual
procedures, DTC mails an Omnibus Proxy to us as soon as possible
after the applicable record date. The Omnibus Proxy assigns
Cede & Co.s consenting or voting rights to those
direct participants to whose accounts securities are credited on
the applicable record date (identified in a listing attached to
the Omnibus Proxy).
S-54
Payments on the junior subordinated debentures will be made in
immediately available funds to DTC. DTCs practice is to
credit direct participants accounts on the applicable
payment date in accordance with their respective holdings shown
on DTCs records unless DTC has reason to believe that it
will not receive payment on such date. Payments by participants
to beneficial owners will be governed by standing instructions
and customary practices, as is the case with securities held for
the accounts of customers in bearer form or registered in
street name, and will be the responsibility of such
participant and not of DTC, the trustee or us, subject to any
statutory or regulatory requirements as may be in effect from
time to time. Any payment due to DTC on behalf of beneficial
owners is our responsibility or the responsibility of the
applicable agent, disbursement of such payments to direct
participants shall be the responsibility of DTC, and
disbursement of such payments to the beneficial owners shall be
the responsibility of direct participants and indirect
participants.
DTC may discontinue providing its services as securities
depositary with respect to the junior subordinated debentures at
any time by giving us or the applicable agent reasonable notice.
Under such circumstances, in the event that a successor
securities depositary is not obtained, offered security
certificates are required to be printed and delivered. We may
decide to discontinue use of the system of book-entry transfers
through DTC (or a successor securities depositary). In that
event, offered security certificates will be printed and
delivered.
About the
Trustee
The Bank of New York Trust Company, N.A. (as successor to
J.P. Morgan Trust Company, National Association) is the
subordinated indenture trustee and will be the principal paying
agent, calculation agent and registrar for the junior
subordinated debentures. We have entered, and from time to time
may continue to enter, into banking or other relationships with
The Bank of New York Trust Company, N.A. or its affiliates.
The trustee may resign or be removed with respect to one or more
series of debt securities under the subordinated indenture, and
a successor trustee may be appointed to act with respect to such
series.
S-55
DESCRIPTION
OF THE REPLACEMENT CAPITAL COVENANT
We have summarized below certain terms of the replacement
capital covenant. This summary is not a complete description of
the replacement capital covenant and is subject to and qualified
in its entirely by the terms and provisions of the full
document, which is available from us upon request, and a copy of
which will be filed with the SEC as an exhibit to a current
report on
Form 8-K.
References to we, us and our
in the following description refer only to MetLife, Inc. and not
any of its subsidiaries.
We will covenant in a replacement capital covenant for the
benefit of persons that buy, hold or sell a specified series of
our long-term indebtedness that ranks senior to the junior
subordinated debentures that we will not repay, redeem or
purchase, and will cause our subsidiaries not to repay, redeem
or purchase, the junior subordinated debentures on or before
December 15, 2056, except to the extent that the principal
amount repaid or the applicable redemption, repayment or
purchase price does not exceed the sum of the applicable
percentage of the aggregate amount of net cash proceeds
received by us and our subsidiaries since the most recent
measurement date (without double counting proceeds
received in any prior measurement period) from the
sale of our common stock, rights to acquire our common stock,
mandatorily convertible preferred stock, debt exchangeable for
equity and qualifying capital securities (collectively,
replacement capital securities), mandatorily
convertible preferred stock, debt exchangeable for
equity and qualifying capital securities to
persons other than us and our subsidiaries.
Our covenants in the replacement capital covenant run only to
the benefit of holders of the covered debt. The
replacement capital covenant is not intended for the benefit of
holders of the junior subordinated debentures and may not be
enforced by them, and the replacement capital covenant is not a
term of the subordinated indenture or the junior subordinated
debentures, except that we will agree in the subordinated
indenture that we will not amend the replacement capital
covenant to impose additional restrictions on the type or amount
of qualifying capital securities that we may include for
purposes of determining when repayment, redemption or purchase
of the junior subordinated debentures is permitted, except with
the consent of the holders of a majority in principal amount of
the junior subordinated debentures. The initial series of
covered debt is our 5.70% senior notes due 2035 (the
initial covered debt). The replacement capital
covenant includes provisions requiring us to redesignate a new
series of indebtedness if the covered debt approaches maturity,
becomes subject to a redemption notice or is reduced to less
than $100 million in outstanding principal amount, subject
to additional procedures. We expect that, at all times prior to
December 15, 2056, we will be subject to the replacement
capital covenant and, accordingly, will be restricted in our
ability to repay, redeem or purchase the junior subordinated
debentures.
Our ability to raise proceeds from the replacement capital
securities during the applicable measurement period with respect
to any proposed repayment, redemption or purchase of the junior
subordinated debentures will depend on, among other things,
market conditions at that time as well as the acceptability to
prospective investors of the terms of those replacement capital
securities.
We may amend or supplement the replacement capital covenant from
time to time with the consent of the holders of at least a
majority in principal amount of the then-effective series of
covered debt. We may, acting alone and without the consent of
the holders of the covered debt (the covered
debtholders), amend or supplement the replacement capital
covenant if (i) the effect of such amendment or supplement
is solely to impose additional restrictions on the types of
securities qualifying as replacement capital securities, and one
of our officers has delivered to the holders of the
then-effective series of covered debt in the manner provided for
in the indenture, fiscal agency agreement or other instrument
with respect to such covered debt a written certificate to that
effect, (ii) such amendment or supplement is not adverse to
the covered debtholders and one of our officers has delivered to
the holders of the then-effective series of covered debt in the
manner provided for in the indenture, fiscal agency agreement or
other instrument with respect to such covered debt a written
certificate stating that, in his or her determination, such
amendment or supplement is not adverse to such covered
debtholders, (iii) such amendment or supplement eliminates
common stock
and/or
mandatorily convertible preferred stock as
replacement capital securities if, in the case of this
clause (iii), we have been advised in writing by a
nationally recognized independent accounting firm that there is
more than an insubstantial risk that the failure to do so would
result in a reduction in our earnings per share as calculated
for financial reporting purposes.
The replacement capital covenant will terminate upon the
earliest to occur of (i) December 15, 2056, or, if
earlier, the date on which the junior subordinated debentures
are otherwise repaid, redeemed or purchased in full,
S-56
(ii) the date, if any, on which the holders of a majority
in principal amount of the then-effective specified series of
covered debt consent or agree to the termination of the
replacement capital covenant and our obligations thereunder,
(iii) the date on which we cease to have any series of
outstanding eligible senior debt or eligible
subordinated debt (in each case, without giving effect to
the rating requirement in clause (b) of the definition of
each such term) and (iv) the date on which an event of
default under the subordinated indenture resulting in an
acceleration of the junior subordinated debentures occurs.
If we are obligated to sell replacement capital securities and
apply the net proceeds to payments of principal of or interest
on any outstanding securities in addition to the junior
subordinated debentures, then on any date and for any period the
amount of net proceeds received by us from those sales and
available for such payments shall be applied to the junior
subordinated debentures and those other securities having the
same scheduled repayment date or scheduled redemption date as
the junior subordinated debentures pro rata in accordance with
their respective outstanding principal amounts (but taking into
account any other payments made on such other securities from
other sources of funds) and none of such net proceeds shall be
applied to any other securities having a later scheduled
repayment date or scheduled redemption date until the principal
of and all accrued and unpaid interest on the junior
subordinated debentures has been paid in full.
For the avoidance of doubt, any reference in this section
Description of the Replacement Capital Covenant to
any repayment of our securities will be deemed to include a
reference to defeasance of our obligations under such securities.
Applicable percentage means:
|
|
|
|
|
in the case of any common stock or rights to acquire common
stock, 100 divided by (a) 75% with respect to any
repayment, redemption or purchase prior to December 15,
2036, (b) 50% with respect to any repayment, redemption or
purchase on or after December 15, 2036 and prior to
December 15, 2046 and (c) 25% with respect to any
repayment, redemption or purchase on or after December 15,
2046 (for example, prior to December 15, 2036, the
applicable percentage in the case of such securities will be
133.33%);
|
|
|
|
in the case of any mandatorily convertible preferred stock or
debt exchangeable for equity, 75 divided by (a) 75% with
respect to any repayment, redemption or purchase prior to
December 15, 2036, (b) 50% with respect to any
repayment, redemption or purchase on or after December 15,
2036 and prior to December 15, 2046 and (c) 25% with
respect to any repayment, redemption or purchase on or after
December 15, 2046 (for example, on or after
December 15, 2036 and prior to December 15, 2046, the
applicable percentage in the case of such securities will be
150%);
|
|
|
|
in the case of any qualifying capital securities described in
first bullet point of the definition of that term, 75 divided by
(a) 75% with respect to any repayment, redemption or
purchase prior to December 15, 2036, (b) 50% with
respect to any repayment, redemption or purchase on or after
December 15, 2036 and prior to December 15, 2046 and
(c) 25% with respect to any repayment, redemption or
purchase on or after December 15, 2046 (for example, after
December 15, 2046, the applicable percentage in the case of
such securities will be 300%);
|
|
|
|
in the case of any qualifying capital securities described in
the second bullet point of the definition of that term, 50
divided by (a) 50% with respect to any repayment,
redemption or purchase on or after December 15, 2036 and
prior to December 15, 2046, and (b) 25% with respect
to any repayment, redemption or purchase on or after
December 15, 2046 (for example, after December 15,
2046, the applicable percentage in the case of such securities
will be 200%); and
|
|
|
|
in the case of any qualifying capital securities described in
the third bullet point of the definition of that term, 100%.
|
Covered debt means (a) at the date of the
replacement capital covenant and continuing to but not including
the first redesignation date, the initial covered debt and
(b) thereafter, commencing with each redesignation date and
continuing to but not including the next succeeding
redesignation date, the eligible subordinated debt or, if no
eligible subordinated debt is then outstanding, eligible senior
debt, identified pursuant to the replacement capital covenant as
the covered debt for such period.
S-57
Debt exchangeable for equity means a security or
combination of securities (together in this definition,
such securities) that:
|
|
|
|
|
gives the holder a beneficial interest in (a) our
subordinated debt securities that include a provision requiring
us to issue (or use commercially reasonable efforts to issue)
one or more types of APM qualifying securities raising proceeds
at least equal to the deferred distributions on such
subordinated debt securities commencing not later than two years
after initial issuance of such securities and that are our most
junior subordinated debt (or rank pari passu with our
most junior subordinated debt) (in this definition, our
subordinated debt) and (b) a fractional
interest in a stock purchase contract for a share of our
non-cumulative perpetual preferred stock that ranks pari
passu with or junior to all of our other preferred stock (in
this definition, our preferred stock);
|
|
|
|
provides that the investors directly or indirectly grant to us a
security interest in such subordinated debt securities and their
proceeds (including any substitute collateral permitted under
the transaction documents) to secure the investors direct
or indirect obligation to purchase our preferred stock pursuant
to such stock purchase contracts;
|
|
|
|
includes a remarketing feature pursuant to which our
subordinated debt is remarketed to new investors commencing not
later than the first distribution date that is at least five
years after the date of issuance of securities or earlier in the
event of an early settlement event based on (a) our capital
ratios as anticipated by any applicable governmental authority
or (b) one or more financial tests set forth in the terms
of such securities or related transaction agreements;
|
|
|
|
provides for the proceeds raised in the remarketing to be used
to purchase our preferred stock under the stock purchase
contracts and, if there has not been a successful remarketing by
the first distribution date that is six years after the date of
issuance of such securities, provides that the stock purchase
contracts will be settled by us foreclosing on our subordinated
debt securities or other collateral directly or indirectly
pledged by investors in the debt exchangeable for equity;
|
|
|
|
includes a replacement capital covenant substantially similar to
the replacement capital covenant that will apply to such
securities and to our preferred stock, and will not include debt
exchangeable for equity as a replacement security; and
|
|
|
|
after the issuance of such preferred stock, provides the holders
of such securities with a beneficial interest in our preferred
stock.
|
Mandatorily convertible preferred stock means
cumulative preferred stock with (a) no prepayment
obligation on the part of the issuer thereof, whether at the
election of the holders or otherwise, and (b) a requirement
that such cumulative preferred stock convert into common stock
within three years from the date of its issuance at a conversion
ratio within a range established at the time of issuance of such
cumulative preferred stock.
Measurement date means: (a) with respect to any
repayment, redemption or purchase of junior subordinated
debentures on or prior to the scheduled redemption date, the
date that is 180 days; and (b) with respect to any
repayment, redemption or purchase of junior subordinated
debentures after the scheduled redemption date, the date that is
90 days, in each case prior to delivery of notice of such
repayment or redemption or prior to the date of such repayment,
redemption or purchase.
Measurement period means the period from a
measurement date to the related notice date or repurchase date.
Measurement periods cannot run concurrently.
Qualifying capital securities means securities
(other than common stock, rights to acquire common stock,
mandatorily convertible preferred stock and debt exchangeable
for equity) that, in the determination of our board of
S-58
directors reasonably construing the definitions and other terms
of the replacement capital covenant, meet one of the following
criteria:
|
|
|
|
|
in connection with any repayment, redemption or purchase of
junior subordinated debentures on or prior to December 15,
2036:
|
|
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) have no maturity or a maturity of at least
60 years and (c) either (x) are subject to a
replacement capital covenant substantially similar to the
replacement capital covenant and have either a no payment
provision or are non-cumulative or (y) have a mandatory
trigger provision and are subject to intent-based replacement
disclosure and have either an optional deferral provision or a
no payment provision; or
|
|
|
|
preferred stock issued by us or our subsidiaries that
(a) is non-cumulative, (b) has no prepayment
obligation on the part of the issuer thereof, whether at the
election of the holders or otherwise, (c) has no maturity
or a maturity of at least 60 years and (d) either
(x) is subject to a replacement capital covenant
substantially similar to the replacement capital covenant or
(y) has a mandatory trigger provision and is subject to
intent-based replacement disclosure; or
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu or junior to other preferred stock of the
issuer, (b) have no maturity or a maturity of at least
40 years, (c) are subject to a replacement capital
covenant substantially similar to the replacement capital
covenant, (d) have an optional deferral provision and
(e) have a mandatory trigger provision; or
|
|
|
|
|
|
in connection with any repayment, redemption or purchase of
junior subordinated debentures at any time after
December 15, 2036 but on or prior to December 15, 2046:
|
|
|
|
|
|
all securities that would be qualifying capital securities prior
to December 15, 2036;
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) have no maturity or a maturity of at least
60 years, (c) are subject to a replacement capital
covenant substantially similar to the replacement capital
covenant and (d) have an optional deferral provision;
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) are non-cumulative or have a no payment provision and
(c) (x) have no maturity or a maturity of at least
60 years and (y) are subject to intent-based
replacement disclosure;
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) are non-cumulative or have a no payment provision,
(c) have no maturity or a maturity of at least
40 years and (d) are subject to a replacement capital
covenant substantially similar to the replacement capital
covenant;
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) have an optional deferral provision, (c) have a
mandatory trigger provision and (d) have no maturity or a
maturity of at least 60 years;
|
|
|
|
cumulative preferred stock issued by us or our subsidiaries that
(a) has no prepayment obligation on the part of the issuer
thereof, whether at the election of the holders or otherwise,
and (b) (x) has no maturity or a maturity of at least
60 years and (y) is subject to a replacement capital
covenant substantially similar to the replacement capital
covenant; or
|
|
|
|
other securities issued by us or our subsidiaries that
(a) rank upon our liquidation, dissolution or
winding-up
either (x) pari passu with or junior to the junior
subordinated debentures or (y) pari passu with the
claims of our trade creditors and junior to all of our long-term
indebtedness for money borrowed (other than our long-term
indebtedness for money borrowed from time to time outstanding
that by its terms ranks pari passu with such securities
on our liquidation, dissolution or
winding-up),
(b) have an optional deferral provision or a no payment
provision and (c) have a mandatory trigger provision and
(d) either
|
S-59
|
|
|
|
|
(x) have no maturity or a maturity of at least
40 years and intent-based replacement disclosure or
(y) have no maturity or a maturity of at least
25 years and are subject to a replacement capital covenant
substantially similar to the replacement capital
covenant; or
|
|
|
|
|
|
in connection with any repayment, redemption or purchase of
junior subordinated debentures at any time after
December 15, 2046:
|
|
|
|
|
|
all securities that would be qualifying capital securities after
December 15, 2036; but on or prior to December 15,
2046;
|
|
|
|
preferred stock issued by us that (a) (x) has no
maturity or a maturity of at least 50 years and (y) is
subject to intent-based replacement disclosure and (b) is
non-cumulative;
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) either (x) have no maturity or a maturity of at
least 60 years and are subject to intent-based replacement
disclosure or (y) have no maturity or a maturity at least
30 years and are subject to a replacement capital covenant
substantially similar to the replacement capital covenant and
(c) are non-cumulative;
|
|
|
|
securities issued by us or our subsidiaries that (a) rank
pari passu with or junior to the junior subordinated
debentures upon our liquidation, dissolution or winding up,
(b) have an optional deferral provision, (c) have a
mandatory trigger provision and (d) (x) have no
maturity or a maturity at least 30 years and (y) are
subject to intent-based replacement disclosure; or
|
|
|
|
cumulative preferred stock issued by us or our subsidiaries that
either (a) (x) has no maturity or a maturity of at
least 60 years and (y) are subject to intent-based
replacement disclosure or (b) has a maturity of at least
40 years and is subject to a replacement capital covenant
substantially similar to the replacement capital covenant.
|
For purposes of the definitions provided above, the following
terms shall have the following meanings:
Alternative payment mechanism means, with respect to
any securities or combination of securities (together in this
definition, such securities), provisions in the
related transaction documents requiring us to issue (or use
commercially reasonable efforts to issue) one or more types of
APM qualifying securities raising eligible proceeds at least
equal to the deferred distributions on such securities and apply
the proceeds to pay unpaid distributions on such securities,
commencing on the earlier of (x) the first distribution
date after commencement of a deferral period on which we pay
current distributions on such securities and (y) the fifth
anniversary of the commencement of such deferral period, and
that:
|
|
|
|
|
define eligible proceeds to mean, for purposes of
such alternative payment mechanism, the net proceeds (after
underwriters or placement agents fees, commissions
or discounts and other expenses relating to the issuance or sale
of the relevant securities, where applicable, and including the
fair market value of property received by us or any of our
subsidiaries as consideration for such securities) that we have
received during the 180 days prior to the related
distribution date from the issuance of APM qualifying
securities, up to the preferred cap (as defined below) in the
case of APM qualifying securities that are qualifying
non-cumulative perpetual preferred stock;
|
|
|
|
permit us to pay current distributions on any distribution date
out of any source of funds but (x) require us to pay
deferred distributions only out of eligible proceeds and
(y) prohibit us from paying deferred distributions out of
any source of funds other than eligible proceeds, unless (if we
elect to so provide in the terms of such securities) an
applicable governmental authority directs otherwise;
|
|
|
|
if deferral of distributions continues for more than one year
(unless we elect to provide for a shorter period in the terms of
such securities), require us not to repay, redeem or purchase
any of our securities that on a bankruptcy or liquidation of us
rank pari passu with or junior to such securities until
at least one year after all deferred distributions have been
paid;
|
|
|
|
notwithstanding the foregoing bullet point, if an applicable
governmental authority disapproves the issuers sale of APM
qualifying securities, may (if we elect to so provide in the
terms of such securities) permit us to
|
S-60
|
|
|
|
|
pay deferred distributions from any source without a breach of
our obligations under the transaction documents;
|
|
|
|
|
|
if an applicable governmental authority does not disapprove our
issuance and sale of APM qualifying securities but disapproves
the use of the proceeds thereof to pay deferred distributions,
may (if we elect to so provide in the terms of such securities)
permit us to use such proceeds for other purposes and to
continue to defer distributions without a breach of our
obligations under the transaction documents; and
|
|
|
|
limit our obligation to issue (or use commercially reasonable
efforts to issue) APM qualifying securities up to:
|
|
|
|
|
|
in the case of APM qualifying securities that are common stock
or rights to purchase common stock, an amount from the issuance
thereof pursuant to the alternative payment mechanism (including
at any point in time from all prior issuances thereof pursuant
to the alternative payment mechanism) with respect to deferred
distributions attributable to the first five years of any
deferral period equal to 2% of the product of the average of the
current stock market prices of the common stock on the ten
consecutive trading days ending on the fourth trading day
immediately preceding the date of issuance multiplied by the
total number of issued and outstanding shares of common stock as
of the date of our most recent publicly available consolidated
financial statements (the common cap), provided (and
it being understood) that the common cap shall cease to apply to
such deferral period by a date (as specified in the related
transaction documents) which shall be not later than the ninth
anniversary of the commencement of such deferral period; and
|
|
|
|
in the case of APM qualifying securities that are qualifying
non-cumulative perpetual preferred stock, an amount from the
issuance thereof pursuant to the related alternative payment
mechanism (including at any point in time from all prior
issuances thereof pursuant to such alternative payment
mechanism) equal to 25% of the initial principal or stated
amount of the securities that are the subject of the related
alternative payment mechanism (the preferred cap);
|
|
|
|
provided (and it being understood) that:
|
|
|
|
|
|
we shall not be obligated to issue (or use commercially
reasonable efforts to issue) APM qualifying securities for so
long as a market disruption event has occurred and is continuing;
|
|
|
|
if, due to a market disruption event or otherwise, we are able
to raise and apply some, but not all, of the eligible proceeds
necessary to pay all deferred distributions on any distribution
date, we will apply any available eligible proceeds to pay
accrued and unpaid distributions on the applicable distribution
date in chronological order subject to the common cap and
preferred cap, as applicable; and
|
|
|
|
if we have outstanding more than one class or series of
securities under which we are obligated to sell a type of APM
qualifying securities and apply some part of the proceeds to the
payment of deferred distributions, then on any date and for any
period the amount of net proceeds received by us from those
sales and available for payment of deferred distributions on
such securities shall be applied to such securities on a pro
rata basis in proportion to the total amounts that are due on
such securities, or on such other basis as an applicable
governmental authority may approve.
|
APM qualifying securities means, with respect to an
alternative payment mechanism, one or more of the following (as
designated in the transaction documents for the qualifying
capital securities that include an alternative payment mechanism
or debt exchangeable for equity):
|
|
|
|
|
common stock;
|
|
|
|
rights to purchase common stock; or
|
|
|
|
qualifying non-cumulative perpetual preferred stock;
|
provided (and it being understood) that if the APM
qualifying securities for any alternative payment mechanism
include both common stock and rights to purchase common stock,
such alternative payment mechanism may permit, but need not
require, that we issue rights to purchase common stock.
S-61
Applicable governmental authority means any
regulatory body, administrative agency, or governmental body
having jurisdiction over us or any subsidiary thereof,
including, without limitation, any insurance regulatory
authority and the Federal Reserve Board.
Covered debtholder means each person (whether a
holder or a beneficial owner holding through a participant in a
clearing agency) that buys, holds or sells our long-term
indebtedness for money borrowed during the period that such
long-term indebtedness for money borrowed is covered debt.
Distribution date means, as to any securities or
combination of securities, the dates on which periodic
distributions on such securities are scheduled to be made.
Distribution period means, as to any securities or
combination of securities, each period from and including the
later of the issue date and a distribution date for such
securities to but excluding the next succeeding distribution
date for such securities.
Distributions means, as to a security or combination
of securities, dividends, interest payments or other income
distributions to the holders thereof that are not our
subsidiaries.
Eligible senior debt means, at any time in respect
of any issuer, each series of outstanding long-term indebtedness
for money borrowed of such issuer that (a) upon a
bankruptcy, liquidation, dissolution or
winding-up
of the issuer, ranks most senior among the issuers then
outstanding classes of indebtedness for money borrowed,
(b) is then assigned a rating by at least one NRSRO
(provided that this clause (b) shall apply on a
redesignation date only if on such date the issuer has
outstanding senior long-term indebtedness for money borrowed
that satisfies the requirements of clauses (a),
(c) and (d) that is then assigned a rating by at least
one NRSRO), (c) has an outstanding principal amount of not
less than $100,000,000, and (d) was issued through or with
the assistance of a commercial or investment banking firm or
firms acting as underwriters, initial purchasers or placement or
distribution agents. For purposes of this definition as applied
to securities with a CUSIP number, each issuance of long-term
indebtedness for money borrowed that has (or, if such
indebtedness is held by a trust or other intermediate entity
established directly or indirectly by the issuer, the securities
of such intermediate entity that have) a separate CUSIP number
shall be deemed to be a series of the issuers long-term
indebtedness for money borrowed that is separate from each other
series of such indebtedness.
Eligible subordinated debt means, at any time in
respect of any issuer, each series of the issuers then
outstanding long-term indebtedness for money borrowed that
(a) upon a bankruptcy, liquidation, dissolution or
winding-up
of the issuer, ranks subordinate to the issuers then
outstanding series of indebtedness for money borrowed that ranks
most senior, (b) is then assigned a rating by at least one
NRSRO (provided that this clause (b) shall apply on a
redesignation date only if on such date the issuer has
outstanding subordinated long-term indebtedness for money
borrowed that satisfies the requirements in clauses (a),
(c) and (d) that is then assigned a rating by at least
one NRSRO), (c) has an outstanding principal amount of not
less than $100,000,000, and (d) was issued through or with
the assistance of a commercial or investment banking firm or
firms acting as underwriters, initial purchasers or placement or
distribution agents. For purposes of this definition as applied
to securities with a CUSIP number, each issuance of long-term
indebtedness for money borrowed that has (or, if such
indebtedness is held by a trust or other intermediate entity
established directly or indirectly by the issuer, the securities
of such intermediate entity that have) a separate CUSIP number
shall be deemed to be a series of the issuers long-term
indebtedness for money borrowed that is separate from each other
series of such indebtedness.
Holder means, as to the covered debt then in effect,
each holder of such covered debt as reflected on the securities
register maintained by or on behalf of us with respect to such
covered debt.
Intent-based replacement disclosure means, as to any
security or combination of securities (together in this
definition, securities), that we have publicly
stated our intention, either in the prospectus or other offering
document under which such securities were initially offered for
sale or in filings with the SEC made by us under the Exchange
Act prior to or contemporaneously with the issuance of such
securities, that we, to the extent the securities provide us
with equity credit, will repay, redeem or purchase such
securities only with the proceeds of specified replacement
capital securities that have terms and provisions at the time of
repayment, redemption or purchase that are as or more
equity-like than the securities then being repaid, redeemed or
purchased, raised within 180 days prior to the applicable
repayment, redemption or purchase date.
S-62
Mandatory trigger provision means, as to any
security or combination of securities (together in this
definition, securities), provisions in the terms
thereof or of the related transaction agreements that
(a) require or, at its option in the case of non-cumulative
perpetual preferred stock, permit the issuer of such securities
to make payment of distributions on such securities only
pursuant to the issue and sale of APM qualifying securities,
within no more than two years of a failure to satisfy one or
more financial tests set forth in the terms of such securities
or related transaction agreements, in an amount such that the
net proceeds of such sale are at least equal to the amount of
unpaid distributions on such securities (including without
limitation all deferred and accumulated amounts) and in either
case require the application of the net proceeds of such sale to
pay such unpaid distributions, provided that if the APM
qualifying securities issued and sold are qualifying
non-cumulative perpetual preferred stock, the amount of the net
proceeds of qualifying non-cumulative perpetual preferred stock
which the issuer may apply to pay such distributions pursuant to
such provision may not exceed 25% of the initial liquidation or
principal amount of such securities, (b) if the APM
qualifying securities are common stock or rights to acquire
common stock, prohibit the issuer from repurchasing any common
stock prior to the date that is six months after the issuer
applies the net proceeds of the sales described in
clause (a) above to pay such unpaid distributions, and
(c) upon any liquidation, dissolution, winding up,
reorganization or in connection with any insolvency,
receivership or proceeding under any bankruptcy law with respect
to us, limit the claim of the holders of such securities (other
than non-cumulative perpetual preferred stock) to distributions
that accumulate during a period in which we fail to satisfy one
or more financial tests set forth in the terms of such
securities or related transaction agreements to (x) 25% of
the principal amount of such securities then outstanding in the
case of securities not permitting the issuance and sale pursuant
to the provisions described in clause (a) above of
securities other than common stock or rights to acquire common
stock or (y) two years of accumulated and unpaid
distributions (including compounded amounts thereon) in all
other cases. no remedy other than permitted remedies may arise
by the terms of such securities or related transaction
agreements in favor of the holders of such securities as a
result of the issuers failure to pay distributions because
of the mandatory trigger provision or as a result of the
issuers exercise of its right under an optional deferral
provision until distributions have been deferred for one or more
distribution periods that total together at least ten years.
Market disruption events means the occurrence or
existence of any of the following events or sets of
circumstances:
|
|
|
|
|
trading in securities generally on any national securities
exchange or
over-the-counter
market on which our common stock
and/or our
preferred stock is then listed or traded is suspended or the
settlement of such trading generally is materially disrupted or
minimum prices are established on any such exchange or such
market by the SEC, by such exchange or by any other regulatory
body or governmental body having jurisdiction, and the
establishment of such minimum prices materially disrupts or
otherwise has a material adverse effect on trading in, and the
issuance and sale of, our common stock and/or our preferred
stock;
|
|
|
|
we were required to obtain the consent or approval of our
stockholders, a regulatory body or governmental authority to
issue or sell APM qualifying securities and, after using our
commercially reasonable efforts to obtain such consent or
approval, we fail to obtain such consent or approval;
|
|
|
|
a material disruption or banking moratorium occurs or has been
declared in commercial banking or securities settlement or
clearance services in the United States;
|
|
|
|
there shall have occurred such a material adverse change in
general domestic or international economic, political or
financial conditions, including without limitation as a result
of terrorist activities, or the effect of international
conditions on the financial markets in the United States is
such, as to make it, in our judgment, impracticable to proceed
with the issuance and sale of APM qualifying securities;
|
|
|
|
an event occurs and is continuing as a result of which the
offering document for the offer and sale of APM qualifying
securities would, in our reasonable judgment, contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the
statements therein not misleading and either (1) the
disclosure of that event at such time, in our judgment, would
have a material adverse effect on our business or (2) the
disclosure relates to a previously undisclosed proposed or
pending material business transaction, and we have a bona fide
reason for keeping the same confidential or its disclosure would
impede our ability to consummate such transaction, provided that
no single suspension
|
S-63
|
|
|
|
|
period contemplated by this bullet point may exceed 90
consecutive days and multiple suspension periods contemplated by
this bullet point may not exceed an aggregate of 180 days
in any
360-day
period; or
|
|
|
|
|
|
we reasonably believe that the offering document for the offer
and sale of APM qualifying securities would not be in compliance
with a rule or regulation of the SEC (for reasons other than
those referred to in the bullet point directly above) and we are
unable to comply with such rule or regulation or such compliance
is impracticable, provided that no single suspension period
contemplated by this bullet point may exceed 90 consecutive days
and multiple suspension periods contemplated by this bullet
point may not exceed an aggregate of 180 days in any
360-day
period.
|
The definition of market disruption event as used in
any securities or combination of securities that constitute
qualifying securities may include less than all of the
paragraphs outlined above, as determined by us at the time of
issuance of such securities, and in the case of the first,
second, third and fourth bullet points above, as applicable to a
circumstance where we would otherwise endeavor to issue
preferred stock, shall be limited to circumstances affecting
markets where our preferred stock trades or where a listing for
its trading is being sought.
No payment provision means a provision or provisions
in the transaction documents for securities (referred to in this
definition as such securities) that include the
following:
|
|
|
|
|
an alternative payment mechanism; and
|
|
|
|
an optional deferral provision modified and supplemented from
the general definition of that term to provide that:
|
|
|
|
|
|
the issuer of such securities may, in its sole discretion, or
(if we elect to so provide in the terms of such securities)
shall in response to a directive or order from any applicable
governmental authority defer in whole or in part payment of
distributions on such securities for one or more consecutive
distribution periods of up to five years or, if a market
disruption event has occurred and is continuing, ten years,
without any remedy other than permitted remedies and the
obligations (and limitations on obligations) described in the
definition of alternative payment mechanism
applying; and
|
|
|
|
if we become subject to a bankruptcy, insolvency, receivership
or similar proceeding prior to the redemption or repayment of
such securities, the holders of such securities will have no
claim to any deferred and unpaid distributions exceeding
(x) if the APM qualifying securities include only common
stock or rights to acquire common stock and do not include
qualifying non-cumulative perpetual preferred stock, 25% of the
principal or stated amount of such securities then outstanding
and (y) if the APM qualifying securities include qualifying
non-cumulative perpetual preferred stock, two years of
distributions on such securities; provided, however, that if the
APM qualifying securities include qualifying non-cumulative
perpetual preferred stock and, accordingly,
clause (y) applies, holders of such securities may
have an additional preferred equity claim in respect of deferred
and unpaid distributions which are in excess of two years of
distributions that is senior to our common stock and is or would
be pari passu with any qualifying non-cumulative
preferred stock up to the amount equal to their pro rata shares
of any unused portion of the preferred cap (as defined in the
definition of alternative payment mechanism).
|
Non-cumulative means, with respect to any
securities, that the issuer may elect not to make any number of
periodic distributions without any remedy arising under the
terms of the securities or related agreements in favor of the
holders, other than one or more permitted remedies.
NRSRO means a nationally recognized statistical
rating organization within the meaning of
Rule 15c3-1(c)(2)(vi)(F)
under the Exchange Act.
Optional deferral provision means, as to any
securities, provisions in the terms thereof or of the related
transaction agreements to the effect of either bullet point
below:
|
|
|
|
|
(a) the issuer of such securities may, in its sole
discretion, defer in whole or in part payment of distributions
on such securities for one or more consecutive distribution
periods of up to five years or, if a market disruption event is
continuing, ten years, without any remedy other than permitted
remedies and (b) an
|
S-64
|
|
|
|
|
alternative payment mechanism (provided that such alternative
payment mechanism need not apply during the first five years of
any deferral period and need not include a common cap or
preferred cap); or
|
|
|
|
|
|
the issuer of such securities may, in its sole discretion, defer
in whole or in part payment of distributions on such securities
for one or more consecutive distribution periods up to ten
years, without any remedy other than permitted remedies.
|
Permitted remedies means, with respect to any
securities, one or more of the following remedies:
|
|
|
|
|
rights in favor of the holders of such securities permitting
such holders to elect one or more directors of the issuer
(including any such rights required by the listing requirements
of any stock or securities exchange on which such securities may
be listed or traded); and
|
|
|
|
complete or partial prohibitions preventing the issuer from
paying distributions on or repurchasing common stock or other
securities that rank pari passu with or junior as to
distributions to such securities for so long as distributions on
such securities, including unpaid distributions, remain unpaid.
|
Qualifying non-cumulative perpetual preferred stock
means our non-cumulative preferred shares that rank pari
passu with or junior to all of our other preferred shares,
are perpetual and (a) are subject to a replacement capital
covenant substantially similar to the replacement capital
covenant or (b) are subject to both (i) mandatory
suspension of dividends in the event we breach certain financial
metrics specified within the offering documents, and
(ii) intent-based replacement disclosure. Additionally, in
both (a) and (b) the transaction documents shall provide for no
remedies as a consequence of non-payment of distributions other
than permitted remedies.
Redesignation date means, as to the covered debt in
effect at any time, the earliest of (a) the date that is
two years prior to the final maturity date of such covered debt,
(b) if we elect to redeem or repay, or we or one of our
subsidiaries elects to repurchase, such covered debt either in
whole or in part with the consequence that after giving effect
to such redemption, repayment or repurchase the outstanding
principal amount of such covered debt is less than $100,000,000,
the applicable redemption, repayment or repurchase date and
(c) if such covered debt is not eligible subordinated debt,
the date on which we issue long-term indebtedness for money
borrowed that is eligible subordinated debt.
S-65
MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS
The following is a general discussion of the material
U.S. Federal income tax considerations relating to the
purchase, ownership and disposition of the junior subordinated
debentures. This discussion is based upon the provisions of the
U.S. Internal Revenue Code of 1986, as amended (the
Code), Treasury regulations promulgated thereunder
and administrative and judicial interpretations thereof, all as
in effect on the date hereof, and all of which are subject to
change, possibly with retroactive effect, or to different
interpretation. This discussion only applies to the junior
subordinated debentures that are held as capital
assets, within the meaning of the Code, by a holder (as
defined below) who purchases the junior subordinated debentures
in the initial offering at their issue price (i.e.,
the first price at which a substantial amount of the junior
subordinated debentures are sold to the public).
This discussion is for general information only and does not
address all of the material tax considerations that may be
relevant to a holder in light of its particular circumstances or
to holders subject to special treatment under U.S. Federal
income tax laws (such as banks, insurance companies, tax-exempt
entities, retirement plans, dealers in securities, real estate
investment trusts, regulated investment companies, persons
holding the junior subordinated debentures as part of a
straddle, hedge, conversion
or other integrated transaction, United States holders (as
defined below) whose functional currency is not the
U.S. dollar, former citizens or residents of the United
States and holders who mark securities to market for
U.S. Federal income tax purposes). This discussion does not
address any state, local or foreign tax consequences or any
U.S. Federal estate, gift or alternative minimum tax
consequences.
For purposes of this discussion, a United States
holder is a beneficial owner of a junior subordinated
debenture that is, for U.S. Federal income tax purposes:
|
|
|
|
|
an individual who is a citizen or resident of the United States;
|
|
|
|
a corporation created or organized in or under the laws of the
United States, any state thereof or the District of Columbia;
|
|
|
|
an estate the income of which is subject to U.S. Federal
income taxation regardless of its source; or
|
|
|
|
a trust if either (1) a United States court can exercise
primary supervision over its administration and one or more
United States persons have the authority to control all of its
substantial decisions, or (2) the trust was in existence on
August 20, 1996, was treated as a United States person
prior to such date, and has made a valid election to continue to
be treated as a United States person.
|
For purposes of this discussion, a
non-United
States holder is a beneficial owner of a junior
subordinated debenture that is neither a United States
holder nor an entity treated as a partnership for
U.S. Federal income tax purposes, and holders
refers to United States holders and
non-United
States holders.
If an entity treated as a partnership for U.S. Federal
income tax purposes holds the junior subordinated debentures,
the tax treatment of the partnership and its partners will
generally depend on the status and activities of the partnership
and its partners. A prospective purchaser of the junior
subordinated debentures that is treated as a partnership for
U.S. Federal income tax purposes should consult its own tax
adviser regarding the U.S. Federal income tax
considerations relating to the purchase, ownership and
disposition of the junior subordinated debentures.
Persons considering the purchase of the junior subordinated
debentures should consult their own tax advisers with respect to
the U.S. Federal income tax considerations relating to the
purchase, ownership and disposition of the junior subordinated
debentures in light of their own particular circumstances, as
well as the effect of any state, local, foreign and other tax
laws.
Classification
of the Junior Subordinated Debentures
The determination of whether a security should be classified as
indebtedness or equity for U.S. Federal income tax purposes
requires a judgment based on all relevant facts and
circumstances. There is no statutory, judicial or administrative
authority that directly addresses the U.S. Federal income
tax treatment of securities similar to the
S-66
junior subordinated debentures. Based upon an analysis of the
relevant facts and circumstances, including certain assumptions
and certain representations made by us, Debevoise &
Plimpton LLP, our special tax counsel, will render its opinion
generally to the effect that, although the matter is not free
from doubt, under then applicable law the junior subordinated
debentures will be treated as indebtedness for U.S. Federal
income tax purposes. Such opinion is not binding on the Internal
Revenue Service (IRS) or any court and there can be
no assurance that the IRS or a court will agree with such
opinion. No ruling is being sought from the IRS on any of the
issues discussed herein.
We agree, and by acquiring an interest in a junior subordinated
debenture each beneficial owner of a junior subordinated
debenture agrees, to treat the junior subordinated debentures as
indebtedness for U.S. Federal income tax purposes, and the
remainder of this discussion assumes such treatment, except
where specified.
United
States Holders
Interest
Income and Original Issue Discount
It is expected, and assumed for purposes of this discussion
that, subject to the discussion below, the junior subordinated
debentures will not be issued with original issue discount
(OID) for U.S. Federal income tax purposes.
Treasury regulations provide that the possibility that interest
on the junior subordinated debentures might be deferred could
result in the junior subordinated debentures being treated as
issued with OID, unless the likelihood of such deferral is
remote. We believe that the likelihood of interest deferral,
whether due to an optional deferral or a trigger event, is
remote and therefore that the possibility of such deferral will
not result in the junior subordinated debentures being treated
as issued with OID. Accordingly, interest paid on the junior
subordinated debentures should be taxable to a United States
holder as ordinary interest income at the time it accrues or is
received in accordance with such United States holders
method of accounting for U.S. Federal income tax purposes.
However, no rulings or other interpretations have been issued by
the IRS that address the meaning of the term remote,
as used in the applicable Treasury regulations, and there can be
no assurance that the IRS or a court will agree with our
position.
If the possibility of interest deferral were determined not to
be remote, or if interest were in fact deferred, the junior
subordinated debentures would be treated as issued with OID at
the time of issuance, or at the time of such deferral, as the
case may be, and all stated interest, or if interest is in fact
deferred all stated interest due after such deferral, would be
treated as OID. In such case, a United States holder would be
required to include such stated interest in income as it
accrues, regardless of its regular method of accounting, using a
constant yield method, before such United States holder receives
any payment attributable to such income, and would not
separately report the actual cash payments of interest on the
junior subordinated debentures as taxable income.
Sale,
Exchange, Redemption or Other Disposition of Junior Subordinated
Debentures
Upon the sale, exchange, redemption or other disposition of a
junior subordinated debenture, a United States holder will
generally recognize gain or loss equal to the difference between
the amount realized (less any accrued interest not previously
included in the United States holders income, which will
be taxable as ordinary income) on the sale, exchange, redemption
or other disposition and such United States holders
adjusted tax basis in the junior subordinated debenture.
Assuming that interest payments on the junior subordinated
debentures are not deferred and that the junior subordinated
debentures are not treated as issued with OID, a United States
holders adjusted tax basis in a junior subordinated
debenture generally will be its initial purchase price. If the
junior subordinated debentures are treated as issued with OID, a
United States holders adjusted tax basis in a junior
subordinated debenture generally will be its initial purchase
price, increased by OID previously includible in such United
States holders gross income to the date of disposition and
decreased by payments received on the junior subordinated
debenture since and including the date that the junior
subordinated debenture was treated as issued with OID. That gain
or loss generally will be capital gain or loss and generally
will be long-term capital gain or loss if the junior
subordinated debenture had been held for more than one year. A
United States holder that is an individual is
S-67
generally entitled to preferential treatment for net long-term
capital gains. The ability of a United States holder to deduct
capital losses is limited.
Non-United
States Holders
Subject to the discussion below concerning backup withholding,
the following is a discussion of U.S. Federal income and
withholding tax considerations generally applicable to
non-United
States holders:
(b) although the matter is not free from doubt, payments of
principal, premium and interest (including OID) with respect to
a junior subordinated debenture held by or for a
non-United
States holder will not be subject to U.S. Federal
withholding tax, provided that, in the case of interest,
(i) such
non-United
States holder does not own, actually or constructively, 10% or
more of the total combined voting power of all classes of our
stock entitled to vote, (ii) such
non-United
States holder is not a controlled foreign corporation, within
the meaning of section 957(a) of the Code, that is related,
directly or indirectly, to us through stock ownership, and
(iii) the statement requirement set forth in
section 871(h) or section 881(c) of the Code
(described below) has been fulfilled with respect to such
non-United
States holder; and
(c) a
non-United
States holder will generally not be subject to U.S. Federal
income or withholding tax on gain realized on the sale,
exchange, redemption or other disposition of a junior
subordinated debenture, unless (i) such non United States
holder is an individual who is present in the U.S. for
183 days or more in the taxable year of such sale,
exchange, redemption or other disposition and certain other
conditions are met or (ii) such gain is effectively
connected with the conduct by such
non-United
States holder of a trade or business in the U.S. (in each
case, subject to the provisions of an income tax treaty).
In general, sections 871(h) and 881(c) of the Code require
that, in order to obtain the exemption from U.S. Federal
withholding tax described in paragraph (a) above, the
non-United
States holder must provide a statement to the withholding agent
to the effect that the
non-United
States holder is not a United States person. Such requirement
generally will be fulfilled if the
non-United
States holder certifies on IRS
Form W-8BEN,
under penalties of perjury, that it is not a United States
person and provides its name and address. In the case of junior
subordinated debentures held by a foreign intermediary (other
than a qualified intermediary) or a foreign
partnership (other than a withholding foreign
partnership), the foreign intermediary or partnership, as
the case may be, generally must provide IRS
Form W-8IMY
to the withholding agent with the required attachments,
including an appropriate certification by each beneficial owner.
If, contrary to the opinion of our special tax counsel, the
junior subordinated debentures were treated as equity for
U.S. Federal income tax purposes, payments of interest on
the junior subordinated debentures would generally be subject to
U.S. withholding tax imposed at a rate of 30% or such lower
rate as might be provided for by an applicable income tax treaty.
If a
non-United
States holder is engaged in a trade or business in the United
States, and if amounts (including OID) treated as interest for
U.S. Federal income tax purposes on a junior subordinated
debenture or gain realized on the sale, exchange, redemption or
other disposition of a junior subordinated debenture are
effectively connected with the conduct of such trade or
business, the
non-United
States holder, although generally exempt from U.S. Federal
withholding tax described in paragraph (a) above, will
generally be subject to regular U.S. Federal income tax on
such effectively connected income or gain in the same manner as
if it were a United States holder (subject to the provisions of
an applicable income tax treaty). In lieu of the IRS forms
described above, such non United States holder will be required
to provide IRS
Form W-8ECI
to the withholding agent in order to claim an exemption from
U.S. Federal withholding tax. In addition, if such
non-United
States holder is a corporation, it may be subject to a branch
profits tax equal to 30% (or such lower rate provided by an
applicable tax treaty) of its effectively connected earnings and
profits for the taxable year, subject to certain adjustments.
S-68
Backup
Withholding and Information Reporting
Backup withholding and information reporting requirements
generally apply to interest (including OID), premium and
principal payments made to, and to the proceeds of sales by,
certain non corporate United States holders. A United States
holder not otherwise exempt from backup withholding generally
can avoid backup withholding by providing IRS
Form W-9.
In the case of a non United States holder, backup withholding
and information reporting will not apply to payments on, or
proceeds from the sale, exchange, redemption or other
disposition of, a junior subordinated debenture if the statement
referred to in clause (a)(iii) of the first paragraph under
the heading
Non-United
States Holder has been received. Withholding agents must
nevertheless report to the IRS and to each
non-United
States holder the amount of interest (including OID) paid with
respect to the junior subordinated debentures held by such
non-United
States holder and the rate of withholding (if any) applicable to
such
non-United
States holder. Any amounts withheld under the backup withholding
rules will be allowed as a refund or a credit against the
holders U.S. Federal income tax liability, provided
the required information is furnished to the IRS.
S-69
UNDERWRITING
Subject to the terms and conditions of the underwriting
agreement dated the date of this prospectus supplement, MetLife,
Inc. has agreed to sell to each of the underwriters named below,
severally, and each of the underwriters has severally agreed to
purchase, the principal amount of the junior subordinated
debentures set forth opposite its name below. Goldman,
Sachs & Co., J.P. Morgan Securities Inc. and
Merrill Lynch, Pierce, Fenner & Smith Incorporated will
act as global coordinators and, together with HSBC Securities
(USA) Inc., will act as book-running managers for the offering.
Goldman, Sachs & Co., J.P. Morgan Securities Inc.
and Merrill Lynch, Pierce, Fenner & Smith Incorporated
are representatives of the underwriters.
|
|
|
|
|
|
|
Principal
|
|
|
|
Amount of
|
|
|
|
Junior Subordinated
|
|
Underwriters
|
|
Debentures
|
|
|
Goldman, Sachs & Co.
|
|
$
|
|
|
J.P. Morgan Securities
Inc.
|
|
|
|
|
Merrill Lynch, Pierce,
Fenner & Smith Incorporated
|
|
|
|
|
HSBC Securities (USA) Inc.
|
|
|
|
|
Banc of America Securities, LLC
|
|
|
|
|
Deutsche Bank Securities Inc.
|
|
|
|
|
Lehman Brothers Inc.
|
|
|
|
|
Morgan Stanley & Co.
Incorporated
|
|
|
|
|
Wachovia Capital Markets LLC
|
|
|
|
|
Guzman & Company
|
|
|
|
|
Samuel A. Ramirez & Co.,
Inc.
|
|
|
|
|
Muriel Siebert & Co.,
Inc.
|
|
|
|
|
Toussaint Capital Partners,
LLC
|
|
|
|
|
The Williams Capital Group,
L.P.
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
|
|
|
|
|
|
|
The underwriting agreement provides that the obligations of the
several underwriters to purchase the junior subordinated
debentures offered hereby are subject to approval of certain
legal matters by counsel and to certain other conditions. The
underwriters are committed to take and pay for all of the junior
subordinated debentures being offered, if any are taken. In the
event of default by any underwriter, the underwriting agreement
provides that, in certain circumstances, the purchase
commitments of the non-defaulting underwriters may be increased
or the underwriting agreement may be terminated.
The following table shows the price to investors, underwriting
discounts and proceeds, before expenses, to MetLife, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds, Before
|
|
|
|
Price to
|
|
|
Underwriting
|
|
|
Expenses,
|
|
|
|
Investors(l)
|
|
|
Discount
|
|
|
to MetLife, Inc.
|
|
|
Per Junior Subordinated Debenture
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Plus accrued interest, if any, from December ,
2006. |
The underwriters initially propose to offer the junior
subordinated debentures to the public at the public offering
price set forth on the cover page of this prospectus supplement
and may offer the junior subordinated debentures to certain
dealers at the public offering price less a concession not to
exceed % of the principal amount of
the junior subordinated debentures. Any such dealers may resell
any junior subordinated debentures purchased from the
underwriters to certain other brokers or dealers at a discount
not to exceed % of the principal
amount of the junior subordinated debentures. After the initial
offering of the junior subordinated
S-70
debentures to the public, the offering price and other selling
terms may from time to time be varied by the representatives.
We do not intend to apply for listing of the junior subordinated
debentures on the New York Stock Exchange or any other
securities exchange. The underwriters have advised us that they
intend to make a market for the junior subordinated debentures,
but they have no obligation to do so and may discontinue market
making at any time without providing any notice. No assurance
can be given as to the liquidity of any trading market for the
junior subordinated debentures. In addition to the underwriting
discount above, MetLife, Inc. estimates that its expenses for
this offering will be approximately
$ .
In addition, the underwriters have agreed to reimburse us for
substantially all costs and expenses of this offering.
We have agreed to indemnify the underwriters against certain
liabilities, including liabilities under the Securities Act of
1933, as amended (the Securities Act), or to
contribute to payments which the underwriters may be required to
make in respect of any such liabilities.
In connection with the offering of the junior subordinated
debentures, the representatives may engage in transactions that
stabilize, maintain or otherwise affect the price of the junior
subordinated debentures. Specifically, the representatives may
overallot in connection with the offering of the junior
subordinated debentures, creating a syndicate short position. In
addition, the representatives may bid for, and purchase, junior
subordinated debentures in the open market to cover syndicate
short positions or to stabilize the price of the junior
subordinated debentures. Finally, the representatives may
reclaim selling concessions allowed for distributing the junior
subordinated debentures in the offering of the junior
subordinated debentures, if the representatives repurchase
previously distributed junior subordinated debentures in
syndicate covering transactions, stabilization transactions or
otherwise. Any of these activities may stabilize or maintain the
market price of the junior subordinated debentures above
independent market levels. The representatives are not required
to engage in any of these activities, may end any of them at any
time, and must bring them to an end after a limited period.
In the ordinary course of their respective businesses, the
underwriters and their affiliates have engaged, are engaged, and
may in the future engage, in commercial banking
and/or
investment banking transactions with us and our affiliates for
which they have in the past received, and may in the future
receive, customary fees. Affiliates of some of the lenders under
MetLife, Inc.s credit agreements are acting as
underwriters for this offering.
It is expected that delivery of the junior subordinated
debentures will be made through the facilities of DTC on or
about December , 2006, which is the fifth
business day following the initial sale of the junior
subordinated debentures. Under
Rule 15c6-1
of the Securities Exchange Act of 1934, trades in the secondary
market generally are required to settle in three business days,
unless the parties to any such trade expressly agree otherwise.
Accordingly, purchasers who wish to trade the junior
subordinated debentures prior to the third business day before
the delivery of the junior subordinated debentures will be
required, by virtue of the fact that the junior subordinated
debentures initially will settle on a delayed basis, to agree to
a delayed settlement cycle at the time of any trade to prevent a
failed settlement. Purchasers of the junior subordinated
debentures who wish to make such trades should consult their own
advisors.
S-71
OFFERING
RESTRICTIONS
The junior subordinated debentures are offered for sale in those
jurisdictions in the United States, Asia, Europe and elsewhere
where it is lawful to make such offers. No action has been
taken, or will be taken, which would permit a public offering of
the junior subordinated debentures in any jurisdiction outside
the United States.
Each of the underwriters has severally represented and agreed
that it has not offered, sold or delivered and it will not
offer, sell or deliver, directly or indirectly, any of the
junior subordinated debentures, in or from any jurisdiction
except under circumstances that are reasonably designed to
result in compliance with the applicable laws and regulations
thereof.
European
Economic Area
In relation to each Member State of the European Economic Area
which has implemented the Prospectus Directive (each, a
Relevant Member State), each underwriter has
represented and agreed that with effect from and including the
date on which the Prospectus Directive is implemented in that
Relevant Member State (the Relevant Implementation
Date) it has not made and will not make an offer of junior
subordinated debentures to the public in that Relevant Member
State prior to the publication of a prospectus in relation to
the junior subordinated debentures which has been approved by
the competent authority in that Relevant Member State or, where
appropriate, approved in another Relevant Member State and
notified to the competent authority in that Relevant Member
State, all in accordance with the Prospectus Directive, except
that it may, with effect from and including the Relevant
Implementation Date, make an offer of junior subordinated
debentures to the public in that Relevant Member State at any
time:
|
|
|
|
(a)
|
to legal entities which are authorized or regulated to operate
in the financial markets or, if not so authorized or regulated,
whose corporate purpose is solely to invest in securities;
|
|
|
(b)
|
to any legal entity which has two or more of (1) an average
of at least 250 employees during the last financial year;
(2) a total balance sheet of more than 43,000,000 and
(3) an annual net turnover of more than 50,000,000,
as shown in its last annual or consolidated accounts; or
|
|
|
(c)
|
in any other circumstances which do not require the publication
by us of a prospectus pursuant to Article 3 of the
Prospectus Directive.
|
For the purposes of this provision, the expression an
offer of junior subordinated debentures to the
public in relation to any junior subordinated debentures
in any Relevant Member State means the communication in any form
and by any means of sufficient information on the terms of the
offer and the junior subordinated debentures to be offered so as
to enable an investor to decide to purchase or subscribe the
junior subordinated debentures, as the same may be varied in
that Member State by any measure implementing the Prospectus
Directive in that Member State and the term Prospectus
Directive means Directive 2003/71/EC and includes any
relevant implementing measure in each Relevant Member State.
United
Kingdom
Each underwriter has represented and agreed that:
|
|
|
|
(a)
|
it has only communicated or caused to be communicated and will
only communicate or cause to be communicated an invitation or
inducement to engage in investment activity (within the meaning
of Section 21 of the Financial Services and Markets Act
2000, as amended (the FSMA)) received by it in
connection with the issue or sale of the junior subordinated
debentures in circumstances in which Section 21(1) of the
FSMA does not apply to us; and
|
|
|
(b)
|
it has complied and will comply with all applicable provisions
of the FSMA with respect to anything done by it in relation to
the junior subordinated debentures in, from or otherwise
involving the United Kingdom.
|
S-72
Hong
Kong
The junior subordinated debentures may not be offered or sold by
means of any document other than (i) in circumstances which
do not constitute an offer to the public within the meaning of
the Companies Ordinance (Cap.32, Laws of Hong Kong), or
(ii) to professional investors within the
meaning of the Securities and Futures Ordinance (Cap.571, Laws
of Hong Kong) and any rules made thereunder, or (iii) in
other circumstances which do not result in the document being a
prospectus within the meaning of the Companies
Ordinance (Cap.32, Laws of Hong Kong), and no advertisement,
invitation or document relating to the junior subordinated
debentures may be issued or may be in the possession of any
person for the purpose of issue (in each case whether in Hong
Kong or elsewhere), which is directed at, or the contents of
which are likely to be accessed or read by, the public in Hong
Kong (except if permitted to do so under the laws of Hong Kong)
other than with respect to junior subordinated debentures which
are or are intended to be disposed of only to persons outside
Hong Kong or only to professional investors within
the meaning of the Securities and Futures Ordinance (Cap.571,
Laws of Hong Kong) and any rules made thereunder.
Japan
The junior subordinated debentures have not been and will not be
registered under the Securities and Exchange Law of Japan (the
Securities and Exchange Law) and each underwriter
has agreed that it will not offer or sell any junior
subordinated debentures, directly or indirectly, in Japan or to,
or for the benefit of, any resident of Japan (which term as used
herein means any person resident in Japan, including any
corporation or other entity organized under the laws of Japan),
or to others for re-offering or resale, directly or indirectly,
in Japan or to a resident of Japan, except pursuant to an
exemption from the registration requirements of, and otherwise
in compliance with, the Securities and Exchange Law and any
other applicable laws, regulations and ministerial guidelines of
Japan.
Singapore
This prospectus supplement and the accompanying prospectus have
not been registered as a prospectus with the Monetary Authority
of Singapore. Accordingly, this prospectus supplement and the
accompanying prospectus, and any other document or material in
connection with the offer or sale, or invitation for
subscription or purchase, of the junior subordinated debentures
may not be circulated or distributed, nor may the junior
subordinated debentures be offered or sold, or be made the
subject of an invitation for subscription or purchase, whether
directly or indirectly, to persons in Singapore other than
(i) to an institutional investor under Section 274 of
the Securities and Futures Act, Chapter 289 of Singapore
(the SFA), (ii) to a relevant person, or any
person pursuant to Section 275(1A), and in accordance with
the conditions, specified in Section 275 of the SFA or
(iii) otherwise pursuant to, and in accordance with the
conditions of, any other applicable provision of the SFA.
Where the junior subordinated debentures are subscribed or
purchased under Section 275 by a relevant person which is:
(a) a corporation (which is not an accredited investor) the
sole business of which is to hold investments and the entire
share capital of which is owned by one or more individuals, each
of whom is an accredited investor; or (b) a trust (where
the trustee is not an accredited investor) whose sole purpose is
to hold investments and each beneficiary is an accredited
investor, shares, debentures and units of shares and debentures
of that corporation or the beneficiaries rights and
interest in that trust shall not be transferable for
6 months after that corporation or that trust has acquired
the junior subordinated debentures under Section 275
except: (1) to an institutional investor under
Section 274 of the SFA or to a relevant person, or any
person pursuant to Section 275(1A), and in accordance with
the conditions, specified in Section 275 of the SFA;
(2) where no consideration is given for the transfer; or
(3) by operation of law.
S-73
LEGAL
OPINIONS
The validity of the junior subordinated debentures offered
hereby will be passed upon for MetLife, Inc. by Richard S.
Collins, Chief Counsel General Corporate of MetLife
and by LeBoeuf, Lamb, Greene & MacRae LLP, New York,
New York. Debevoise & Plimpton LLP, which has acted as
special tax counsel for MetLife, Inc., will pass upon certain
U.S. Federal income tax matters for MetLife, Inc.
Mr. Collins is paid a salary by MetLife Group, Inc., is a
participant in various employee benefit plans offered by
MetLife, Inc. and its affiliates to employees generally, holds
MetLife. Inc. common stock and has options to purchase
additional shares of MetLife, Inc. common stock. LeBoeuf, Lamb,
Greene & MacRae LLP maintains various group and other
insurance policies with Metropolitan Life. LeBoeuf, Lamb,
Greene & MacRae LLP has, from time to time,
represented, currently represents, and may continue to
represent, some or all of the underwriters in connection with
various legal matters. Skadden, Arps, Slate, Meagher &
Flom LLP will pass upon certain legal matters for the
underwriters. Skadden, Arps, Slate, Meagher & Flom LLP
has, from time to time, represented, currently represents, and
may continue to represent, us in connection with various legal
matters. Skadden, Arps, Slate, Meagher & Flom LLP
maintains a group life insurance policy and short- and long-term
disability insurance policies with Metropolitan Life. Helene L.
Kaplan and Curtis H. Barnette who are of counsel to Skadden,
Arps, Slate, Meagher & Flom LLP, are directors of
MetLife, Inc. and Metropolitan Life, and serve as chair or
members of certain committees of the boards of directors of
MetLife, Inc. and Metropolitan Life.
S-74
PROSPECTUS
$14,876,994,500
METLIFE,
INC.
DEBT
SECURITIES, PREFERRED STOCK, DEPOSITARY SHARES,
COMMON STOCK, WARRANTS,
PURCHASE CONTRACTS AND UNITS
METLIFE
CAPITAL TRUST II
METLIFE CAPITAL TRUST III
TRUST
PREFERRED SECURITIES
Fully and Unconditionally Guaranteed by MetLife, Inc.,
As Set Forth Herein
MetLife, Inc., MetLife Capital Trust II and MetLife Capital
Trust III will provide the specific terms of these
securities in supplements to this prospectus. You should read
this prospectus and the accompanying prospectus supplement
carefully before you make your investment decision.
THIS PROSPECTUS MAY NOT BE USED TO SELL SECURITIES UNLESS
ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.
MetLife, Inc., MetLife Capital Trust II and MetLife Capital
Trust III may offer securities through underwriting
syndicates managed or co-managed by one or more underwriters,
through agents, or directly to purchasers. The prospectus
supplement for each offering of securities will describe in
detail the plan of distribution for that offering. For general
information about the distribution of securities offered, please
see Plan of Distribution in this prospectus.
MetLife, Inc.s common stock is listed on the New York
Stock Exchange under the trading symbol MET. Unless
otherwise stated in this prospectus or an accompanying
prospectus supplement, none of these securities will be listed
on a securities exchange, other than MetLife, Inc.s common
stock.
None of the Securities and Exchange Commission, any state
securities commission, the New York Superintendent of Insurance
or any other regulatory body has approved or disapproved of
these securities or determined if this prospectus or the
accompanying prospectus supplement is truthful or complete. They
have not made, nor will they make, any determination as to
whether anyone should buy these securities. Any representation
to the contrary is a criminal offense.
The date of this prospectus is April 27, 2005
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
14
|
|
|
|
|
20
|
|
|
|
|
22
|
|
|
|
|
23
|
|
|
|
|
24
|
|
|
|
|
25
|
|
|
|
|
27
|
|
|
|
|
30
|
|
|
|
|
32
|
|
|
|
|
32
|
|
ABOUT
THIS PROSPECTUS
Unless otherwise stated or the context otherwise requires,
references in this prospectus to MetLife,
we, our, or us refer to
MetLife, Inc., together with Metropolitan Life Insurance
Company, and their respective direct and indirect subsidiaries,
while references to MetLife, Inc. refer only to
MetLife, Inc. on an unconsolidated basis. References in this
prospectus to the trusts refer to MetLife Capital
Trust II and MetLife Capital Trust III.
This prospectus is part of a registration statement that
MetLife, Inc., MetLife Capital Trust II and MetLife Capital
Trust III filed with the U.S. Securities and Exchange
Commission (the SEC) using a shelf
registration process. Under this shelf process, MetLife, Inc.
may, from time to time, sell any combination of debt securities,
preferred stock, depositary shares, common stock, warrants,
purchase contracts and units and MetLife Capital Trust II
and MetLife Capital Trust III may, from time to time, sell
trust preferred securities guaranteed by MetLife, Inc., as
described in this prospectus, in one or more offerings up to a
total dollar amount of $14,876,994,500 or the equivalent thereof
on the date of issuance in one or more foreign currencies,
foreign currency units or composite currencies. This prospectus
provides you with a general description of the securities
MetLife, Inc. and the trusts may offer. Each time that
securities are sold, a prospectus supplement that will contain
specific information about the terms of that offering will be
provided. The prospectus supplement may also add, update or
change information contained in this prospectus. You should read
both this prospectus and any prospectus supplement together with
additional information described under the heading Where
You Can Find More Information.
You should rely on the information contained or incorporated by
reference in this prospectus. Neither MetLife, Inc. nor the
trusts have authorized anyone to provide you with different
information. If anyone provides you with different or
inconsistent information, you should not rely on it. Neither
MetLife, Inc. nor the trusts are making an offer to sell these
securities in any jurisdiction where the offer or sale is not
permitted.
You should assume that the information in this prospectus is
accurate as of the date of the prospectus. Our business,
financial condition, results of operations and prospects may
have changed since that date.
WHERE YOU
CAN FIND MORE INFORMATION
MetLife, Inc. files reports, proxy statements and other
information with the SEC. These reports, proxy statements and
other information, including the registration statement of which
this prospectus is a part, can be read and copied at the
SECs public reference room at 450 Fifth Street, N.W.,
Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330
for further information on the operation of the public reference
room. The SEC maintains an internet site at www.sec.gov that
contains reports, proxy and information statements and other
information regarding companies that file electronically with
the SEC, including MetLife, Inc. MetLife, Inc.s common
stock is listed and traded on the New York Stock Exchange. These
reports, proxy statements and other information can also be read
at the offices of the New York Stock Exchange, 11 Wall
Street, New York, New York 10005.
The SEC allows incorporation by reference into this
prospectus of information that MetLife, Inc. files with the SEC.
This permits MetLife, Inc. to disclose important information to
you by referencing these filed documents. Any information
referenced this way is considered part of this prospectus, and
any information filed with the SEC subsequent to the date of
this prospectus will automatically be deemed to update and
supersede this information. Information furnished under
Item 2.02 and Item 7.01 of MetLife, Inc.s
Current Reports on
Form 8-K
is not incorporated by reference in this registration statement
and prospectus. MetLife, Inc. incorporates by reference the
following documents which have been filed with the SEC:
|
|
|
|
|
Registration Statement on Form 8-A, dated March 31,
2000, relating to registration of shares of MetLife, Inc.s
common stock and Registration Statement on Form 8-A, dated
March 31, 2000, relating to registration of MetLife,
Inc.s Series A Junior Participating Preferred Stock
purchase rights;
|
|
|
|
Annual Report on
Form 10-K
for the year ended December 31, 2004; and
|
|
|
|
Current Reports on
Form 8-K
filed February 1, 2005, February 4, 2005,
February 28, 2005, March 15, 2005, March 30,
2005, April 4, 2005, April 15, 2005 and April 22,
2005.
|
MetLife, Inc. incorporates by reference the documents listed
above and any future filings made with the SEC in accordance
with Sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934 until MetLife, Inc.,
1
MetLife Capital Trust II and MetLife Capital Trust III
file a post-effective amendment which indicates the termination
of the offering of the securities made by this prospectus.
MetLife, Inc. will provide without charge upon written or oral
request, a copy of any or all of the documents which are
incorporated by reference into this prospectus, other than
exhibits to those documents, unless those exhibits are
specifically incorporated by reference into those documents.
Requests should be directed to Investor Relations, MetLife,
Inc., 1 MetLife Plaza, Long Island City, New York 11101 by
electronic mail (metir@metlife.com) or by telephone
(212-578-2211). You may also obtain some of the documents
incorporated by reference into this document at MetLifes
website, www.metlife.com. You should be aware that all other
information contained on MetLifes website is not a part of
this document.
SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus and the accompanying prospectus supplement may
contain or incorporate by reference information that includes or
is based upon forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of
future events. You can identify these statements by the fact
that they do not relate strictly to historical or current facts.
They use words such as anticipate,
estimate, expect, project,
intend, plan, believe, and
other words and terms of similar meaning in connection with a
discussion of future operating or financial performance. In
particular, these include statements relating to future actions,
prospective services or products, future performance or results
of current and anticipated services or products, sales efforts,
expenses, the outcome of contingencies such as legal
proceedings, trends in operations and financial results.
Any or all forward-looking statements may turn out to be wrong.
They can be affected by inaccurate assumptions or by known or
unknown risks and uncertainties. Many such factors will be
important in determining MetLifes actual future results.
These statements are based on current expectations and the
current economic environment. They involve a number of risks and
uncertainties that are difficult to predict. These statements
are not guarantees of future performance, and there are no
guarantees about the performance of any securities offered by
this prospectus. Actual results could differ materially from
those expressed or implied in the forward-looking statements.
Among factors that could cause actual results to differ
materially are:
|
|
|
|
|
changes in general economic conditions, including the
performance of financial markets and interest rates;
|
|
|
|
heightened competition, including with respect to pricing, entry
of new competitors and the development of new products by new
and existing competitors;
|
|
|
|
unanticipated changes in industry trends;
|
|
|
|
MetLife, Inc.s primary reliance, as a holding company, on
dividends from its subsidiaries to meet debt payment obligations
and the existence of regulatory restrictions on the ability of
its subsidiaries to pay such dividends;
|
|
|
|
deterioration in the experience of the closed block
established in connection with the reorganization of
Metropolitan Life Insurance Company;
|
|
|
|
catastrophe losses;
|
|
|
|
adverse results from litigation, arbitration or regulatory
investigations;
|
|
|
|
regulatory, accounting or tax changes that may affect the cost
of, or demand for, our products or services;
|
|
|
|
downgrades in our and our affiliates claims paying
ability, financial strength or credit ratings;
|
|
|
|
changes in rating agency policies or practices;
|
|
|
|
discrepancies between actual claims experience and assumptions
used in setting prices for our products and establishing the
liabilities for our obligations for future policy benefits and
claims;
|
|
|
|
discrepancies between actual experience and assumptions used in
establishing liabilities related to other contingencies or
obligations;
|
2
|
|
|
|
|
the effects of business disruption or economic contraction due
to terrorism or other hostilities;
|
|
|
|
our ability to identify and consummate on successful terms any
pending or future acquisitions, including our announced
agreement to acquire Travelers Insurance Company, certain
affiliated companies and substantially all of the international
insurance business of Citigroup Inc., and to successfully
integrate acquired businesses with minimal disruption;
|
|
|
|
other risks and uncertainties described from time to time in
MetLife, Inc.s or the trusts filings with the SEC;
|
|
|
|
the risk factors or uncertainties set forth herein or listed
from time to time in prospectus supplements or any document
incorporated by reference herein; and
|
|
|
|
other risks and uncertainties that have not been identified at
this time.
|
Neither MetLife, Inc. nor the trusts undertake any obligation to
publicly correct or update any forward-looking statement if any
of MetLife, Inc. or the trusts later become aware that it is not
likely to be achieved. You are advised, however, to consult any
further disclosures MetLife, Inc. or the trusts make on related
subjects in reports to the SEC.
METLIFE,
INC.
We are a leading provider of insurance and other financial
services to a broad spectrum of individual and institutional
customers. We offer life insurance, annuities, automobile and
homeowners insurance and mutual funds to individuals, as well as
group insurance, reinsurance, and retirement and savings
products and services to corporations and other institutions. We
serve individuals in approximately 13 million households in
the United States and provide benefits to 37 million
employees and family members through their plan sponsors.
We distribute our products and services nationwide through
multiple channels, with the primary distribution systems being
our core career agency system, our general agency distribution
systems, our regional sales forces, our dedicated sales forces,
financial intermediaries, independent agents and product
specialists. We operate in the international markets that we
serve through subsidiaries and joint ventures. Our international
segment focuses on the Asia/Pacific region and Latin America and
currently has insurance operations in 11 countries serving
approximately 9 million customers.
MetLife, Inc. is incorporated under the laws of the State of
Delaware. MetLife, Inc.s principal executive offices are
located at 200 Park Avenue, New York, New York 10166-0188,
and its telephone number is
212-578-2211.
THE
TRUSTS
MetLife Capital Trust II and MetLife Capital Trust III
are statutory trusts formed on May 17, 2001 under Delaware
law pursuant to declarations of trust between the trustees named
therein and MetLife, Inc. and the filing of certificates of
trust with the Secretary of State of the State of Delaware.
MetLife, Inc., as sponsor of the trusts, and the trustees named
in the declarations of trust will amend and restate the
declarations of trust in their entirety substantially in the
forms which are incorporated by reference as exhibits to the
registration statement of which this prospectus forms a part, as
of or prior to the date the trusts issue any trust preferred
securities. The declarations of trust will be qualified as
indentures under the Trust Indenture Act of 1939.
The trusts exist for the exclusive purposes of:
|
|
|
|
|
issuing preferred securities offered by this prospectus and
common securities to MetLife, Inc.;
|
|
|
|
investing the gross proceeds of the preferred securities and
common securities in related series of debt securities, which
may be senior or subordinated, issued by MetLife, Inc.; and
|
|
|
|
engaging in only those other activities which are necessary,
appropriate, convenient or incidental to the purposes set forth
above.
|
The payment of periodic cash distributions on the trust
preferred securities and payments on liquidation and redemption
with respect to the trust preferred securities, in each case to
the extent the trusts have funds legally and
3
immediately available, will be guaranteed by MetLife, Inc. to
the extent set forth under Description of Guarantees.
MetLife, Inc. will own, directly or indirectly, all of the
common securities of the trusts. The common securities will
represent an aggregate liquidation amount equal to at least 3%
of each trusts total capitalization. The preferred
securities of each trust will represent the remaining 97% of
each trusts total capitalization. The common securities
will have terms substantially identical to, and will rank equal
in priority of payment with, the preferred securities. However,
if MetLife, Inc. defaults on the related series of debt
securities, then cash distributions and liquidation, redemption
and other amounts payable on the common securities will be
subordinate to the trust preferred securities in priority of
payment.
The trusts each have a term of approximately 55 years, but
may dissolve earlier as provided in their respective
declarations of trust. The trusts business and affairs
will be conducted by the trustees appointed by MetLife, Inc., as
the direct or indirect holder of all of the common securities.
The holder of the common securities of each trust will be
entitled to appoint, remove or replace any of, or increase or
reduce the number of, the trustees of the trust. However, the
number of trustees shall be at least two, at least one of which
shall be an administrative trustee. The duties and obligations
of the trustees will be governed by the declaration of trust for
each trust. A majority of the trustees of each trust will be
persons who are employees or officers of or affiliated with
MetLife, Inc. One trustee of each trust will be a financial
institution which will be unaffiliated with MetLife, Inc. and
which will act as property trustee and as indenture trustee for
purposes of the Trust Indenture Act of 1939, pursuant to the
terms set forth in a prospectus supplement. In addition, unless
the property trustee maintains a principal place of business in
the State of Delaware, and otherwise meets the requirements of
applicable law, one trustee of each trust will have its
principal place of business or reside in the State of Delaware.
The property trustee will hold title to the debt securities for
the benefit of the holders of the trust securities and the
property trustee will have the power to exercise all rights,
powers and privileges under the indenture as the holder of the
debt securities. In addition, the property trustee will maintain
exclusive control of a segregated non-interest bearing bank
account to hold all payments made in respect of the debt
securities for the benefit of the holders of the trust
securities. The property trustee will make payments of
distributions and payments on liquidation, redemption and
otherwise to the holders of the trust securities out of funds
from this property account.
The rights of the holders of the trust preferred securities,
including economic rights, rights to information and voting
rights, are provided in the declarations of trust of MetLife
Capital Trust II and MetLife Capital Trust III,
including any amendments thereto, the trust preferred
securities, the Delaware Statutory Trust Act and the Trust
Indenture Act.
MetLife, Inc. will pay all fees and expenses related to the
trusts and the offering of trust preferred securities. The
principal offices of each trust is: c/o Chase Bank USA,
National Association, 500 Stanton Christiana Road,
3rd Floor/OPS4, Newark, Delaware 19713, Attention:
Institutional Trust Services. The telephone number of each
trust is:
302-552-6279.
For financial reporting purposes,
|
|
|
|
|
the trusts will not be treated as MetLife, Inc.s
subsidiaries; and
|
|
|
|
the accounts of the trusts will not be included in MetLife,
Inc.s consolidated financial statements.
|
In January 2003, the Financial Accounting Standards Board issued
Interpretation No. 46 (FIN 46),
Consolidation of Variable Interest Entities, and, in December
2003, issued Revised Interpretation No. 46
(FIN 46R), Consolidation of Variable Interest
Entities, which amended FIN 46. Prior to the issuance of
FIN 46 and FIN 46R, issuer trusts that issued capital
securities were generally consolidated by their parent
companies. Under FIN 46 and FIN 46R, MetLifes
issuer trusts will no longer be consolidated. MetLife, Inc. is a
bank holding company, subject to the rules and regulations of
the Board of Governors of the Federal Reserve System regarding
capital treatment of trust preferred securities. On
March 1, 2005, the Federal Reserve Board adopted a final
rule that allows the continued inclusion of trust preferred
securities in the Tier 1 capital of bank holding companies.
Please read the prospectus supplement relating to the trust
preferred securities for further information concerning the
trusts and the trust preferred securities.
4
USE OF
PROCEEDS
We may use the proceeds of securities sold under this
registration statement for, among other things, general
corporate purposes and to finance a portion of the purchase
price of MetLifes proposed acquisition of the life
insurance and annuity operations commonly known as Travelers
Life & Annuity and certain international insurance
businesses from Citigroup Inc. The prospectus supplement for
each offering of securities will specify the intended use of the
proceeds of that offering. The trusts will use all of the
proceeds they receive from the sale of trust preferred
securities to purchase debt securities issued by MetLife, Inc.
RATIO OF
EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed
charges.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
2001
|
|
|
2000
|
|
|
Ratio of Earnings to Fixed
Charges(1)
|
|
|
2.09
|
|
|
|
1.78
|
|
|
|
1.53
|
|
|
|
1.14
|
|
|
|
1.32
|
|
|
|
(1) |
For purposes of this computation, earnings are defined as income
from continuing operations before provision for income taxes
excluding undistributed income and losses from equity method
investments, minority interest and fixed charges. Fixed charges
are the sum of interest and debt issue costs, interest credited
to policyholder account balances, interest on bank deposits and
an estimated interest component of rent expense. As of the date
of this prospectus, there is no preferred stock outstanding and
accordingly, the ratio of earnings to fixed charges and
preferred stock dividends is equal to the ratio of earnings to
fixed charges and is not disclosed separately.
|
DESCRIPTION
OF SECURITIES
This prospectus contains summary descriptions of the debt
securities, preferred stock, depositary shares, common stock,
warrants, purchase contracts and units that MetLife, Inc. may
sell from time to time, and the trust preferred securities
guaranteed by MetLife, Inc. that MetLife Capital Trust II
and MetLife Capital Trust III may sell from time to time.
These summary descriptions are not meant to be complete
descriptions of each security. However, this prospectus and the
accompanying prospectus supplement contain the material terms of
the securities being offered.
DESCRIPTION
OF DEBT SECURITIES
As used in this prospectus, debt securities means the
debentures, notes, bonds and other evidences of indebtedness
that MetLife, Inc. may issue from time to time. The debt
securities will either be senior debt securities or subordinated
debt securities. Unless the applicable prospectus supplement
states otherwise, senior debt securities will be issued under
the Senior Indenture dated as of November 9, 2001 between
us and Bank One Trust Company, N.A. (predecessor to
J.P. Morgan Trust Company, National Association) (the
Senior Indenture) and subordinated debt securities
will be issued under a Subordinated Indenture to be
entered into with J.P. Morgan Trust Company, National
Association. This prospectus sometimes refers to the Senior
Indenture and the Subordinated Indenture collectively as the
Indentures.
The Senior Indenture and form of Subordinated Indenture are
incorporated by reference as exhibits to the registration
statement of which this prospectus forms a part. The statements
and descriptions in this prospectus or in any prospectus
supplement regarding provisions of the Indentures and debt
securities are summaries thereof, do not purport to be complete
and are subject to, and are qualified in their entirety by
reference to, all of the provisions of the Indentures and the
debt securities, including the definitions therein of certain
terms.
The debt securities will be direct unsecured obligations of
MetLife, Inc. The senior debt securities will rank equally with
all of MetLife, Inc.s other senior and unsubordinated
debt. The subordinated debt securities will be subordinate and
junior in right of payment to all of MetLife, Inc.s
present and future senior indebtedness.
5
Because MetLife, Inc. is principally a holding company, its
right to participate in any distribution of assets of any
subsidiary, including Metropolitan Life Insurance Company, upon
the subsidiarys liquidation or reorganization or
otherwise, is subject to the prior claims of creditors of the
subsidiary, except to the extent MetLife, Inc. may be recognized
as a creditor of that subsidiary. Accordingly, MetLife,
Inc.s obligations under the debt securities will be
effectively subordinated to all existing and future indebtedness
and liabilities of its subsidiaries, including liabilities under
contracts of insurance and annuities written by MetLife,
Inc.s insurance subsidiaries, and holders of debt
securities should look only to MetLife, Inc.s assets for
payment thereunder.
The Indentures do not limit the aggregate principal amount of
debt securities that MetLife, Inc. may issue and provide that
MetLife, Inc. may issue debt securities from time to time in one
or more series, in each case with the same or various
maturities, at par or at a discount. MetLife, Inc. may issue
additional debt securities of a particular series without the
consent of the holders of the debt securities of such series
outstanding at the time of the issuance. Any such additional
debt securities, together with all other outstanding debt
securities of that series, will constitute a single series of
debt securities under the applicable Indenture. The Indentures
also do not limit our ability to incur other debt.
Each prospectus supplement will describe the terms relating to
the specific series of debt securities being offered. These
terms will include some or all of the following:
|
|
|
|
|
the title of debt securities and whether they are subordinated
debt securities or senior debt securities;
|
|
|
|
any limit on the aggregate principal amount of the debt
securities;
|
|
|
|
the price or prices at which MetLife, Inc. will sell the debt
securities;
|
|
|
|
the maturity date or dates of the debt securities;
|
|
|
|
the rate or rates of interest, if any, which may be fixed or
variable, per annum at which the debt securities will bear
interest, or the method of determining such rate or rates, if
any;
|
|
|
|
the date or dates from which any interest will accrue, the dates
on which interest will be payable, or the method by which such
date or dates will be determined;
|
|
|
|
the right, if any, to extend the interest payment periods and
the duration of any such deferral period, including the maximum
consecutive period during which interest payment periods may be
extended;
|
|
|
|
whether the amount of payments of principal of (and premium, if
any) or interest on the debt securities may be determined with
reference to any index, formula or other method, such as one or
more currencies, commodities, equity indices or other indices,
and the manner of determining the amount of such payments;
|
|
|
|
the dates on which MetLife, Inc. will pay interest on the debt
securities and the regular record date for determining who is
entitled to the interest payable on any interest payment date;
|
|
|
|
the place or places where the principal of (and premium, if any)
and interest on the debt securities will be payable;
|
|
|
|
if MetLife, Inc. possesses the option to do so, the periods
within which and the prices at which MetLife, Inc. may redeem
the debt securities, in whole or in part, pursuant to optional
redemption provisions, and the other terms and conditions of any
such provisions;
|
|
|
|
MetLife, Inc.s obligation, if any, to redeem, repay or
purchase debt securities by making periodic payments to a
sinking fund or through an analogous provision or at the option
of holders of the debt securities, and the period or periods
within which and the price or prices at which MetLife, Inc. will
redeem, repay or purchase the debt securities, in whole or in
part, pursuant to such obligation, and the other terms and
conditions of such obligation;
|
|
|
|
the denominations in which the debt securities will be issued,
if other than denominations of $1,000 and integral multiples of
$1,000;
|
6
|
|
|
|
|
the portion, or methods of determining the portion, of the
principal amount of the debt securities which MetLife, Inc. must
pay upon the acceleration of the maturity of the debt securities
in connection with an Event of Default (as described below), if
other than the full principal amount;
|
|
|
|
the currency, currencies or currency unit in which MetLife, Inc.
will pay the principal of (and premium, if any) or interest, if
any, on the debt securities, if not United States dollars and
the manner of determining the equivalent thereof in United
States dollars;
|
|
|
|
provisions, if any, granting special rights to holders of the
debt securities upon the occurrence of specified events;
|
|
|
|
any deletions from, modifications of or additions to the Events
of Default or MetLife, Inc.s covenants with respect to the
applicable series of debt securities, and whether or not such
Events of Default or covenants are consistent with those
contained in the applicable Indenture;
|
|
|
|
the application, if any, of the terms of the Indenture relating
to defeasance and covenant defeasance (which terms are described
below) to the debt securities;
|
|
|
|
whether the subordination provisions summarized below or
different subordination provisions will apply to the debt
securities;
|
|
|
|
the terms, if any, upon which the holders may or are required to
convert or exchange such debt securities into or for MetLife,
Inc.s common stock or other securities or property or into
Securities of a third party, including conversion price (which
may be adjusted), the method of calculating the conversion
price, or the conversion period;
|
|
|
|
whether any of the debt securities will be issued in global or
certificated form and, if so, the terms and conditions upon
which global debt securities may be exchanged for certificated
debt securities;
|
|
|
|
any change in the right of the trustee or the requisite holders
of debt securities to declare the principal amount thereof due
and payable because of an Event of Default;
|
|
|
|
the depositary for global or certificated debt securities;
|
|
|
|
if applicable, a discussion of the U.S. federal income tax
considerations applicable to specific debt securities;
|
|
|
|
any trustees, authenticating or paying agents, transfer agents
or registrars or other agents with respect to the debt
securities;
|
|
|
|
any other terms of the debt securities not inconsistent with the
provisions of the Indentures, as amended or supplemented.
|
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will not be listed on any
securities exchange.
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will be issued in fully
registered form without coupons.
Debt securities may be sold at a substantial discount below
their stated principal amount, bearing no interest or interest
at a rate which at the time of issuance is below market rates.
The applicable prospectus supplement will describe the federal
income tax consequences and special considerations applicable to
any such debt securities. The debt securities may also be issued
as indexed securities or securities denominated in foreign
currencies or currency units, as described in more detail in the
prospectus supplement relating to any of the particular debt
securities. The prospectus supplement relating to specific debt
securities will also describe any special considerations and
certain additional tax considerations applicable to such debt
securities.
The prospectus supplement relating to any offering of
subordinated debt securities will describe the specific
subordination provisions. However, unless otherwise noted in the
prospectus supplement, subordinated debt
7
securities will be subordinate and junior in right of payment to
all of MetLife, Inc.s Senior Indebtedness (as described
below).
Under the Subordinated Indenture, Senior
Indebtedness means all amounts due on obligations in
connection with any of the following, whether outstanding at the
date of execution of the Subordinated Indenture or thereafter
incurred or created:
|
|
|
|
|
the principal of (and premium, if any) and interest in respect
of indebtedness of MetLife, Inc. for borrowed money and
indebtedness evidenced by securities, debentures, bonds or other
similar instruments issued by MetLife, Inc.;
|
|
|
|
all capital lease obligations of MetLife, Inc.;
|
|
|
|
all obligations of MetLife, Inc. issued or assumed as the
deferred purchase price of property, all conditional sale
obligations of MetLife, Inc. and all obligations of MetLife,
Inc. under any title retention agreement (but excluding trade
accounts payable in the ordinary course of business);
|
|
|
|
all obligations of MetLife, Inc. for the reimbursement on any
letter of credit, bankers acceptance, security purchase
facility or similar credit transaction;
|
|
|
|
all obligations of MetLife, Inc. in respect of interest rate
swap, cap or other agreements, interest rate future or options
contracts, currency swap agreements, currency future or option
contracts and other similar agreements;
|
|
|
|
all obligations of the types referred to above of other persons
for the payment of which MetLife, Inc. is responsible or liable
as obligor, guarantor or otherwise; and
|
|
|
|
all obligations of the types referred to above of other persons
secured by any lien on any property or asset of MetLife, Inc.
whether or not such obligation is assumed by MetLife, Inc.
|
Senior Indebtedness does not include:
|
|
|
|
|
indebtedness or monetary obligations to trade creditors created
or assumed by MetLife, Inc. in the ordinary course of business
in connection with the obtaining of materials or services;
|
|
|
|
indebtedness that is, by its terms, subordinated to, or ranks
equal with, the subordinated debt securities; and
|
|
|
|
any indebtedness of MetLife, Inc. to its affiliates (including
all debt securities and guarantees in respect of those debt
securities issued to any trust, partnership or other entity
affiliated with MetLife, Inc. that is a financing vehicle of
MetLife, Inc. in connection with the issuance by such financing
entity of preferred securities or other securities guaranteed by
MetLife, Inc.) unless otherwise expressly provided in the terms
of any such indebtedness.
|
At December 31, 2004, Senior Indebtedness aggregated
approximately $5.7 billion. The amount of Senior
Indebtedness which MetLife, Inc. may issue is subject to
limitations imposed by its board of directors.
Senior Indebtedness shall continue to be Senior Indebtedness and
be entitled to the benefits of the subordination provisions
irrespective of any amendment, modification or waiver of any
term of such Senior Indebtedness.
Unless otherwise noted in the accompanying prospectus
supplement, if MetLife, Inc. defaults in the payment of any
principal of (or premium, if any) or interest on any Senior
Indebtedness when it becomes due and payable, whether at
maturity or at a date fixed for prepayment or by declaration or
otherwise, then, unless and until such default is cured or
waived or ceases to exist, MetLife, Inc. will make no direct or
indirect payment (in cash, property, securities, by set-off or
otherwise) in respect of the principal of or interest on the
subordinated debt securities or in respect of any redemption,
retirement, purchase or other requisition of any of the
subordinated debt securities.
In the event of the acceleration of the maturity of any
subordinated debt securities, the holders of all senior debt
securities outstanding at the time of such acceleration will
first be entitled to receive payment in full of all amounts due
on the senior debt securities before the holders of the
subordinated debt securities will be entitled to receive any
payment of principal (and premium, if any) or interest on the
subordinated debt securities.
8
If any of the following events occurs, MetLife, Inc. will pay in
full all Senior Indebtedness before it makes any payment or
distribution under the subordinated debt securities, whether in
cash, securities or other property, to any holder of
subordinated debt securities:
|
|
|
|
|
any dissolution or winding-up or liquidation or reorganization
of MetLife, Inc., whether voluntary or involuntary or in
bankruptcy, insolvency or receivership;
|
|
|
|
any general assignment by MetLife, Inc. for the benefit of
creditors; or
|
|
|
|
any other marshaling of MetLife, Inc.s assets or
liabilities.
|
In such event, any payment or distribution under the
subordinated debt securities, whether in cash, securities or
other property, which would otherwise (but for the subordination
provisions) be payable or deliverable in respect of the
subordinated debt securities, will be paid or delivered directly
to the holders of Senior Indebtedness in accordance with the
priorities then existing among such holders until all Senior
Indebtedness has been paid in full. If any payment or
distribution under the subordinated debt securities is received
by the trustee of any subordinated debt securities in
contravention of any of the terms of the Subordinated Indenture
and before all the Senior Indebtedness has been paid in full,
such payment or distribution or security will be received in
trust for the benefit of, and paid over or delivered and
transferred to, the holders of the Senior Indebtedness at the
time outstanding in accordance with the priorities then existing
among such holders for application to the payment of all Senior
Indebtedness remaining unpaid to the extent necessary to pay all
such Senior Indebtedness in full.
The Subordinated Indenture does not limit the issuance of
additional Senior Indebtedness.
If debt securities are issued to a trust in connection with the
issuance of trust preferred securities, such debt securities may
thereafter be distributed pro rata to the holders of such trust
securities in connection with the dissolution of such trust upon
the occurrence of certain events described in the applicable
prospectus supplement.
Unless an accompanying prospectus supplement states otherwise,
the following restrictive covenants shall apply to each series
of senior debt securities:
Limitation on Liens. So long as any senior
debt securities are outstanding, neither MetLife, Inc. nor any
of its subsidiaries will create, assume, incur or guarantee any
debt which is secured by any mortgage, pledge, lien, security
interest or other encumbrance on any capital stock of:
|
|
|
|
|
Metropolitan Life Insurance Company;
|
|
|
|
any successor to substantially all of the business of
Metropolitan Life Insurance Company which is also a subsidiary
of MetLife, Inc.; or
|
|
|
|
any corporation (other than MetLife, Inc.) having direct or
indirect control of Metropolitan Life Insurance Company or any
such successor.
|
However, this restriction will not apply if the debt securities
then outstanding are secured at least equally and ratably with
the otherwise prohibited secured debt so long as it is
outstanding.
Limitations on Dispositions of Stock of Certain
Subsidiaries. So long as any senior debt
securities are outstanding and subject to the provisions of the
Senior Indenture regarding mergers, consolidations and sales of
assets, neither MetLife, Inc. nor any of its subsidiaries will
sell or otherwise dispose of any shares of capital stock (other
than preferred stock having no voting rights of any kind) of:
|
|
|
|
|
Metropolitan Life Insurance Company;
|
|
|
|
any successor to substantially all of the business of
Metropolitan Life Insurance Company which is also a subsidiary
of MetLife, Inc.; or
|
|
|
|
any corporation (other than MetLife, Inc.) having direct or
indirect control of Metropolitan Life Insurance Company or any
such successor;
|
9
except for, in each case:
|
|
|
|
|
a sale or other disposition of any of such stock to a
wholly-owned subsidiary of MetLife, Inc. or of such subsidiary;
or
|
|
|
|
a sale or other disposition of all of such stock for at least
fair value (as determined by MetLife, Inc.s board of
directors acting in good faith); or a sale or other disposition
required to comply with an order of a court or regulatory
authority of competent jurisdiction, other than an order issued
at MetLife, Inc.s request or the request of any of
MetLife, Inc.s subsidiaries.
|
|
|
|
Consolidation,
Merger, Sale of Assets and Other Transactions
|
(i) MetLife, Inc. may not merge with or into or consolidate
with another corporation or sell, assign, transfer, lease or
convey all or substantially all of its properties and assets to,
any other corporation other than a direct or indirect
wholly-owned subsidiary of MetLife, Inc., and (ii) no
corporation may merge with or into or consolidate with MetLife,
Inc. or, except for any direct or indirect wholly-owned
subsidiary of MetLife, Inc., sell, assign, transfer, lease or
convey all or substantially all of its properties and assets to
MetLife, Inc., unless:
|
|
|
|
|
MetLife, Inc. is the surviving corporation or the corporation
formed by or surviving such merger or consolidation or to which
such sale, assignment, transfer, lease or conveyance has been
made, if other than MetLife, Inc., has expressly assumed by
supplemental indenture all the obligations of MetLife, Inc.
under the debt securities, the Indentures, and any guarantees of
preferred securities or common securities issued by the trusts;
|
|
|
|
immediately after giving effect to such transaction, no default
or Event of Default has occurred and is continuing;
|
|
|
|
if at the time any preferred securities of the trusts are
outstanding, such transaction is not prohibited under the
applicable declaration of trust and the applicable preferred
securities guarantee of each trust; and
|
|
|
|
MetLife, Inc. delivers to the trustee an officers
certificate and an opinion of counsel, each stating that the
supplemental indenture complies with the applicable Indenture.
|
|
|
|
Events
of Default, Notice and Waiver
|
Unless an accompanying prospectus supplement states otherwise,
the following shall constitute Events of Default
under the Indentures with respect to each series of debt
securities:
|
|
|
|
|
MetLife, Inc.s failure to pay any interest on any debt
security of such series when due and payable, continued for
30 days;
|
|
|
|
MetLife, Inc.s failure to pay principal (or premium, if
any) on any debt security of such series when due, regardless of
whether such payment became due because of maturity, redemption,
acceleration or otherwise, or is required by any sinking fund
established with respect to such series;
|
|
|
|
MetLife, Inc.s failure to observe or perform any other of
its covenants or agreements with respect to such series for
90 days after MetLife, Inc. receives notice of such failure;
|
|
|
|
certain defaults with respect to MetLife, Inc.s debt which
result in a principal amount in excess of $100,000,000 becoming
or being declared due and payable prior to the date on which it
would otherwise have become due and payable (other than the debt
securities or non-recourse debt);
|
|
|
|
certain events of bankruptcy, insolvency or reorganization of
MetLife, Inc.; and
|
|
|
|
certain events of dissolution or winding-up of the trusts in the
event that debt securities are issued to the trusts or a trustee
of the trusts in connection with the issuance of securities by
the trusts.
|
If an Event of Default with respect to any debt securities of
any series outstanding under either of the Indentures shall
occur and be continuing, the trustee under such Indenture or the
holders of at least 25% in aggregate principal amount of the
debt securities of that series outstanding may declare, by
notice as provided in the applicable
10
Indenture, the principal amount (or such lesser amount as may be
provided for in the debt securities of that series) of all the
debt securities of that series outstanding to be due and payable
immediately; provided that, in the case of an Event of Default
involving certain events in bankruptcy, insolvency or
reorganization, acceleration is automatic; and, provided
further, that after such acceleration, but before a judgment or
decree based on acceleration, the holders of a majority in
aggregate principal amount of the outstanding debt securities of
that series may, under certain circumstances, rescind and annul
such acceleration if all Events of Default, other than the
nonpayment of accelerated principal, have been cured or waived.
Upon the acceleration of the maturity of original issue discount
securities, an amount less than the principal amount thereof
will become due and payable. Reference is made to the prospectus
supplement relating to any original issue discount securities
for the particular provisions relating to acceleration of
maturity thereof.
Any past default under either Indenture with respect to debt
securities of any series, and any Event of Default arising
therefrom, may be waived by the holders of a majority in
principal amount of all debt securities of such series
outstanding under such Indenture, except in the case of
(i) default in the payment of the principal of (or premium,
if any) or interest on any debt securities of such series or
(ii) default in respect of a covenant or provision which
may not be amended or modified without the consent of the holder
of each outstanding debt security of such series affected.
The trustee is required, within 90 days after the
occurrence of a default (which is known to the trustee and is
continuing), with respect to the debt securities of any series
(without regard to any grace period or notice requirements), to
give to the holders of the debt securities of such series notice
of such default; provided, however, that, except in the case of
a default in the payment of the principal of (and premium, if
any) or interest, or in the payment of any sinking fund
installment, on any debt securities of such series, the trustee
shall be protected in withholding such notice if it in good
faith determines that the withholding of such notice is in the
interests of the holders of the debt securities of such series.
The trustee, subject to its duties during default to act with
the required standard of care, may require indemnification by
the holders of the debt securities of any series with respect to
which a default has occurred before proceeding to exercise any
right or power under the Indentures at the request of the
holders of the debt securities of such series. Subject to such
right of indemnification and to certain other limitations, the
holders of a majority in aggregate principal amount of the
outstanding debt securities of any series under either Indenture
may direct the time, method and place of conducting any
proceeding for any remedy available to the trustee, or
exercising any trust or power conferred on the trustee with
respect to the debt securities of such series.
No holder of a debt security of any series may institute any
action against MetLife, Inc. under either of the Indentures
(except actions for payment of overdue principal of (and
premium, if any) or interest on such debt security or for the
conversion or exchange of such debt security in accordance with
its terms) unless (i) the holder has given to the trustee
written notice of an Event of Default and of the continuance
thereof with respect to the debt securities of such series
specifying an Event of Default, as required under the applicable
Indenture, (ii) the holders of at least 25% in aggregate
principal amount of the debt securities of that series then
outstanding under such Indenture shall have requested the
trustee to institute such action and offered to the trustee
reasonable indemnity against the costs, expenses and liabilities
to be incurred in compliance with such request, and
(iii) the trustee shall not have instituted such action
within 60 days of such request.
MetLife, Inc. is required to furnish annually to the trustee
statements as to MetLife, Inc.s compliance with all
conditions and covenants under each Indenture.
|
|
|
Discharge,
Defeasance and Covenant Defeasance
|
If indicated in the applicable prospectus supplement, MetLife,
Inc. may discharge or defease its obligations under each
Indenture as set forth below.
MetLife, Inc. may discharge certain obligations to holders of
any series of debt securities issued under either the Senior
Indenture or the Subordinated Indenture which have not already
been delivered to the trustee for cancellation and which have
either become due and payable or are by their terms due and
payable within one year (or scheduled for redemption within one
year) by irrevocably depositing with the trustee cash or, in the
case of debt
11
securities payable only in U.S. dollars,
U.S. government obligations (as defined in either
Indenture), as trust funds in an amount certified to be
sufficient to pay when due, whether at maturity, upon redemption
or otherwise, the principal of (and premium, if any) and
interest on such debt securities.
If indicated in the applicable prospectus supplement, MetLife,
Inc. may elect either (i) to defease and be discharged from
any and all obligations with respect to the debt securities of
or within any series (except as otherwise provided in the
relevant Indenture) (defeasance) or (ii) to be
released from its obligations with respect to certain covenants
applicable to the debt securities of or within any series
(covenant defeasance), upon the deposit with the
relevant Indenture trustee, in trust for such purpose, of money
and/or government obligations which, through the payment of
principal and interest in accordance with their terms, will
provide money in an amount sufficient, without reinvestment, to
pay the principal of (and premium, if any) or interest on such
debt securities to maturity or redemption, as the case may be,
and any mandatory sinking fund or analogous payments thereon. As
a condition to defeasance or covenant defeasance, MetLife, Inc.
must deliver to the trustee an opinion of counsel to the effect
that the holders of such debt securities will not recognize
income, gain or loss for federal income tax purposes as a result
of such defeasance or covenant defeasance and will be subject to
federal income tax on the same amounts and in the same manner
and at the same times as would have been the case if such
defeasance or covenant defeasance had not occurred. Such opinion
of counsel, in the case of defeasance under clause (i)
above, must refer to and be based upon a ruling of the Internal
Revenue Service or a change in applicable federal income tax law
occurring after the date of the relevant Indenture. In addition,
in the case of either defeasance or covenant defeasance,
MetLife, Inc. shall have delivered to the trustee (i) an
officers certificate to the effect that the relevant debt
securities exchange(s) have informed it that neither such debt
securities nor any other debt securities of the same series, if
then listed on any securities exchange, will be delisted as a
result of such deposit, and (ii) an officers
certificate and an opinion of counsel, each stating that all
conditions precedent with respect to such defeasance or covenant
defeasance have been complied with.
MetLife, Inc. may exercise its defeasance option with respect to
such debt securities notwithstanding its prior exercise of its
covenant defeasance option.
Under the Indentures, MetLife, Inc. and the applicable trustee
may supplement the Indentures for certain purposes which would
not materially adversely affect the interests or rights of the
holders of debt securities of a series without the consent of
those holders. MetLife, Inc. and the applicable trustee may also
modify the Indentures or any supplemental indenture in a manner
that affects the interests or rights of the holders of debt
securities with the consent of the holders of at least a
majority in aggregate principal amount of the outstanding debt
securities of each affected series issued under the Indenture.
However, the Indentures require the consent of each holder of
debt securities that would be affected by any modification which
would:
|
|
|
|
|
extend the fixed maturity of any debt securities of any series,
or reduce the principal amount thereof, or reduce the rate or
extend the time of payment of interest thereon, or reduce any
premium payable upon the redemption thereof;
|
|
|
|
reduce the amount of principal of an original issue discount
debt security or any other debt security payable upon
acceleration of the maturity thereof;
|
|
|
|
change the currency in which any debt security or any premium or
interest is payable;
|
|
|
|
impair the right to enforce any payment on or with respect to
any debt security;
|
|
|
|
adversely change the right to convert or exchange, including
decreasing the conversion rate or increasing the conversion
price of, any debt security (if applicable);
|
|
|
|
reduce the percentage in principal amount of outstanding debt
securities of any series, the consent of whose holders is
required for modification or amendment of the Indentures or for
waiver of compliance with certain provisions of the Indentures
or for waiver of certain defaults;
|
12
|
|
|
|
|
reduce the requirements contained in the Indentures for quorum
or voting; or
|
|
|
|
modify any of the above provisions.
|
If debt securities are held by a trust or a trustee of a trust,
a supplemental indenture that affects the interests or rights of
the holders of debt securities will not be effective until the
holders of not less than a majority in liquidation preference of
the preferred securities and common securities of the applicable
trust, collectively, have consented to the supplemental
indenture; provided, further, that if the consent of the holder
of each outstanding debt security is required, the supplemental
indenture will not be effective until each holder of the
preferred securities and the common securities of the applicable
trust has consented to the supplemental indenture.
The Indentures permit the holders of at least a majority in
aggregate principal amount of the outstanding debt securities of
any series issued under the Indenture which is affected by the
modification or amendment to waive MetLife, Inc.s
compliance with certain covenants contained in the Indentures.
|
|
|
Payment
and Paying Agents
|
Unless otherwise indicated in the applicable prospectus
supplement, payment of interest on a debt security on any
interest payment date will be made to the person in whose name a
debt security is registered at the close of business on the
record date for the interest.
Unless otherwise indicated in the applicable prospectus
supplement, principal, interest and premium on the debt
securities of a particular series will be payable at the office
of such paying agent or paying agents as MetLife, Inc. may
designate for such purpose from time to time. Notwithstanding
the foregoing, at MetLife, Inc.s option, payment of any
interest may be made by check mailed to the address of the
person entitled thereto as such address appears in the security
register.
Unless otherwise indicated in the applicable prospectus
supplement, a paying agent designated by MetLife, Inc. and
located in the Borough of Manhattan, The City of New York, will
act as paying agent for payments with respect to debt securities
of each series. All paying agents initially designated by
MetLife, Inc. for the debt securities of a particular series
will be named in the applicable prospectus supplement. MetLife,
Inc. may at any time designate additional paying agents or
rescind the designation of any paying agent or approve a change
in the office through which any paying agent acts, except that
MetLife, Inc. will be required to maintain a paying agent in
each place of payment for the debt securities of a particular
series.
All moneys paid by MetLife, Inc. to a paying agent for the
payment of the principal, interest or premium on any debt
security which remain unclaimed at the end of two years after
such principal, interest or premium has become due and payable
will be repaid to MetLife, Inc. upon request, and the holder of
such debt security thereafter may look only to MetLife, Inc. for
payment thereof.
|
|
|
Denominations,
Registrations and Transfer
|
Unless an accompanying prospectus supplement states otherwise,
debt securities will be represented by one or more global
certificates registered in the name of a nominee for The
Depository Trust Company (DTC). In such case, each
holders beneficial interest in the global securities will
be shown on the records of DTC and transfers of beneficial
interests will only be effected through DTCs records.
A holder of debt securities may only exchange a beneficial
interest in a global security for certificated securities
registered in the holders name if:
|
|
|
|
|
DTC notifies MetLife, Inc. that it is unwilling or unable to
continue serving as the depositary for the relevant global
securities or DTC ceases to maintain certain qualifications
under the Securities Exchange Act of 1934 and no successor
depositary has been appointed for 90 days; or
|
|
|
|
MetLife, Inc. determines, in its sole discretion and subject to
the procedures of DTC, that the global security shall be
exchangeable.
|
If debt securities are issued in certificated form, they will
only be issued in the minimum denomination specified in the
accompanying prospectus supplement and integral multiples of
such denomination. Transfers and
13
exchanges of such debt securities will only be permitted in such
minimum denomination. Transfers of debt securities in
certificated form may be registered at the trustees
corporate office or at the offices of any paying agent or
trustee appointed by MetLife, Inc. under the Indentures.
Exchanges of debt securities for an equal aggregate principal
amount of debt securities in different denominations may also be
made at such locations.
The Indentures and debt securities will be governed by, and
construed in accordance with, the internal laws of the State of
New York, without regard to its principles of conflicts of laws.
|
|
|
Relationship
with the Trustees
|
The trustee under the Indentures is J.P. Morgan Trust
Company, National Association (as successor to Bank One Trust
Company, N.A.). MetLife, Inc. and its subsidiaries maintain
ordinary banking and trust relationships with a number of banks
and trust companies, including the trustee under the Indentures.
|
|
|
Conversion
or Exchange Rights
|
The prospectus supplement will describe the terms, if any, on
which a series of debt securities may be convertible into or
exchangeable for securities described in this prospectus. These
terms will include provisions as to whether conversion or
exchange is mandatory, at the option of the holder or at
MetLife, Inc.s option. These provisions may allow or
require the number of shares of MetLife, Inc.s common
stock or other securities to be received by the holders of such
series of debt securities to be adjusted.
DESCRIPTION
OF CAPITAL STOCK
MetLife, Inc.s authorized capital stock consists of:
|
|
|
|
|
200,000,000 shares of preferred stock, par value
$0.01 per share, of which no shares were issued or
outstanding as of the date of this prospectus;
|
|
|
|
10,000,000 shares of Series A Junior Participating
Preferred Stock, par value $0.01 per share, of which no
shares were issued or outstanding as of the date of this
prospectus; and
|
|
|
|
3,000,000,000 shares of common stock, par value
$0.01 per share, of which 732,487,999 shares, as well
as the same number of rights to purchase shares of Series A
Junior Participating Preferred Stock pursuant to the stockholder
rights plan adopted by MetLife, Inc.s board of directors
on September 29, 1999, were outstanding as of
December 31, 2004. See Stockholder Rights
Plan for a description of the Series A Junior
Participating Preferred Stock. The remaining shares of
authorized and unissued common stock will be available for
future issuance without additional stockholder approval.
|
Dividends. The holders of common stock, after
any preferences of holders of any preferred stock, are entitled
to receive dividends as determined by the board of directors.
The issuance of dividends will depend upon, among other factors
deemed relevant by MetLife, Inc.s board of directors,
MetLifes financial condition, results of operations, cash
requirements, future prospects and regulatory restrictions on
the payment of dividends by Metropolitan Life Insurance Company
and MetLife, Inc.s other subsidiaries. There is no
requirement or assurance that MetLife, Inc. will declare and pay
any dividends. In addition, the indenture, as supplemented by a
supplemental indenture, governing the terms of MetLife,
Inc.s 3.911% Debentures due May 15, 2005,
prohibits the payment of dividends on common stock of MetLife,
Inc. during a deferral of interest payments on such securities
or an event of default under the indenture, as supplemented, or
the related guarantee.
Voting Rights. The holders of common stock are
entitled to one vote per share on all matters on which the
holders of common stock are entitled to vote and do not have any
cumulative voting rights.
14
Liquidation and Dissolution. In the event of
MetLife, Inc.s liquidation, dissolution or winding-up, the
holders of common stock are entitled to share equally and
ratably in MetLife, Inc.s assets, if any, remaining after
the payment of all of MetLife, Inc.s liabilities and the
liquidation preference of any outstanding class or series of
preferred stock.
Other Rights. The holders of common stock have
no preemptive, conversion, redemption or sinking fund rights.
The holders of shares of MetLife, Inc.s common stock are
not required to make additional capital contributions.
Transfer Agent and Registrar. The transfer
agent and registrar for MetLife, Inc.s common stock is
Mellon Investor Services, successor to ChaseMellon Shareholder
Services, L.L.C.
General. MetLife, Inc.s board of
directors has the authority to issue preferred stock in one or
more series and to fix the title and number of shares
constituting any such series and the designations, powers,
preferences, limitations and relative rights including offering
price, any dividend rights (including whether dividends will be
cumulative or non-cumulative), dividend rate, voting rights,
terms of any redemption, any redemption price or prices,
conversion or exchange rights and any liquidation preferences of
the shares constituting any series, without any further vote or
action by stockholders. The specific terms of the preferred
stock will be described in the prospectus supplement.
MetLife, Inc. has authorized 10,000,000 shares of
Series A Junior Participating Preferred Stock for issuance
in connection with its stockholder rights plan. See
Stockholder Rights Plan for a
description of the Series A Junior Participating Preferred
Stock.
Voting Rights. The Delaware General
Corporation Law provides that the holders of preferred stock
will have the right to vote separately as a class on any
proposal involving fundamental changes in the rights of holders
of such preferred stock. The prospectus supplement will describe
the voting rights, if any, of the preferred stock.
Conversion or Exchange. The prospectus
supplement will describe the terms, if any, on which the
preferred stock may be convertible into or exchangeable for
securities described in this prospectus. These terms will
include provisions as to whether conversion or exchange is
mandatory, at the option of the holder or at MetLife,
Inc.s option. These provisions may set forth the
conversion price, the method of determining the conversion price
and the conversion period and may allow or require the number of
shares of MetLife, Inc.s common stock or other securities
to be received by the holders of preferred stock to be adjusted.
Redemption. The prospectus supplement will
describe the obligation, if any, to redeem the preferred stock
in whole or in part at the times and at the redemption prices
set forth in the applicable prospectus supplement.
Unless otherwise indicated in the applicable prospectus
supplement, MetLife, Inc. may not purchase or redeem any of the
outstanding shares or any series of preferred stock unless full
cumulative dividends, if any, have been paid or declared and set
apart for payment upon all outstanding shares of any series of
preferred stock for all past dividend periods, and unless all of
MetLife, Inc.s matured obligations with respect to all
sinking funds, retirement funds or purchase funds for all series
of preferred stock then outstanding have been met.
|
|
|
Certain
Provisions in MetLife, Inc.s Certificate of Incorporation
and By-Laws and in Delaware and New York Law
|
A number of provisions of MetLife, Inc.s certificate of
incorporation and by-laws deal with matters of corporate
governance and rights of stockholders. The following discussion
is a general summary of selected provisions of MetLife,
Inc.s certificate of incorporation and by-laws and
regulatory provisions that might be deemed to have a potential
anti-takeover effect. These provisions may have the
effect of discouraging a future takeover attempt which is not
approved by MetLife, Inc.s board of directors but which
individual stockholders may deem to be in their best interests
or in which stockholders may receive a substantial premium for
their shares over then current market prices. As a result,
stockholders who might desire to participate in such a
transaction may not have an opportunity to do so. Such
provisions will also render the removal of the incumbent board
of directors or
15
management more difficult. Some provisions of the Delaware
General Corporation Law and the New York Insurance Law may also
have an anti-takeover effect. The following description of
selected provisions of MetLife, Inc.s certificate of
incorporation and by-laws and selected provisions of the
Delaware General Corporation Law and the New York Insurance Law
is necessarily general and reference should be made in each case
to MetLife, Inc.s certificate of incorporation and
by-laws, which are incorporated by reference as exhibits to the
registration statement of which this prospectus forms a part,
and to the provisions of those laws.
|
|
|
Classified
Board of Directors and Removal of Directors
|
Pursuant to MetLife, Inc.s certificate of incorporation,
the directors are divided into three classes, as nearly equal in
number as possible, with each class having a term of three
years. The classes serve staggered terms, such that the term of
one class of directors expires each year. Any effort to obtain
control of MetLife, Inc.s board of directors by causing
the election of a majority of the board may require more time
than would be required without a staggered election structure.
MetLife, Inc.s certificate of incorporation also provides
that, subject to the rights of the holders of any class of
preferred stock, directors may be removed only for cause at a
meeting of stockholders by a vote of a majority of the shares
then entitled to vote. This provision may have the effect of
slowing or impeding a change in membership of MetLife,
Inc.s board of directors that would effect a change of
control.
|
|
|
Exercise
of Duties by Board of Directors
|
MetLife, Inc.s certificate of incorporation provides that
while the MetLife Policyholder Trust (as described below) is in
existence, each MetLife, Inc. director is required, in
exercising his or her duties as a director, to take the
interests of the trust beneficiaries into account as if they
were holders of the shares of common stock held in the trust,
except to the extent that any such director determines, based on
advice of counsel, that to do so would violate his or her duties
as a director under Delaware law.
|
|
|
Restriction
on Maximum Number of Directors and Filling of Vacancies on
MetLife, Inc.s Board of Directors
|
Pursuant to MetLife, Inc.s by-laws and subject to the
rights of the holders of any class of preferred stock, the
number of directors may be fixed and increased or decreased from
time to time by resolution of the board of directors, but the
board of directors will at no time consist of fewer than three
directors. Subject to the rights of the holders of any class of
preferred stock, stockholders can only remove a director for
cause by a vote of a majority of the shares entitled to vote, in
which case the vacancy caused by such removal may be filled at
such meeting by the stockholders entitled to vote for the
election of the director so removed. Any vacancy on the board of
directors, including a vacancy resulting from an increase in the
number of directors or resulting from a removal for cause where
the stockholders have not filled the vacancy, subject to the
rights of the holders of any class of preferred stock, may be
filled by a majority of the directors then in office, although
less than a quorum. If the vacancy is not so filled it will be
filled by the stockholders at the next annual meeting of
stockholders. The stockholders are not permitted to fill
vacancies between annual meetings, except where the vacancy
resulted from a removal for cause. These provisions give
incumbent directors significant authority that may have the
effect of limiting the ability of stockholders to effect a
change in management.
|
|
|
Advance
Notice Requirements for Nomination of Directors and Presentation
of New Business at Meetings of Stockholders; Action by Written
Consent
|
MetLife, Inc.s by-laws provide for advance notice
requirements for stockholder proposals and nominations for
director. In addition, pursuant to the provisions of both the
certificate of incorporation and the by-laws, action may not be
taken by written consent of stockholder. Rather, any action
taken by the stockholders must be effected at a duly called
meeting. Moreover, the stockholders do not have the power to
call a special meeting. Only the chief executive officer or the
secretary pursuant to a board resolution or, under some
circumstances, the president or a director who also is an
officer, may call a special meeting. These provisions make it
more difficult for a stockholder to place a proposal or
nomination on the meeting agenda and prohibit a stockholder from
taking action without a meeting, and therefore may reduce the
likelihood that a stockholder will seek to take independent
action to replace directors or with respect to other matters
that are not supported by management for stockholder vote.
16
|
|
|
Limitations
on Director Liability
|
MetLife, Inc.s certificate of incorporation contains a
provision that is designed to limit the directors
liability to the extent permitted by the Delaware General
Corporation Law and any amendments to that law. Specifically,
directors will not be held liable to MetLife, Inc. or its
stockholders for an act or omission in their capacity as a
director, except for liability as a result of:
|
|
|
|
|
a breach of the duty of loyalty to MetLife, Inc. or its
stockholders;
|
|
|
|
acts or omissions not in good faith or which involve intentional
misconduct or a knowing violation of law;
|
|
|
|
payment of an improper dividend or improper repurchase of
MetLife, Inc.s stock under Section 174 of the
Delaware General Corporation Law; or
|
|
|
|
actions or omissions pursuant to which the director received an
improper personal benefit.
|
The principal effect of the limitation on liability provision is
that a stockholder is unable to prosecute an action for monetary
damages against a director of MetLife, Inc. unless the
stockholder can demonstrate one of the specified bases for
liability. This provision, however, does not eliminate or limit
director liability arising in connection with causes of action
brought under the federal securities laws. MetLife, Inc.s
certificate of incorporation also does not eliminate the
directors duty of care. The inclusion of the limitation on
liability provision in the certificate may, however, discourage
or deter stockholders or management from bringing a lawsuit
against directors for a breach of their fiduciary duties, even
though such an action, if successful, might otherwise have
benefited MetLife, Inc. and its stockholders. This provision
should not affect the availability of equitable remedies such as
injunction or rescission based upon a directors breach of
the duty of care.
MetLife, Inc.s by-laws also provide that MetLife, Inc.
indemnify its directors and officers to the fullest extent
permitted by Delaware law. MetLife, Inc. is required to
indemnify its directors and officers for all judgments, fines,
settlements, legal fees and other expenses reasonably incurred
in connection with pending or threatened legal proceedings
because of the directors or officers position with
MetLife, Inc. or another entity, including Metropolitan Life
Insurance Company, that the director or officer serves at
MetLife, Inc.s request, subject to certain conditions, and
to advance funds to MetLife, Inc.s directors and officers
to enable them to defend against such proceedings. To receive
indemnification, the director or officer must succeed in the
legal proceeding or act in good faith and in a manner reasonably
believed to be in or not opposed to the best interests of
MetLife, Inc. and with respect to any criminal action or
proceeding, in a manner he or she reasonably believed to be
lawful.
|
|
|
Supermajority
Voting Requirement for Amendment of Certain Provisions of the
Certificate of Incorporation and By-Laws
|
Some of the provisions of MetLife, Inc.s certificate of
incorporation, including those that authorize the board of
directors to create stockholder rights plans, that set forth the
duties, election and exculpation from liability of directors and
that prohibit stockholders from taking actions by written
consent, may not be amended, altered, changed or repealed unless
the amendment is approved by the vote of holders of 75% of the
then outstanding shares entitled to vote at an election of
directors. This requirement exceeds the majority vote of the
outstanding stock that would otherwise be required by the
Delaware General Corporation Law for the repeal or amendment of
such provisions of the certificate of incorporation. MetLife,
Inc.s by-laws may be amended, altered or repealed by the
board of directors or by the vote of holders of 75% of the then
outstanding shares entitled to vote in the election of
directors. These provisions make it more difficult for any
person to remove or amend any provisions that have an
anti-takeover effect.
|
|
|
Business
Combination Statute
|
In addition, as a Delaware corporation, MetLife, Inc. is subject
to Section 203 of the Delaware General Corporation Law,
unless it elects in its certificate of incorporation not to be
governed by the provisions of Section 203. MetLife, Inc.
has not made that election. Section 203 can affect the
ability of an interested stockholder of MetLife,
Inc. to engage in certain business combinations, including
mergers, consolidations or acquisitions of additional shares of
MetLife, Inc. for a period of three years following the time
that the stockholder becomes an interested
stockholder. An interested stockholder is
defined to include any person owning, directly
17
or indirectly, 15% or more of the outstanding voting stock of a
corporation. The provisions of Section 203 are not
applicable in some circumstances, including those in which
(1) the business combination or transaction which results
in the stockholder becoming an interested
stockholder is approved by the corporations board of
directors prior to the time the stockholder becomes an
interested stockholder or (2) the
interested stockholder, upon consummation of such
transaction, owns at least 85% of the voting stock of the
corporation outstanding prior to such transaction.
|
|
|
Restrictions
on Acquisitions of Securities
|
The insurance laws and regulations of New York, the jurisdiction
in which MetLife, Inc.s principal insurance subsidiary,
Metropolitan Life Insurance Company, is organized, may delay or
impede a business combination involving MetLife, Inc. In
addition to the limitations described in the immediately
preceding paragraph, the New York Insurance Law prohibits any
person from acquiring control of MetLife, Inc., and thus
indirect control of Metropolitan Life Insurance Company, without
the prior approval of the New York Superintendent of Insurance.
That law presumes that control exists where any person, directly
or indirectly, owns, controls, holds the power to vote or holds
proxies representing 10% or more of MetLife, Inc.s
outstanding voting stock, unless the New York Superintendent,
upon application, determines otherwise. Even persons who do not
acquire beneficial ownership of more than 10% of the outstanding
shares of MetLife, Inc.s common stock may be deemed to
have acquired such control, if the New York Superintendent
determines that such persons, directly or indirectly, exercise a
controlling influence over MetLife, Inc.s management or
policies. Therefore, any person seeking to acquire a controlling
interest in MetLife, Inc. would face regulatory obstacles which
may delay, deter or prevent an acquisition.
The insurance holding company law and other insurance laws of
many states also regulate changes of control (generally presumed
upon acquisitions of 10% or more of voting securities) of
insurance holding companies such as MetLife, Inc.
MetLife, Inc.s board of directors has adopted a
stockholder rights plan under which each outstanding share of
MetLife, Inc.s common stock issued between April 4,
2000 and the earlier of the distribution date (as described
below) and the expiration of the rights (as described below)
will be coupled with a stockholder right. Initially, the
stockholder rights will be attached to the certificates
representing outstanding shares of common stock, and no separate
rights certificates will be distributed. Each right will entitle
the holder to purchase one one-hundredth of a share of MetLife,
Inc.s Series A Junior Participating Preferred Stock.
Each one one-hundredth of a share of Series A Junior
Participating Preferred Stock will have economic and voting
terms equivalent to one share of MetLife, Inc.s common
stock. Until it is exercised, the right itself will not entitle
the holder thereof to any rights as a stockholder, including the
right to receive dividends or to vote at stockholder meetings.
The description and terms of the rights are set forth in a
rights agreement entered into between MetLife, Inc. and Mellon
Investor Services, successor to ChaseMellon Shareholder
Services, L.L.C., as rights agent. Although the material
provisions of the rights agreement have been accurately
summarized, the statements below concerning the rights agreement
are not necessarily complete and in each instance reference is
made to the rights agreement itself, which is incorporated by
reference into this prospectus in its entirety. Each statement
is qualified in its entirety by such reference.
Stockholder rights are not exercisable until the distribution
date and will expire at the close of business on April 4,
2010, unless earlier redeemed or exchanged by MetLife, Inc. A
distribution date would occur upon the earlier of:
|
|
|
|
|
the tenth day after the first public announcement or
communication to MetLife, Inc. that a person or group of
affiliated or associated persons (referred to as an
acquiring person) has acquired beneficial ownership
of 10% or more of MetLife, Inc.s outstanding common stock
(the date of such announcement or communication is referred to
as the stock acquisition time); or
|
|
|
|
the tenth business day after the commencement or announcement of
the intention to commence a tender offer or exchange offer that
would result in a person or group becoming an acquiring person.
|
18
If any person becomes an acquiring person, each holder of a
stockholder right will be entitled to exercise the right and
receive, instead of Series A Junior Participating Preferred
Stock, common stock (or, in certain circumstances, cash, a
reduction in purchase price, property or other securities of
MetLife, Inc.) having a value equal to two times the purchase
price of the stockholder right. All stockholder rights that are
beneficially owned by an acquiring person or its transferee will
become null and void.
If at any time after a public announcement has been made or
MetLife, Inc. has received notice that a person has become an
acquiring person, (1) MetLife, Inc. is acquired in a merger
or other business combination, or (2) 50% or more of
MetLife, Inc.s and its subsidiaries assets, cash
flow or earning power is sold or transferred, each holder of a
stockholder right (except rights which previously have been
voided as set forth above) will have the right to receive, upon
exercise, common stock of the acquiring company having a value
equal to two times the purchase price of the right.
The purchase price payable, the number of one one-hundredths of
a share of Series A Junior Participating Preferred Stock or
other securities or property issuable upon exercise of rights
and the number of rights outstanding, are subject to adjustment
from time to time to prevent dilution. With certain exceptions,
no adjustment in the purchase price or the number of shares of
Series A Junior Participating Preferred Stock issuable upon
exercise of a stockholder right will be required until the
cumulative adjustment would require an increase or decrease of
at least one percent in the purchase price or number of shares
for which a right is exercisable.
At any time until the earlier of (1) the stock acquisition
time, or (2) the final expiration date of the rights
agreement, MetLife, Inc. may redeem all the stockholder rights
at a price of $0.01 per right. At any time after a person
has become an acquiring person and prior to the acquisition of
beneficial ownership by such person of 50% or more of the
outstanding shares of MetLife, Inc.s common stock,
MetLife, Inc. may exchange the stockholder rights, in whole or
in part, at an exchange ratio of one share of common stock, or
one one-hundredth of a share of Series A Junior
Participating Preferred Stock (or of a share of a class or
series of preferred stock having equivalent rights, preferences
and privileges), per right.
The stockholder rights plan is designed to protect stockholders
in the event of unsolicited offers to acquire MetLife, Inc. and
other coercive takeover tactics which, in the opinion of its
board of directors, could impair its ability to represent
stockholder interests. The provisions of the stockholder rights
plan may render an unsolicited takeover more difficult or less
likely to occur or may prevent such a takeover, even though such
takeover may offer MetLife, Inc.s stockholders the
opportunity to sell their stock at a price above the prevailing
market rate and may be favored by a majority of MetLife,
Inc.s stockholders.
|
|
|
MetLife
Policyholder Trust
|
Under a plan of reorganization adopted in September 1999,
Metropolitan Life Insurance Company converted from a mutual life
insurance company to a stock life insurance company subsidiary
of MetLife, Inc. MetLife established the MetLife Policyholder
Trust to hold the shares of common stock allocated to eligible
policyholders. A total of 494,466,664 shares of common
stock were distributed to the MetLife Policyholder Trust on the
effective date of the plan of reorganization. As of
December 31, 2004, the trust held 321,314,794 shares
of MetLife, Inc.s common stock. Because of the number of
shares held by the trust and the voting provisions of the trust,
the trust may affect the outcome of matters brought to a
stockholder vote.
The trustee will generally vote all of the shares of common
stock held in the trust in accordance with the recommendations
given by MetLife, Inc.s board of directors to its
stockholders or, if the board gives no such recommendation, as
directed by the board, except on votes regarding certain
fundamental corporate actions. As a result of the voting
provisions of the trust, MetLife, Inc.s board of directors
will effectively be able to control votes on all matters
submitted to a vote of stockholders, excluding those fundamental
corporate actions described below, so long as the trust holds a
substantial number of shares of MetLife, Inc.s common
stock.
19
If the vote relates to fundamental corporate actions specified
in the trust, the trustee will solicit instructions from the
beneficiaries and vote all shares held in the trust in
proportion to the instructions it receives, which would give
disproportionate weight to the instructions actually given by
trust beneficiaries. These actions include:
|
|
|
|
|
an election or removal of directors in which a stockholder has
properly nominated one or more candidates in opposition to a
nominee or nominees of MetLife, Inc.s board of directors
or a vote on a stockholders proposal to oppose a board
nominee for director, remove a director for cause or fill a
vacancy caused by the removal of a director by stockholders,
subject to certain conditions;
|
|
|
|
a merger or consolidation, a sale, lease or exchange of all or
substantially all of the assets, or a recapitalization or
dissolution of MetLife, Inc., in each case requiring a vote of
MetLife, Inc.s stockholders under applicable Delaware law;
|
|
|
|
any transaction that would result in an exchange or conversion
of shares of common stock held by the trust for cash, securities
or other property; and
|
|
|
|
any proposal requiring MetLife, Inc.s board of directors
to amend or redeem the rights under the stockholder rights plan,
other than a proposal with respect to which MetLife, Inc. has
received advice of nationally-recognized legal counsel to the
effect that the proposal is not a proper subject for stockholder
action under Delaware law.
|
DESCRIPTION
OF DEPOSITARY SHARES
The following outlines some of the general terms and provisions
of the depositary shares. Further terms of the depositary shares
and the applicable deposit agreement will be stated in the
applicable prospectus supplement. The following description and
any description of the depositary shares in a prospectus
supplement may not be complete and is subject to and qualified
in its entirety by reference to the terms and provisions of the
deposit agreement, a form of which has been filed as an exhibit
to the registration statement of which this prospectus forms a
part.
The particular terms of the depositary shares offered by any
prospectus supplement and the extent to which the general
provisions described below may apply to such depositary shares
will be outlined in the applicable prospectus supplement.
MetLife, Inc. may choose to offer fractional interests in debt
securities or fractional shares of common stock or preferred
stock. MetLife, Inc. may issue fractional interests in debt
securities, common stock or preferred stock, as the case may be,
in the form of depositary shares. Each depositary share would
represent a fractional interest in a security of a particular
series of debt securities or a fraction of a share of common
stock or of a particular series of preferred stock, as the case
may be, and would be evidenced by a depositary receipt.
MetLife, Inc. will deposit the debt securities or shares of
common stock or preferred stock represented by depositary shares
under a deposit agreement between MetLife, Inc. and a depositary
which will be named in the applicable prospectus supplement.
Subject to the terms of the deposit agreement, as an owner of a
depositary share, you will be entitled, in proportion to the
applicable fraction of a debt security or share of common stock
or preferred stock represented by the depositary share, to all
the rights and preferences of the debt security, common stock or
preferred stock, as the case may be, represented by the
depositary share, including, as the case may be, interest,
dividend, voting, conversion, redemption, sinking fund,
repayment at maturity, subscription and liquidation rights.
|
|
|
Interest,
Dividends and Other Distributions
|
The depositary will distribute all payments of interest, cash
dividends or other cash distributions received on the debt
securities, common stock or preferred stock, as the case may be,
to you in proportion to the number of depositary shares that you
own. In the event of a distribution other than in cash, the
depositary will distribute property received by it to you in an
equitable manner, unless the depositary determines that it is
not feasible to make a distribution. In that case, the
depositary may sell the property and distribute the net proceeds
from the sale to you.
20
|
|
|
Redemption
of Depositary Shares
|
If a debt security, common stock or series of preferred stock
represented by depositary shares is redeemed, the depositary
will redeem your depositary shares from the proceeds received by
the depositary resulting from the redemption. The redemption
price per depositary share will be equal to the applicable
fraction of the redemption price per debt security or share of
common stock or preferred stock, as the case may be, payable in
relation to the redeemed series of debt securities, common stock
or preferred stock. Whenever MetLife, Inc. redeems debt
securities or shares of common stock or preferred stock held by
the depositary, the depositary will redeem, as of the same
redemption date, the number of depositary shares representing,
as the case may be, fractional interests in the debt securities
or shares of common stock or preferred stock redeemed. If fewer
than all the depositary shares are to be redeemed, the
depositary shares to be redeemed will be selected by lot,
proportionately or by any other equitable method as the
depositary may determine.
|
|
|
Exercise
of Rights under the Indentures or Voting the Common Stock or
Preferred
|
Upon receipt of notice of any meeting at which you are entitled
to vote, or of any request for instructions or directions from
you as holder of fractional interests in debt securities, common
stock or preferred stock, the depositary will mail to you the
information contained in that notice. Each record holder of the
depositary shares on the record date will be entitled to
instruct the depositary how to give instructions or directions
with respect to the debt securities represented by that
holders depositary shares or how to vote the amount of the
common stock or preferred stock represented by that
holders depositary shares. The record date for the
depositary shares will be the same date as the record date for
the debt securities, common stock or preferred stock, as the
case may be. The depositary will endeavor, to the extent
practicable, to give instructions or directions with respect to
the debt securities or to vote the amount of the common stock or
preferred stock, as the case may be, represented by the
depositary shares in accordance with those instructions.
MetLife, Inc. will agree to take all reasonable action which the
depositary may deem necessary to enable the depositary to do so.
The depositary will abstain from giving instructions or
directions with respect to your fractional interests in the debt
securities or voting shares of the common stock or preferred
stock, as the case may be, if it does not receive specific
instructions from you.
|
|
|
Amendment
and Termination of the Deposit Agreement
|
MetLife, Inc. and the depositary may amend the form of
depositary receipt evidencing the depositary shares and any
provision of the deposit agreement at any time. However, any
amendment which materially and adversely affects the rights of
the holders of the depositary shares will not be effective
unless the amendment has been approved by the holders of at
least a majority of the depositary shares then outstanding.
The deposit agreement will terminate if:
|
|
|
|
|
all outstanding depositary shares have been redeemed;
|
|
|
|
if applicable, the debt securities and the preferred stock
represented by depositary shares have been converted into or
exchanged for common stock or, in the case of debt securities,
repaid in full; or
|
|
|
|
there has been a final distribution in respect of the common
stock or preferred stock, including in connection with the
liquidation, dissolution or winding-up of MetLife, Inc., and the
distribution proceeds have been distributed to you.
|
|
|
|
Resignation
and Removal of Depositary
|
The depositary may resign at any time by delivering to MetLife,
Inc. notice of its election to do so. MetLife, Inc. also may, at
any time, remove the depositary. Any resignation or removal will
take effect upon the appointment of a successor depositary and
its acceptance of such appointment. MetLife, Inc. must appoint
the successor depositary within 60 days after delivery of
the notice of resignation or removal. The successor depositary
must be a bank or trust company having its principal office in
the United States and having total assets of not less than
$1,000,000,000.
21
MetLife, Inc. will pay all transfer and other taxes and
governmental charges arising solely from the existence of the
depositary arrangements. MetLife, Inc. will pay charges of the
depositary in connection with the initial deposit of the debt
securities or preferred stock, as the case may be, and issuance
of depositary receipts, all withdrawals of depositary shares of
debt securities or preferred stock, as the case may be, by you
and any repayment or redemption of the debt securities or
preferred stock, as the case may be. You will pay other transfer
and other taxes and governmental charges, as well as the other
charges that are expressly provided in the deposit agreement to
be for your account.
The depositary will forward all reports and communications from
MetLife, Inc. which are delivered to the depositary and which
MetLife, Inc. is required or otherwise determines to furnish to
holders of debt securities, common stock or preferred stock, as
the case may be. Neither MetLife, Inc. nor the depositary will
be liable under the deposit agreement to you other than for its
gross negligence, willful misconduct or bad faith. Neither
MetLife, Inc. nor the depositary will be obligated to prosecute
or defend any legal proceedings relating to any depositary
shares, debt securities, common stock or preferred stock unless
satisfactory indemnity is furnished. MetLife, Inc. and the
depositary may rely upon written advice of counsel or
accountants, or upon information provided by persons presenting
debt securities or shares of common stock or preferred stock for
deposit, you or other persons believed to be competent and on
documents which MetLife, Inc. and the depositary believe to be
genuine.
DESCRIPTION
OF WARRANTS
MetLife, Inc. may issue warrants to purchase debt securities,
preferred stock, common stock or other securities described in
this prospectus, or any combination of these securities, and
these warrants may be issued independently or together with any
underlying securities and may be attached or separate from the
underlying securities. MetLife, Inc. will issue each series of
warrants under a separate warrant agreement to be entered into
between MetLife, Inc. and a warrant agent. The warrant agent
will act solely as MetLife, Inc.s agent in connection with
the warrants of such series and will not assume any obligation
or relationship of agency for or with holders or beneficial
owners of warrants.
The following outlines some of the general terms and provisions
of the warrants. Further terms of the warrants and the
applicable warrant agreement will be stated in the applicable
prospectus supplement. The following description and any
description of the warrants in a prospectus supplement may not
be complete and is subject to and qualified in its entirety by
reference to the terms and provisions of the warrant agreement,
a form of which has been filed as an exhibit to the registration
statement of which this prospectus forms a part.
The applicable prospectus supplement will describe the terms of
any warrants that MetLife, Inc. may offer, including the
following:
|
|
|
|
|
the title of the warrants;
|
|
|
|
the total number of warrants;
|
|
|
|
the price or prices at which the warrants will be issued;
|
|
|
|
the currency or currencies investors may use to pay for the
warrants;
|
|
|
|
the designation and terms of the underlying securities
purchasable upon exercise of the warrants;
|
|
|
|
the price at which and the currency, currencies, or currency
units in which investors may purchase the underlying securities
purchasable upon exercise of the warrants;
|
|
|
|
the date on which the right to exercise the warrants will
commence and the date on which the right will expire;
|
|
|
|
whether the warrants will be issued in registered form or bearer
form;
|
22
|
|
|
|
|
information with respect to book-entry procedures, if any;
|
|
|
|
if applicable, the minimum or maximum amount of warrants which
may be exercised at any one time;
|
|
|
|
if applicable, the designation and terms of the underlying
securities with which the warrants are issued and the number of
warrants issued with each underlying security;
|
|
|
|
if applicable, the date on and after which the warrants and the
related underlying securities will be separately transferable;
|
|
|
|
if applicable, a discussion of material United States federal
income tax considerations;
|
|
|
|
the identity of the warrant agent;
|
|
|
|
the procedures and conditions relating to the exercise of the
warrants; and
|
|
|
|
any other terms of the warrants, including terms, procedures and
limitations relating to the exchange and exercise of the
warrants.
|
Warrant certificates may be exchanged for new warrant
certificates of different denominations, and warrants may be
exercised at the warrant agents corporate trust office or
any other office indicated in the applicable prospectus
supplement. Prior to the exercise of their warrants, holders of
warrants exercisable for debt securities will not have any of
the rights of holders of the debt securities purchasable upon
such exercise and will not be entitled to payments of principal
(or premium, if any) or interest, if any, on the debt securities
purchasable upon such exercise. Prior to the exercise of their
warrants, holders of warrants exercisable for shares of
preferred stock or common stock will not have any rights of
holders of the preferred stock or common stock purchasable upon
such exercise and will not be entitled to dividend payments, if
any, or voting rights of the preferred stock or common stock
purchasable upon such exercise. Prior to the exercise of their
warrants, holders of warrants exercisable for other securities
described in this prospectus will not have any rights of holders
of such securities purchasable upon such exercise.
A warrant will entitle the holder to purchase for cash an amount
of securities at an exercise price that will be stated in, or
that will be determinable as described in, the applicable
prospectus supplement. Warrants may be exercised at any time up
to the close of business on the expiration date set forth in the
applicable prospectus supplement. After the close of business on
the expiration date, unexercised warrants will become void.
Warrants may be exercised as set forth in the applicable
prospectus supplement. Upon receipt of payment and the warrant
certificate properly completed and duly executed at the
corporate trust office of the warrant agent or any other office
indicated in the prospectus supplement, MetLife, Inc. will, as
soon as practicable, forward the securities purchasable upon
such exercise. If less than all of the warrants represented by
such warrant certificate is exercised, a new warrant certificate
will be issued for the remaining warrants.
|
|
|
Enforceability
of Rights; Governing Law
|
The holders of warrants, without the consent of the warrant
agent, may, on their own behalf and for their own benefit,
enforce, and may institute and maintain any suit, action or
proceeding against MetLife, Inc. to enforce their rights to
exercise and receive the securities purchasable upon exercise of
their warrants. Unless otherwise stated in the prospectus
supplement, each issue of warrants and the applicable warrant
agreement will be governed by, and construed in accordance with,
the internal laws of the State of New York, without regard to
its principles of conflicts of laws.
DESCRIPTION
OF PURCHASE CONTRACTS
As may be specified in a prospectus supplement, MetLife, Inc.
may issue purchase contracts obligating holders to purchase from
MetLife, Inc., and MetLife, Inc. to sell to the holders, a
number of debt securities, shares of common stock or preferred
stock, or other securities described in this prospectus or the
applicable prospectus
23
supplement at a future date or dates. The purchase contracts may
require MetLife, Inc. to make periodic payments to the holders
of the purchase contracts. These payments may be unsecured or
prefunded on some basis to be specified in the applicable
prospectus supplement.
The prospectus supplement relating to any purchase contracts
will specify the material terms of the purchase contracts and
any applicable pledge or depositary arrangements, including one
or more of the following:
|
|
|
|
|
The stated amount that a holder will be obligated to pay under
the purchase contract in order to purchase debt securities,
common stock, preferred stock, or other securities described in
this prospectus or the formula by which such amount shall be
determined.
|
|
|
|
The settlement date or dates on which the holder will be
obligated to purchase such securities. The prospectus supplement
will specify whether the occurrence of any events may cause the
settlement date to occur on an earlier date and the terms on
which an early settlement would occur.
|
|
|
|
The events, if any, that will cause MetLife, Inc.s
obligations and the obligations of the holder under the purchase
contract to terminate.
|
|
|
|
The settlement rate, which is a number that, when multiplied by
the stated amount of a purchase contract, determines the number
of securities that MetLife, Inc. or a trust will be obligated to
sell and a holder will be obligated to purchase under that
purchase contract upon payment of the stated amount of that
purchase contract. The settlement rate may be determined by the
application of a formula specified in the prospectus supplement.
If a formula is specified, it may be based on the market price
of such securities over a specified period or it may be based on
some other reference statistic.
|
|
|
|
Whether the purchase contracts will be issued separately or as
part of units consisting of a purchase contract and an
underlying security with an aggregate principal amount equal to
the stated amount. Any underlying securities will be pledged by
the holder to secure its obligations under a purchase contract.
|
|
|
|
The type of underlying security, if any, that is pledged by the
holder to secure its obligations under a purchase contract.
Underlying securities may be debt securities, common stock,
preferred stock, or other securities described in this
prospectus or the applicable prospectus supplement.
|
|
|
|
The terms of the pledge arrangement relating to any underlying
securities, including the terms on which distributions or
payments of interest and principal on any underlying securities
will be retained by a collateral agent, delivered to MetLife,
Inc. or be distributed to the holder.
|
|
|
|
The amount of the contract fee, if any, that may be payable by
MetLife, Inc. to the holder or by the holder to MetLife, Inc.,
the date or dates on which the contract fee will be payable and
the extent to which MetLife, Inc. or the holder, as applicable,
may defer payment of the contract fee on those payment dates.
The contract fee may be calculated as a percentage of the stated
amount of the purchase contract or otherwise.
|
The descriptions of the purchase contracts and any applicable
underlying security or pledge or depository arrangements in this
prospectus and in any prospectus supplement are summaries of the
material provisions of the applicable agreements and are subject
to and qualified in their entirety by reference to the terms and
provisions of the purchase contract agreement, pledge agreement
and deposit agreement, forms of which have been or will be filed
as exhibits to the registration statement of which this
prospectus forms a part.
DESCRIPTION
OF UNITS
As specified in the applicable prospectus supplement, MetLife,
Inc. may issue units comprised of one or more of the other
securities described in this prospectus in any combination. Each
unit may also include debt obligations of third parties, such as
U.S. Treasury securities. Each unit will be issued so that
the holder of the unit is also the holder of each security
included in the unit. Thus, the holder of a unit will have the
rights and obligations of a holder of each included security.
The prospectus supplement will describe:
|
|
|
|
|
the designation and terms of the units and of the securities
comprising the units, including whether and under what
circumstances the securities comprising the units may be held or
transferred separately;
|
24
|
|
|
|
|
a description of the terms of any unit agreement governing the
units;
|
|
|
|
a description of the provisions for the payment, settlement,
transfer or exchange of the units; and
|
|
|
|
whether the units will be issued in fully registered or global
form.
|
The descriptions of the units and any applicable underlying
security or pledge or depositary arrangements in this prospectus
and in any prospectus supplement are summaries of the material
provisions of the applicable agreements and are subject to, and
qualified in their entirety by reference to, the terms and
provisions of the applicable agreements, forms of which have
been or will be filed as exhibits to the registration statement
of which this prospectus forms a part.
DESCRIPTION
OF TRUST PREFERRED SECURITIES
The following outlines some of the general terms and provisions
of the trust preferred securities. Further terms of the trust
preferred securities and the amended and restated declarations
of trust will be stated in the applicable prospectus supplement.
The prospectus supplement will also indicate whether the general
terms described in this section apply to that particular series
of trust preferred securities. The following description and any
description of the trust preferred securities and amended and
restated declarations of trust in a prospectus supplement may
not be complete and are subject to and qualified in their
entirety by reference to the terms and provisions of the amended
and restated declarations of trust, forms of which have been or
will be filed as exhibits to the registration statement of which
this prospectus forms a part.
Each trust may issue only one series of trust preferred
securities having terms described in the prospectus supplement.
The declaration of trust of each trust will authorize the
administrative trustees, on behalf of the trust, to issue the
trust preferred securities of the trust. The trusts will use all
of the proceeds they receive from the sale of trust preferred
securities and common securities to purchase debt securities
issued by MetLife, Inc. The debt securities will be held in
trust by the trusts property trustee for the benefit of
the holders of the trust preferred securities and common
securities.
The trust preferred securities of each trust will have such
terms as are set forth in the trusts declaration of trust,
including as relates to distributions, redemption, voting,
liquidation rights and the other preferred, deferral and special
rights and restrictions. A prospectus supplement relating to the
trust preferred securities being offered will include specific
terms relating to the offering. These terms will include some or
all of the following:
|
|
|
|
|
the distinctive designation of the trust preferred securities;
|
|
|
|
the number of trust preferred securities issued by the trust;
|
|
|
|
the total and per-security liquidation amount of the trust
preferred securities;
|
|
|
|
the annual distribution rate, or method of determining such
rate, for trust preferred securities of the trust;
|
|
|
|
the date or dates on which distributions will be payable and any
corresponding record dates;
|
|
|
|
whether distributions on the trust preferred securities will be
cumulative;
|
|
|
|
if the trust preferred securities have cumulative distribution
rights, the date or dates, or method of determining the date or
dates, from which distributions on the trust preferred
securities will be cumulative;
|
|
|
|
the amount or amounts that will be paid out of the assets of the
trust to the holders of the trust preferred securities of the
trust upon voluntary or involuntary dissolution, winding-up or
termination of the trust;
|
|
|
|
the obligation, if any, of the trust to purchase or redeem the
trust preferred securities;
|
|
|
|
if the trust is to purchase or redeem the trust preferred
securities:
|
|
|
|
the price or prices at which the trust preferred securities will
be purchased or redeemed in whole or in part;
|
25
|
|
|
|
|
the period or periods within which the trust preferred
securities will be purchased or redeemed, in whole or in part;
|
|
|
|
the terms and conditions upon which the trust preferred
securities will be purchased or redeemed, in whole or in part;
|
|
|
|
the voting rights, if any, of the trust preferred securities in
addition to those required by law, including:
|
|
|
|
|
|
the number of votes per trust preferred security; and
|
|
|
|
any requirement for the approval by the holders of trust
preferred securities as a condition to specified action or
amendments to the trusts declaration of trust;
|
|
|
|
|
|
the rights, if any, to defer distributions on the trust
preferred securities by extending the interest payment period on
the related debt securities;
|
|
|
|
if the trust preferred securities may be converted into or
exercised or exchanged for MetLifes common stock or
preferred stock or any other securities, the terms on which
conversion, exercise or exchange is mandatory, at the option of
the holder or at the option of each trust, the date on or the
period during which conversion, exercise or exchange may occur,
the initial conversion, exercise or exchange price or rate and
the circumstances or manner in which the amount of common stock
or preferred stock or other securities issuable upon conversion,
exercise or exchange may be adjusted;
|
|
|
|
the terms upon which the debt securities may be distributed to
holders of trust preferred securities;
|
|
|
|
whether the preferred securities are to be issued in book-entry
form and represented by one or more global certificates;
|
|
|
|
certain U.S. federal income tax considerations;
|
|
|
|
if applicable, any securities exchange upon which the trust
preferred securities shall be listed;
|
|
|
|
provisions relating to events of default and the rights of
holders of trust preferred securities in the event of default;
|
|
|
|
other agreements or other rights including upon the
consolidation or merger of the trust; and
|
|
|
|
any other relative rights, preferences, privileges, limitations
or restrictions of the trust preferred securities not
inconsistent with the trusts declaration of trust or
applicable law.
|
All trust preferred securities offered will be guaranteed by
MetLife, Inc. to the extent set forth under Description of
Guarantees. Any material United States federal income tax
considerations applicable to an offering of trust preferred
securities will be described in the applicable prospectus
supplement.
In connection with the issuance of preferred securities, each
trust will issue one series of common securities. The
declaration of each trust authorizes the regular trustees to
issue on behalf of such trust one series of common securities
having such terms including distributions, redemption, voting,
liquidation rights or such restrictions as shall be set forth
therein. The terms of the common securities issued by the trust
will be substantially identical to the terms of the preferred
securities issued by such trust and the common securities will
rank equally, and payments will be made thereon pro rata, with
the preferred securities. However, upon an event of default
under the declaration of trust, the rights of the holders of the
common securities to payment in respect of distributions and
payments upon liquidation, redemption and otherwise will be
subordinated to the rights of the holders of the preferred
securities. Except in certain limited circumstances, the common
securities will also carry the right to vote, and appoint,
remove or replace any of the trustees of a trust. MetLife, Inc.
will own, directly or indirectly, all of the common securities
of each trust.
|
|
|
Enforcement
of Certain Rights by Holders of Trust Preferred
Securities
|
If an event of default occurs, and is continuing, under the
declaration of trust of MetLife Capital Trust II or MetLife
Capital Trust III, the holders of the preferred securities
of that trust would typically rely on the property
26
trustee to enforce its rights as a holder of the related debt
securities against MetLife, Inc. Additionally, those who
together hold a majority of the liquidation amount of the
trusts preferred securities will have the right to:
|
|
|
|
|
direct the time, method and place of conducting any proceeding
for any remedy available to the property trustee; or
|
|
|
|
direct the exercise of any trust or power that the property
trustee holds under the declaration of trust, including the
right to direct the property trustee to exercise the remedies
available to it as a holder of MetLife, Inc.s debt
securities.
|
If the property trustee fails to enforce its rights under the
applicable series of debt securities, to the fullest extent
permitted by law, a holder of trust preferred securities of such
trust may institute a legal proceeding directly against MetLife,
Inc. to enforce the property trustees rights under the
applicable series of debt securities without first instituting
any legal proceeding against the property trustee or any other
person or entity.
Notwithstanding the foregoing, if an event of default occurs and
the event is attributable to MetLife, Inc.s failure to pay
interest or principal on the debt securities when due, including
any payment on redemption, and this debt payment failure is
continuing, a preferred securities holder of the trust may
directly institute a proceeding for the enforcement of this
payment. Such a proceeding will be limited, however, to
enforcing the payment of this principal or interest only up to
the value of the aggregate liquidation amount of the
holders preferred securities as determined after the due
date specified in the applicable series of debt securities.
DESCRIPTION
OF GUARANTEES
The following outlines some of the general terms and provisions
of the guarantees. Further terms of the guarantees will be
stated in the applicable prospectus supplement. The prospectus
supplement will also indicate whether the general terms
described in this section apply to those guarantees. The
following description and any description of the guarantees in a
prospectus supplement may not be complete and is subject to and
qualified in its entirety by reference to the terms and
provisions of the guarantee agreements, forms of which have been
or will be filed as exhibits to the registration statement of
which this prospectus forms a part, and the Trust Indenture Act.
MetLife, Inc. will execute and deliver the guarantees for the
benefit of the holders of the trust preferred securities. Each
guarantee will be held by the guarantee trustee for the benefit
of holders of the trust preferred securities to which it relates.
Each guarantee will be qualified as an indenture under the Trust
Indenture Act. J.P. Morgan Trust Company, National
Association (as successor to Bank One Trust Company, N.A.) will
act as indenture trustee under each guarantee for purposes of
the Trust Indenture Act.
Pursuant to each guarantee, MetLife, Inc. will irrevocably and
unconditionally agree, to the extent set forth in the guarantee,
to pay in full, to the holders of the related trust preferred
securities, the following guarantee payments, to the extent
these guarantee payments are not paid by, or on behalf of, the
related trust, regardless of any defense, right of set-off or
counterclaim that MetLife, Inc. may have or assert against any
person:
|
|
|
|
|
any accrued and unpaid distributions required to be paid on the
trust preferred securities of the trust, but if and only if and
to the extent that the trust has funds legally and immediately
available to make those payments;
|
|
|
|
any distributions of MetLifes common stock or preferred
stock or any of its other securities, in the event that the
trust preferred securities may be converted into or exercised
for our common stock or preferred stock, to the extent the
conditions of such conversion or exercise have occurred or have
been satisfied and the trust does not distribute such shares or
other securities but has received such shares or other
securities;
|
|
|
|
the redemption price, including all accrued and unpaid
distributions to the date of redemption, with respect to any
trust preferred securities called for redemption by the trust,
but if and only to the extent the trust has funds legally and
immediately available to make that payment; and
|
27
|
|
|
|
|
upon a dissolution, winding-up or termination of the trust,
other than in connection with the distribution of debt
securities to the holders of trust preferred securities of the
trust, the lesser of:
|
|
|
|
|
|
the total of the liquidation amount and all accrued and unpaid
distributions on the trust preferred securities of the trust to
the date of payment, to the extent the trust has funds legally
and immediately available to make that payment; and
|
|
|
|
the amount of assets of the trust remaining available for
distribution to holders of trust preferred securities of the
trust in liquidation of the trust.
|
MetLife, Inc. may satisfy its obligation to make a guarantee
payment by directly paying the required amounts to the holders
of the related trust preferred securities or by causing the
related trust to pay such amounts to such holders.
Each guarantee will constitute a guarantee of payments with
respect to the related trust preferred securities from the time
of issuance of the trust preferred securities. The guarantees
will not apply to the payment of distributions and other
payments on the trust preferred securities when the related
trust does not have sufficient funds legally and immediately
available to make the distributions or other payments. If
MetLife, Inc. does not make interest payments on the debt
securities purchased by a trust, such trust will not pay
distributions on the preferred securities issued by such trust
and will not have funds available therefor. The guarantee, when
taken together with MetLife, Inc.s obligations under the
debt securities, the Indentures and the declarations of trust,
will provide a full and unconditional guarantee by MetLife, Inc.
of payments due on the trust preferred securities.
MetLife, Inc. will also agree separately, through guarantees of
the common securities, to irrevocably and unconditionally
guarantee the obligations of the trusts with respect to the
common securities to the same extent as the guarantees of the
preferred securities. However, upon an event of default under
the Indentures, holders of preferred securities shall have
priority over holders of common securities with respect to
distributions and payments on liquidation, redemption or
otherwise.
MetLife, Inc.s obligation under each guarantee to make the
guarantee payments will be an unsecured obligation of MetLife,
Inc. and, if subordinated debt securities are issued to the
applicable trust and unless otherwise noted in the prospectus
supplement, will rank:
|
|
|
|
|
subordinate and junior in right of payment to all of MetLife,
Inc.s other liabilities, including the subordinated debt
securities, except those obligations or liabilities ranking
equal or subordinate to the guarantees by their terms;
|
|
|
|
equally with any other securities, liabilities or obligations
that may have equal ranking by their terms; and
|
|
|
|
senior to all of MetLife, Inc.s common stock.
|
If subordinated debt securities are issued to the applicable
trust, the terms of the trust preferred securities will provide
that each holder of trust preferred securities, by accepting the
trust preferred securities, agrees to the subordination
provisions and other terms of the guarantee related to
subordination.
Each guarantee will constitute a guarantee of payment and not of
collection. This means that the holder of trust preferred
securities may institute a legal proceeding directly against
MetLife, Inc. to enforce its rights under the guarantee without
first instituting a legal proceeding against any other person or
entity.
Each guarantee will be unsecured and, because MetLife, Inc. is
principally a holding company, will be effectively subordinated
to all existing and future liabilities of MetLife, Inc.s
subsidiaries, including liabilities under contracts of insurance
and annuities written by MetLife, Inc.s insurance
subsidiaries. The guarantee does not limit the incurrence or
issuance of other secured or unsecured debt by MetLife, Inc.
28
|
|
|
Amendments
and Assignment
|
For any changes that materially and adversely affect the rights
of holders of the related trust preferred securities, each
guarantee may be amended only if there is prior approval of the
holders of more than 50% in liquidation amount of the
outstanding trust preferred securities issued by the applicable
trust. All guarantees and agreements contained in each guarantee
will bind the successors, assigns, receivers, trustees and
representatives of MetLife, Inc. and will inure to the benefit
of the holders of the related trust preferred securities of the
applicable trust then outstanding.
Each guarantee will terminate and will have no further force and
effect as to the related trust preferred securities upon:
|
|
|
|
|
distribution of debt securities to the holders of all trust
preferred securities of the applicable trust; or
|
|
|
|
full payment of the amounts payable upon liquidation of the
applicable trust.
|
Each guarantee will continue to be effective or will be
reinstated, as the case may be, if at any time any holder of the
related trust preferred securities must restore payment of any
sums paid with respect to the trust preferred securities or
under the guarantee.
Each guarantee provides that an event of default under a
guarantee occurs upon MetLife, Inc.s failure to perform
any of its obligations under the applicable guarantee.
The holders of a majority or more in liquidation amount of the
trust preferred securities to which any guarantee relates may
direct the time, method and place of conducting any proceeding
for any remedy available to the guarantee trustee with respect
to the guarantee or may direct the exercise of any trust or
power conferred upon the guarantee trustee in respect of the
guarantee.
If the guarantee trustee fails to enforce the guarantee, any
holder of the related trust preferred securities may institute a
legal proceeding directly against MetLife, Inc. to enforce the
holders rights under such guarantee without first
instituting a legal proceeding against the trust, the guarantee
trustee or any other person or entity.
Furthermore, if MetLife, Inc. fails to make a guarantee payment,
a holder of trust preferred securities may directly institute a
proceeding against MetLife, Inc. for enforcement of the
preferred securities guarantee for such payment.
The holders of a majority or more in liquidation amount of trust
preferred securities of any series may, by vote, on behalf of
the holders of all the trust preferred securities of the series,
waive any past event of default and its consequences.
|
|
|
Information
Concerning the Guarantee Trustee
|
Prior to an event of default with respect to any guarantee and
after the curing or waiving of all events of default with
respect to the guarantee, the guarantee trustee may perform only
the duties that are specifically set forth in the guarantee.
Once a guarantee event of default has occurred and is
continuing, the guarantee trustee is to exercise, with respect
to the holder of the trust preferred securities of the series,
the same degree of care as a prudent individual would exercise
in the conduct of his or her own affairs. Unless the guarantee
trustee is offered reasonable indemnity against the costs,
expenses and liabilities which may be incurred by the guarantee
trustee by a holder of the related trust preferred securities,
the guarantee trustee is not required to exercise any of its
powers under any guarantee at the request of the holder.
Additionally, the guarantee trustee is not required to expend or
risk its own funds or otherwise incur any financial liability in
the performance of its duties if the guarantee trustee
reasonably believes that it is not assured repayment or adequate
indemnity.
29
The guarantee trustee is J.P. Morgan Trust Company,
National Association (as successor to Bank One Trust Company,
N.A.), which is one of a number of banks and trust companies
with which MetLife, Inc. and its subsidiaries maintain ordinary
banking and trust relationships.
Each guarantee will be governed by, and construed in accordance
with, the internal laws of the State of New York, without regard
to its principles of conflicts of laws.
PLAN OF
DISTRIBUTION
MetLife, Inc. may sell the securities being offered hereby in
one or more of the following ways from time to time:
|
|
|
|
|
to underwriters or dealers for resale to the public or to
institutional investors;
|
|
|
|
directly to institutional investors; or
|
|
|
|
through agents to the public or to institutional investors.
|
The prospectus supplement with respect to each series of
securities will state the terms of the offering of the
securities, including:
|
|
|
|
|
the name or names of any underwriters or agents;
|
|
|
|
the purchase price of the securities and the proceeds to be
received by MetLife, Inc. or the applicable trust from the sale;
|
|
|
|
any underwriting discounts or agency fees and other items
constituting underwriters or agents compensation;
|
|
|
|
any initial public offering price;
|
|
|
|
any discounts or concessions allowed or reallowed or paid to
dealers; and
|
|
|
|
any securities exchange on which the securities may be listed.
|
If MetLife, Inc. or the trusts use underwriters in the sale, the
securities will be acquired by the underwriters for their own
account and may be resold from time to time in one or more
transactions, including:
|
|
|
|
|
negotiated transactions;
|
|
|
|
at a fixed public offering price or prices, which may be changed;
|
|
|
|
at market prices prevailing at the time of sale;
|
|
|
|
at prices related to prevailing market prices; or
|
|
|
|
at negotiated prices.
|
The securities may also be offered and sold, if so indicated in
the prospectus supplement, in connection with a remarketing upon
their purchase, in accordance with a redemption or repayment
pursuant to their terms, or otherwise, by one or more
remarketing firms, acting as principals for their own accounts
or as agents for MetLife, Inc. or the trusts. The prospectus
supplement will identify any remarketing firm and will describe
the terms of its agreement, if any, with MetLife, Inc. or the
trusts and its compensation.
Unless otherwise stated in a prospectus supplement, the
obligations of the underwriters to purchase any securities will
be conditioned on customary closing conditions and the
underwriters will be obligated to purchase all of such series of
securities, if any are purchased.
If MetLife, Inc. sells the securities directly or through agents
designated by it, MetLife, Inc. will identify any agent involved
in the offering and sale of the securities and will list any
commissions payable by MetLife, Inc. to the
30
agent in the accompanying prospectus supplement. Unless
indicated otherwise in the prospectus supplement, any such agent
will be acting on a best efforts basis to solicit purchases for
the period of its appointment.
MetLife, Inc. may authorize agents, underwriters or dealers to
solicit offers by certain institutional investors to purchase
securities and provide for payment and delivery on a future date
specified in an accompanying prospectus supplement. MetLife,
Inc. will describe any such arrangement in the prospectus
supplement. Any such institutional investor may be subject to
limitations on the minimum amount of securities that it may
purchase or on the portion of the aggregate principal amount of
such securities that it may sell under such arrangements.
Institutional investors from which such authorized offers may be
solicited include:
|
|
|
|
|
commercial and savings banks;
|
|
|
|
insurance companies;
|
|
|
|
pension funds;
|
|
|
|
investment companies;
|
|
|
|
educational and charitable institutions; and
|
|
|
|
such other institutions as MetLife, Inc. may approve.
|
Underwriters, dealers, agents and remarketing firms may be
entitled under agreements entered into with MetLife, Inc. and/or
the applicable trust, or both, to indemnification by MetLife,
Inc. against certain civil liabilities, including liabilities
under the Securities Act, or to contribution with respect to
payments which the underwriters, dealers, agents and remarketing
firms may be required to make. Underwriters, dealers, agents and
remarketing agents may be customers of, engage in transactions
with, or perform services for MetLife, Inc., any trust and/or
MetLife, Inc.s affiliates in the ordinary course of
business.
Each series of securities will be a new issue of securities and
will have no established trading market other than the common
stock which is listed on the New York Stock Exchange. Any common
stock sold will be listed on the New York Stock Exchange, upon
official notice of issuance. The securities, other than the
common stock, may or may not be listed on a national securities
exchange. Any underwriters to whom securities are sold by
MetLife, Inc. or any trust for public offering and sale may make
a market in the securities, but such underwriters will not be
obligated to do so and may discontinue any market making at any
time without notice.
Any offering of trust preferred securities will be made in
compliance with Rule 2810 of the NASD Conduct Rules.
31
LEGAL
OPINIONS
Unless otherwise indicated in the applicable prospectus
supplement, the validity of the securities offered hereby will
be passed upon for MetLife, Inc. by Richard S. Collins,
Chief Counsel General Corporate, of MetLife, Inc.
Mr. Collins is paid a salary by MetLife, is a participant
in various employee benefit plans offered by MetLife to
employees generally and has options to purchase shares of
MetLife, Inc. common stock. Certain matters of Delaware law
relating to the validity of the trust preferred securities of
MetLife Capital Trust II and MetLife Capital Trust III
will be passed upon for the trust by Richards, Layton &
Finger, P.A., Wilmington, Delaware, special Delaware counsel for
the trusts.
EXPERTS
The consolidated financial statements and consolidated financial
statement schedules, and managements report on the
effectiveness of internal control over financial reporting
incorporated in this prospectus by reference from MetLife,
Inc.s Annual Report on
Form 10-K
have been audited by Deloitte & Touche LLP, an
independent registered public accounting firm, as stated in
their reports, which are incorporated by reference herein,
(which reports (1) express an unqualified opinion on the
consolidated financial statements and consolidated financial
statements schedules and include an explanatory paragraph
relating to MetLife, Inc.s change of its method of
accounting for certain non-traditional long duration contracts
and separate accounts, and for embedded derivatives in certain
insurance products as required by new accounting guidance which
became effective on January 1, 2004 and October 1,
2003, respectively, (2) express an unqualified opinion on
managements assessment regarding the effectiveness of
internal control over financial reporting, and (3) express
an unqualified opinion on the effectiveness of internal control
over financial reporting), and have been so incorporated in
reliance upon the reports of such firm given upon their
authority as experts in accounting and auditing.
32